STUDYID,USUBJID,SUBJID,SITEID,PART,PARTN,SAFFL,SAFFN,PKPOPFL,PKPOPFN,TRTSEQP,TRTSEQPN,TRTSEQA,TRTSEQAN,TRTSDT,TRTSTM,TRTSDTM,TRTEDT,TRTETM,TRTEDTM,PCSEQ,EPOCH,TRTP,TRTPN,TRTA,TRTAN,ADT,ATM,ADTM,ADY,AVISIT,AVISITN,APERIOD,APERIODC,ATPT,ATPTN,APERSDT,APERSTM,APERSDTM,ARELTM,ARELTMU,DIFTM,PARAMN,PARAM,PARAMCD,PARAML,AVAL,AVALC,AVALL,AVALU,PCLLOQ,PCNAM,TRT,TRTL
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,33480.0,1837415880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,35280.0,1837417680.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,37080.0,1837419480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,35280.0,1837417680.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),74.46,74.46,74.46,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,38880.0,1837421280.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,35280.0,1837417680.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),255.88,255.88,255.88,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,40680.0,1837423080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,35280.0,1837417680.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),167.78,167.78,167.78,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,42480.0,1837424880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,35280.0,1837417680.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),174.34,174.34,174.34,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,46080.0,1837428480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,35280.0,1837417680.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),116.0,116.00,116.00,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,49680.0,1837432080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,35280.0,1837417680.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),92.91,92.91,92.91,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,53280.0,1837435680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,35280.0,1837417680.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),55.31,55.31,55.31,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,56945.0,1837439345.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,35280.0,1837417680.0,6.018055555555556,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),45.15,45.15,45.15,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,64080.0,1837446480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,35280.0,1837417680.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),25.5,25.50,25.50,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,78480.0,1837460880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,35280.0,1837417680.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.44,9.44,9.44,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,85861.0,1837468261.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,35280.0,1837417680.0,14.050277777777778,HOURS,3.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.13,7.13,7.13,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,35280.0,1837504080.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,35280.0,1837417680.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.31,2.31,2.31,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,14.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,33480.0,1838020680.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,35280.0,1838022480.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,15.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,37080.0,1838024280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,35280.0,1838022480.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),68.91,68.91,68.91,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,16.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,38880.0,1838026080.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,35280.0,1838022480.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),241.67,241.67,241.67,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,17.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,40680.0,1838027880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,35280.0,1838022480.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),241.95,241.95,241.95,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,18.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,42480.0,1838029680.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,35280.0,1838022480.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),213.53,213.53,213.53,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,19.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,46080.0,1838033280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,35280.0,1838022480.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),165.06,165.06,165.06,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,20.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,49680.0,1838036880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,35280.0,1838022480.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),134.6,134.60,134.60,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,21.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,53280.0,1838040480.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,35280.0,1838022480.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),96.95,96.95,96.95,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,22.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,56880.0,1838044080.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,35280.0,1838022480.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),74.45,74.45,74.45,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,23.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,64080.0,1838051280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,35280.0,1838022480.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),41.25,41.25,41.25,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,24.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,78480.0,1838065680.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,35280.0,1838022480.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.65,15.65,15.65,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,25.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,85680.0,1838072880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,35280.0,1838022480.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.6,10.60,10.60,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,26.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,35280.0,1838108880.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,35280.0,1838022480.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.46,2.46,2.46,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,27.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,33480.0,1838625480.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,35280.0,1838627280.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,28.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,37080.0,1838629080.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,35280.0,1838627280.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),163.87,163.87,163.87,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,29.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,38880.0,1838630880.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,35280.0,1838627280.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),209.0,209.00,209.00,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,30.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,40680.0,1838632680.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,35280.0,1838627280.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),142.47,142.47,142.47,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,31.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,42480.0,1838634480.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,35280.0,1838627280.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),160.65,160.65,160.65,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,32.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,46080.0,1838638080.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,35280.0,1838627280.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),118.79,118.79,118.79,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,33.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,49680.0,1838641680.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,35280.0,1838627280.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),71.18,71.18,71.18,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,34.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,53280.0,1838645280.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,35280.0,1838627280.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),53.99,53.99,53.99,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,35.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,56880.0,1838648880.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,35280.0,1838627280.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),56.0,56.00,56.00,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,36.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,64080.0,1838656080.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,35280.0,1838627280.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),34.44,34.44,34.44,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,37.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,78480.0,1838670480.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,35280.0,1838627280.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.88,14.88,14.88,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,38.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,85680.0,1838677680.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,35280.0,1838627280.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.3,10.30,10.30,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001005,103001005,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35280.0,1837417680.0,21280.0,35280.0,1838627280.0,39.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,35280.0,1838713680.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,35280.0,1838627280.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.95,2.95,2.95,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001007,103001007,001,Part A,1.0,Y,1.0,N,0.0,6: CBA,6.0,6: CBA,6.0,21266.0,34860.0,1837417260.0,21266.0,34860.0,1837417260.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,33060.0,1837415460.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,34860.0,1837417260.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001007,103001007,001,Part A,1.0,Y,1.0,N,0.0,6: CBA,6.0,6: CBA,6.0,21266.0,34860.0,1837417260.0,21266.0,34860.0,1837417260.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,36660.0,1837419060.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,34860.0,1837417260.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),56.97,56.97,56.97,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001007,103001007,001,Part A,1.0,Y,1.0,N,0.0,6: CBA,6.0,6: CBA,6.0,21266.0,34860.0,1837417260.0,21266.0,34860.0,1837417260.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,38460.0,1837420860.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,34860.0,1837417260.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),309.24,309.24,309.24,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001007,103001007,001,Part A,1.0,Y,1.0,N,0.0,6: CBA,6.0,6: CBA,6.0,21266.0,34860.0,1837417260.0,21266.0,34860.0,1837417260.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,40260.0,1837422660.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,34860.0,1837417260.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),401.28,401.28,401.28,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001007,103001007,001,Part A,1.0,Y,1.0,N,0.0,6: CBA,6.0,6: CBA,6.0,21266.0,34860.0,1837417260.0,21266.0,34860.0,1837417260.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,42060.0,1837424460.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,34860.0,1837417260.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),406.84,406.84,406.84,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001007,103001007,001,Part A,1.0,Y,1.0,N,0.0,6: CBA,6.0,6: CBA,6.0,21266.0,34860.0,1837417260.0,21266.0,34860.0,1837417260.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,45660.0,1837428060.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,34860.0,1837417260.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),226.57,226.57,226.57,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001007,103001007,001,Part A,1.0,Y,1.0,N,0.0,6: CBA,6.0,6: CBA,6.0,21266.0,34860.0,1837417260.0,21266.0,34860.0,1837417260.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,49260.0,1837431660.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,34860.0,1837417260.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),139.46,139.46,139.46,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001007,103001007,001,Part A,1.0,Y,1.0,N,0.0,6: CBA,6.0,6: CBA,6.0,21266.0,34860.0,1837417260.0,21266.0,34860.0,1837417260.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,52860.0,1837435260.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,34860.0,1837417260.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),111.84,111.84,111.84,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001007,103001007,001,Part A,1.0,Y,1.0,N,0.0,6: CBA,6.0,6: CBA,6.0,21266.0,34860.0,1837417260.0,21266.0,34860.0,1837417260.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,56460.0,1837438860.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,34860.0,1837417260.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),84.9,84.90,84.90,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001007,103001007,001,Part A,1.0,Y,1.0,N,0.0,6: CBA,6.0,6: CBA,6.0,21266.0,34860.0,1837417260.0,21266.0,34860.0,1837417260.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,63660.0,1837446060.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,34860.0,1837417260.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),55.2,55.20,55.20,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001007,103001007,001,Part A,1.0,Y,1.0,N,0.0,6: CBA,6.0,6: CBA,6.0,21266.0,34860.0,1837417260.0,21266.0,34860.0,1837417260.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,78060.0,1837460460.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,34860.0,1837417260.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.78,17.78,17.78,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001007,103001007,001,Part A,1.0,Y,1.0,N,0.0,6: CBA,6.0,6: CBA,6.0,21266.0,34860.0,1837417260.0,21266.0,34860.0,1837417260.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,85260.0,1837467660.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,34860.0,1837417260.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.07,11.07,11.07,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001007,103001007,001,Part A,1.0,Y,1.0,N,0.0,6: CBA,6.0,6: CBA,6.0,21266.0,34860.0,1837417260.0,21266.0,34860.0,1837417260.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,34860.0,1837503660.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,34860.0,1837417260.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.21,2.21,2.21,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,33540.0,1837415940.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,35340.0,1837417740.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,37322.0,1837419722.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,35340.0,1837417740.0,0.5505555555555556,HOURS,3.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),240.45,240.45,240.45,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,38940.0,1837421340.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,35340.0,1837417740.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),525.64,525.64,525.64,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,40740.0,1837423140.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,35340.0,1837417740.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),262.53,262.53,262.53,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,42920.0,1837425320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,35340.0,1837417740.0,2.1055555555555556,HOURS,6.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),187.02,187.02,187.02,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,46140.0,1837428540.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,35340.0,1837417740.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),125.33,125.33,125.33,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,49740.0,1837432140.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,35340.0,1837417740.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),99.59,99.59,99.59,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,53340.0,1837435740.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,35340.0,1837417740.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),75.52,75.52,75.52,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,56940.0,1837439340.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,35340.0,1837417740.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),58.51,58.51,58.51,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,64401.0,1837446801.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,35340.0,1837417740.0,8.0725,HOURS,4.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),30.36,30.36,30.36,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,11.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,78540.0,1837460940.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,35340.0,1837417740.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.95,10.95,10.95,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,12.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,85740.0,1837468140.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,35340.0,1837417740.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.51,6.51,6.51,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,13.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,35340.0,1837504140.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,35340.0,1837417740.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.5,2.50,2.50,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,14.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,33540.0,1838020740.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,35340.0,1838022540.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,15.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,37361.0,1838024561.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,35340.0,1838022540.0,0.5613888888888889,HOURS,4.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),235.15,235.15,235.15,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,16.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,38940.0,1838026140.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,35340.0,1838022540.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),478.33,478.33,478.33,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,17.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,40740.0,1838027940.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,35340.0,1838022540.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),273.63,273.63,273.63,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,18.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,42769.0,1838029969.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,35340.0,1838022540.0,2.0636111111111113,HOURS,4.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),204.45,204.45,204.45,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,19.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,46205.0,1838033405.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,35340.0,1838022540.0,3.0180555555555557,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),131.78,131.78,131.78,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,20.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,49823.0,1838037023.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,35340.0,1838022540.0,4.023055555555556,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),103.98,103.98,103.98,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,21.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,53340.0,1838040540.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,35340.0,1838022540.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),72.33,72.33,72.33,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,22.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,56940.0,1838044140.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,35340.0,1838022540.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.31,61.31,61.31,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,23.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,64140.0,1838051340.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,35340.0,1838022540.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),31.02,31.02,31.02,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,24.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,78787.0,1838065987.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,35340.0,1838022540.0,12.06861111111111,HOURS,4.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.2,11.20,11.20,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,25.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,85740.0,1838072940.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,35340.0,1838022540.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.16,7.16,7.16,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,26.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,35340.0,1838108940.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,35340.0,1838022540.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.86,1.86,1.86,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,27.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,33540.0,1838625540.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,35340.0,1838627340.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,28.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,37140.0,1838629140.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,35340.0,1838627340.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),182.78,182.78,182.78,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,29.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,38940.0,1838630940.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,35340.0,1838627340.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),565.24,565.24,565.24,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,30.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,40740.0,1838632740.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,35340.0,1838627340.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),292.67,292.67,292.67,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,31.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,42540.0,1838634540.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,35340.0,1838627340.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),210.78,210.78,210.78,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,32.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,46140.0,1838638140.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,35340.0,1838627340.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),136.62,136.62,136.62,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,33.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,49740.0,1838641740.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,35340.0,1838627340.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),97.49,97.49,97.49,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,34.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,53340.0,1838645340.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,35340.0,1838627340.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),77.25,77.25,77.25,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,35.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,56940.0,1838648940.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,35340.0,1838627340.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),55.42,55.42,55.42,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,36.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,64140.0,1838656140.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,35340.0,1838627340.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),33.46,33.46,33.46,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,37.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,78540.0,1838670540.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,35340.0,1838627340.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.81,9.81,9.81,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,38.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,85740.0,1838677740.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,35340.0,1838627340.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.07,7.07,7.07,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001008,103001008,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35340.0,1837417740.0,21280.0,35340.0,1838627340.0,39.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,35340.0,1838713740.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,35340.0,1838627340.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.82,1.82,1.82,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,1.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,34560.0,1837416960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,36360.0,1837418760.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,2.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,38160.0,1837420560.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,36360.0,1837418760.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),140.14,140.14,140.14,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,3.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,39960.0,1837422360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,36360.0,1837418760.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),259.24,259.24,259.24,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,4.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,41760.0,1837424160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,36360.0,1837418760.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),188.52,188.52,188.52,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,5.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,43560.0,1837425960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,36360.0,1837418760.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),120.66,120.66,120.66,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,6.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,47160.0,1837429560.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,36360.0,1837418760.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),81.38,81.38,81.38,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,7.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,50760.0,1837433160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,36360.0,1837418760.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),65.08,65.08,65.08,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,8.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,54360.0,1837436760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,36360.0,1837418760.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),56.59,56.59,56.59,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,9.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,57960.0,1837440360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,36360.0,1837418760.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),43.97,43.97,43.97,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,10.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,65160.0,1837447560.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,36360.0,1837418760.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),22.27,22.27,22.27,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,11.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,79560.0,1837461960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,36360.0,1837418760.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.73,7.73,7.73,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,12.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,360.0,1837469160.0,2.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,36360.0,1837418760.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.33,4.33,4.33,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,13.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,36360.0,1837505160.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,36360.0,1837418760.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.14,1.14,1.14,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,14.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,34560.0,1838021760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,36360.0,1838023560.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,15.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,38160.0,1838025360.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,36360.0,1838023560.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.25,14.25,14.25,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,16.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,39960.0,1838027160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,36360.0,1838023560.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),68.67,68.67,68.67,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,17.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,41760.0,1838028960.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,36360.0,1838023560.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),286.37,286.37,286.37,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,18.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,43560.0,1838030760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,36360.0,1838023560.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),331.25,331.25,331.25,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,19.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,47160.0,1838034360.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,36360.0,1838023560.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),175.78,175.78,175.78,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,20.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,50760.0,1838037960.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,36360.0,1838023560.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),100.52,100.52,100.52,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,21.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,54360.0,1838041560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,36360.0,1838023560.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),80.15,80.15,80.15,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,22.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,57960.0,1838045160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,36360.0,1838023560.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),47.22,47.22,47.22,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,23.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,65160.0,1838052360.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,36360.0,1838023560.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),27.41,27.41,27.41,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,24.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,79560.0,1838066760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,36360.0,1838023560.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.0,7.00,7.00,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,25.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,360.0,1838073960.0,9.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,36360.0,1838023560.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.03,5.03,5.03,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,26.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,36360.0,1838109960.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,36360.0,1838023560.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.34,1.34,1.34,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,27.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,34560.0,1838626560.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,36360.0,1838628360.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,28.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,38160.0,1838630160.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,36360.0,1838628360.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),130.51,130.51,130.51,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,29.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,39960.0,1838631960.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,36360.0,1838628360.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),378.04,378.04,378.04,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,30.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,41760.0,1838633760.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,36360.0,1838628360.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),241.75,241.75,241.75,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,31.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,43560.0,1838635560.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,36360.0,1838628360.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),170.82,170.82,170.82,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,32.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,47160.0,1838639160.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,36360.0,1838628360.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),114.43,114.43,114.43,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,33.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,50760.0,1838642760.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,36360.0,1838628360.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),73.66,73.66,73.66,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,34.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,54360.0,1838646360.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,36360.0,1838628360.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),53.47,53.47,53.47,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,35.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,57960.0,1838649960.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,36360.0,1838628360.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),41.85,41.85,41.85,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,36.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,65160.0,1838657160.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,36360.0,1838628360.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),21.35,21.35,21.35,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,37.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,79560.0,1838671560.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,36360.0,1838628360.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.08,6.08,6.08,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,38.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,360.0,1838678760.0,16.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,36360.0,1838628360.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.59,3.59,3.59,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001009,103001009,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36360.0,1837418760.0,21280.0,36360.0,1838628360.0,39.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,36360.0,1838714760.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,36360.0,1838628360.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.76,1.76,1.76,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,32520.0,1837414920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,34320.0,1837416720.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,36120.0,1837418520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,34320.0,1837416720.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),159.85,159.85,159.85,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,37920.0,1837420320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,34320.0,1837416720.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),209.38,209.38,209.38,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,39720.0,1837422120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,34320.0,1837416720.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),168.45,168.45,168.45,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,41520.0,1837423920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,34320.0,1837416720.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),171.82,171.82,171.82,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,45120.0,1837427520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,34320.0,1837416720.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),144.41,144.41,144.41,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,48720.0,1837431120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,34320.0,1837416720.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),109.35,109.35,109.35,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,52320.0,1837434720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,34320.0,1837416720.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),73.8,73.80,73.80,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,55920.0,1837438320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,34320.0,1837416720.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),58.83,58.83,58.83,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,63120.0,1837445520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,34320.0,1837416720.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),31.56,31.56,31.56,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,11.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,77520.0,1837459920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,34320.0,1837416720.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.81,15.81,15.81,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,12.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,84720.0,1837467120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,34320.0,1837416720.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.95,10.95,10.95,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,13.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,34320.0,1837503120.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,34320.0,1837416720.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.66,3.66,3.66,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,14.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,32520.0,1838019720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,34320.0,1838021520.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,15.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,36120.0,1838023320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,34320.0,1838021520.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),132.93,132.93,132.93,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,16.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,37920.0,1838025120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,34320.0,1838021520.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),432.34,432.34,432.34,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,17.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,39720.0,1838026920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,34320.0,1838021520.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),298.0,298.00,298.00,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,18.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,41520.0,1838028720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,34320.0,1838021520.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),199.68,199.68,199.68,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,19.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,45120.0,1838032320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,34320.0,1838021520.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),141.54,141.54,141.54,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,20.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,48720.0,1838035920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,34320.0,1838021520.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),106.48,106.48,106.48,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,21.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,52320.0,1838039520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,34320.0,1838021520.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),86.49,86.49,86.49,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,22.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,55920.0,1838043120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,34320.0,1838021520.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),66.24,66.24,66.24,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,23.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,63120.0,1838050320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,34320.0,1838021520.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),32.13,32.13,32.13,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,24.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,77520.0,1838064720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,34320.0,1838021520.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.97,12.97,12.97,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,25.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,84803.0,1838072003.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,34320.0,1838021520.0,14.023055555555555,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.68,8.68,8.68,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,26.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21274.0,34320.0,1838107920.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,34320.0,1838021520.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.97,1.97,1.97,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,27.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,32520.0,1838624520.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,34320.0,1838626320.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,28.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,36120.0,1838628120.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,34320.0,1838626320.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),119.67,119.67,119.67,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,29.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,37920.0,1838629920.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,34320.0,1838626320.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),138.31,138.31,138.31,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,30.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,39720.0,1838631720.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,34320.0,1838626320.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),120.37,120.37,120.37,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,31.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,41520.0,1838633520.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,34320.0,1838626320.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),135.59,135.59,135.59,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,32.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,45120.0,1838637120.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,34320.0,1838626320.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),126.93,126.93,126.93,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,33.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,48720.0,1838640720.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,34320.0,1838626320.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),89.31,89.31,89.31,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,34.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,52320.0,1838644320.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,34320.0,1838626320.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),68.16,68.16,68.16,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,35.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,55920.0,1838647920.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,34320.0,1838626320.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),52.5,52.50,52.50,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,36.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,63120.0,1838655120.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,34320.0,1838626320.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),28.18,28.18,28.18,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,37.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,77520.0,1838669520.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,34320.0,1838626320.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),16.17,16.17,16.17,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,38.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,84720.0,1838676720.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,34320.0,1838626320.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.79,10.79,10.79,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001010,103001010,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34320.0,1837416720.0,21280.0,34320.0,1838626320.0,39.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,34320.0,1838712720.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,34320.0,1838626320.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.99,3.99,3.99,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,32580.0,1837414980.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,34380.0,1837416780.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,36180.0,1837418580.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,34380.0,1837416780.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.08,20.08,20.08,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,37980.0,1837420380.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,34380.0,1837416780.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),223.81,223.81,223.81,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,39780.0,1837422180.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,34380.0,1837416780.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),427.65,427.65,427.65,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,41580.0,1837423980.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,34380.0,1837416780.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),402.34,402.34,402.34,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,45180.0,1837427580.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,34380.0,1837416780.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),236.91,236.91,236.91,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,48780.0,1837431180.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,34380.0,1837416780.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),162.81,162.81,162.81,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,52380.0,1837434780.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,34380.0,1837416780.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),116.46,116.46,116.46,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,55980.0,1837438380.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,34380.0,1837416780.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),92.73,92.73,92.73,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,63180.0,1837445580.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,34380.0,1837416780.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),50.31,50.31,50.31,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,11.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,77580.0,1837459980.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,34380.0,1837416780.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.69,17.69,17.69,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,12.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,84780.0,1837467180.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,34380.0,1837416780.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.14,11.14,11.14,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,13.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,34380.0,1837503180.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,34380.0,1837416780.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.29,2.29,2.29,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,14.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,32580.0,1838019780.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,34380.0,1838021580.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,15.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,36180.0,1838023380.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,34380.0,1838021580.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),105.12,105.12,105.12,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,16.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,37980.0,1838025180.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,34380.0,1838021580.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),256.02,256.02,256.02,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,17.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,39780.0,1838026980.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,34380.0,1838021580.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),263.42,263.42,263.42,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,18.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,41580.0,1838028780.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,34380.0,1838021580.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),229.52,229.52,229.52,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,19.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,45180.0,1838032380.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,34380.0,1838021580.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),204.5,204.50,204.50,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,20.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,48780.0,1838035980.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,34380.0,1838021580.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),173.94,173.94,173.94,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,21.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,52380.0,1838039580.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,34380.0,1838021580.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),128.04,128.04,128.04,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,22.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,55980.0,1838043180.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,34380.0,1838021580.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),91.39,91.39,91.39,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,23.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,63180.0,1838050380.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,34380.0,1838021580.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),57.69,57.69,57.69,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,24.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,77580.0,1838064780.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,34380.0,1838021580.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),19.49,19.49,19.49,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,25.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,84780.0,1838071980.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,34380.0,1838021580.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.58,11.58,11.58,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,26.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,34380.0,1838107980.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,34380.0,1838021580.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.61,2.61,2.61,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,27.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,32580.0,1838624580.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,34380.0,1838626380.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,28.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,36180.0,1838628180.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,34380.0,1838626380.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),82.53,82.53,82.53,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,29.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,37980.0,1838629980.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,34380.0,1838626380.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),248.87,248.87,248.87,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,30.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,39780.0,1838631780.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,34380.0,1838626380.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),185.27,185.27,185.27,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,31.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,41580.0,1838633580.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,34380.0,1838626380.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),169.12,169.12,169.12,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,32.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,45180.0,1838637180.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,34380.0,1838626380.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),131.52,131.52,131.52,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,33.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,48780.0,1838640780.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,34380.0,1838626380.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),102.95,102.95,102.95,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,34.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,52380.0,1838644380.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,34380.0,1838626380.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),76.93,76.93,76.93,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,35.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,55980.0,1838647980.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,34380.0,1838626380.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),56.59,56.59,56.59,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,36.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,63180.0,1838655180.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,34380.0,1838626380.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),35.96,35.96,35.96,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,37.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,77580.0,1838669580.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,34380.0,1838626380.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.91,11.91,11.91,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,38.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,84780.0,1838676780.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,34380.0,1838626380.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.18,8.18,8.18,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001015,103001015,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34380.0,1837416780.0,21280.0,34380.0,1838626380.0,39.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,34380.0,1838712780.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,34380.0,1838626380.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.1,2.10,2.10,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,34620.0,1837417020.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,36420.0,1837418820.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,38220.0,1837420620.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,36420.0,1837418820.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),155.8,155.80,155.80,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,40020.0,1837422420.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,36420.0,1837418820.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),357.43,357.43,357.43,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,41820.0,1837424220.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,36420.0,1837418820.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),242.05,242.05,242.05,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,43620.0,1837426020.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,36420.0,1837418820.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),194.17,194.17,194.17,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,47220.0,1837429620.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,36420.0,1837418820.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),119.68,119.68,119.68,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,50820.0,1837433220.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,36420.0,1837418820.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),77.59,77.59,77.59,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,54420.0,1837436820.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,36420.0,1837418820.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),59.05,59.05,59.05,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,58020.0,1837440420.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,36420.0,1837418820.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),48.98,48.98,48.98,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,65220.0,1837447620.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,36420.0,1837418820.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),21.05,21.05,21.05,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,11.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,79720.0,1837462120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,36420.0,1837418820.0,12.027777777777779,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.25,8.25,8.25,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,12.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,420.0,1837469220.0,2.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,36420.0,1837418820.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.36,6.36,6.36,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,13.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,36420.0,1837505220.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,36420.0,1837418820.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.47,2.47,2.47,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,14.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,34620.0,1838021820.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,36420.0,1838023620.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,15.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,38220.0,1838025420.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,36420.0,1838023620.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),169.06,169.06,169.06,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,16.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,40020.0,1838027220.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,36420.0,1838023620.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),391.51,391.51,391.51,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,17.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,41820.0,1838029020.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,36420.0,1838023620.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),259.07,259.07,259.07,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,18.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,43620.0,1838030820.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,36420.0,1838023620.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),178.28,178.28,178.28,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,19.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,47220.0,1838034420.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,36420.0,1838023620.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),131.61,131.61,131.61,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,20.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,50820.0,1838038020.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,36420.0,1838023620.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),95.07,95.07,95.07,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,21.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,54420.0,1838041620.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,36420.0,1838023620.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),62.41,62.41,62.41,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,22.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,58020.0,1838045220.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,36420.0,1838023620.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),48.39,48.39,48.39,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,23.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,65220.0,1838052420.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,36420.0,1838023620.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),21.53,21.53,21.53,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,24.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,79620.0,1838066820.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,36420.0,1838023620.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.17,9.17,9.17,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,25.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,420.0,1838074020.0,9.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,36420.0,1838023620.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.23,6.23,6.23,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,26.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,36420.0,1838110020.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,36420.0,1838023620.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.65,2.65,2.65,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,27.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,34620.0,1838626620.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,36420.0,1838628420.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,28.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,38220.0,1838630220.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,36420.0,1838628420.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),132.09,132.09,132.09,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,29.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,40020.0,1838632020.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,36420.0,1838628420.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),375.46,375.46,375.46,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,30.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,41820.0,1838633820.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,36420.0,1838628420.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),283.95,283.95,283.95,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,31.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,43620.0,1838635620.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,36420.0,1838628420.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),212.38,212.38,212.38,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,32.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,47220.0,1838639220.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,36420.0,1838628420.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),141.28,141.28,141.28,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,33.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,50820.0,1838642820.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,36420.0,1838628420.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),80.78,80.78,80.78,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,34.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,54420.0,1838646420.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,36420.0,1838628420.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),70.08,70.08,70.08,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,35.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,58020.0,1838650020.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,36420.0,1838628420.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),47.24,47.24,47.24,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,36.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,65220.0,1838657220.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,36420.0,1838628420.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),23.23,23.23,23.23,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,37.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,79620.0,1838671620.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,36420.0,1838628420.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.24,11.24,11.24,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,38.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,420.0,1838678820.0,16.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,36420.0,1838628420.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.39,6.39,6.39,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001022,103001022,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36420.0,1837418820.0,21280.0,36420.0,1838628420.0,39.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,36420.0,1838714820.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,36420.0,1838628420.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.21,2.21,2.21,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,1.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,33666.0,1837416066.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,35400.0,1837417800.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,2.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,37330.0,1837419730.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,35400.0,1837417800.0,0.5361111111111111,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),49.05,49.05,49.05,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,3.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,39000.0,1837421400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,35400.0,1837417800.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),141.03,141.03,141.03,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,4.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,40800.0,1837423200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,35400.0,1837417800.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),81.74,81.74,81.74,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,5.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,42600.0,1837425000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,35400.0,1837417800.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),100.57,100.57,100.57,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,6.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,46200.0,1837428600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,35400.0,1837417800.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),313.49,313.49,313.49,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,7.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,49889.0,1837432289.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,35400.0,1837417800.0,4.0247222222222225,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),201.62,201.62,201.62,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,8.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,53400.0,1837435800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,35400.0,1837417800.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),131.67,131.67,131.67,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,9.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,57278.0,1837439678.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,35400.0,1837417800.0,6.077222222222222,HOURS,5.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),74.41,74.41,74.41,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,10.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,64352.0,1837446752.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,35400.0,1837417800.0,8.042222222222222,HOURS,3.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),43.6,43.60,43.60,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,11.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,78600.0,1837461000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,35400.0,1837417800.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.26,13.26,13.26,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,12.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,86041.0,1837468441.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,35400.0,1837417800.0,14.066944444444445,HOURS,4.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.94,7.94,7.94,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,13.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,35400.0,1837504200.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,35400.0,1837417800.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.64,2.64,2.64,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,14.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,33600.0,1838020800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,35400.0,1838022600.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,15.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,37200.0,1838024400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,35400.0,1838022600.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),51.96,51.96,51.96,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,16.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,39000.0,1838026200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,35400.0,1838022600.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),152.95,152.95,152.95,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,17.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,40800.0,1838028000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,35400.0,1838022600.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),138.85,138.85,138.85,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,18.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,42600.0,1838029800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,35400.0,1838022600.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),205.82,205.82,205.82,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,19.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,46287.0,1838033487.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,35400.0,1838022600.0,3.0241666666666664,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),216.91,216.91,216.91,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,20.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,49800.0,1838037000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,35400.0,1838022600.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),135.82,135.82,135.82,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,21.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,53400.0,1838040600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,35400.0,1838022600.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),87.54,87.54,87.54,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,22.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,57000.0,1838044200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,35400.0,1838022600.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),67.75,67.75,67.75,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,23.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,64200.0,1838051400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,35400.0,1838022600.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),37.27,37.27,37.27,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,24.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,78600.0,1838065800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,35400.0,1838022600.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.9,14.90,14.90,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,25.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,85800.0,1838073000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,35400.0,1838022600.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.98,7.98,7.98,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,26.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,35520.0,1838109120.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,35400.0,1838022600.0,24.033333333333335,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.73,2.73,2.73,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,27.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,33600.0,1838625600.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,35400.0,1838627400.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,28.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,37200.0,1838629200.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,35400.0,1838627400.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),60.57,60.57,60.57,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,29.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,39000.0,1838631000.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,35400.0,1838627400.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),256.96,256.96,256.96,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,30.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,40800.0,1838632800.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,35400.0,1838627400.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),162.11,162.11,162.11,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,31.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,42600.0,1838634600.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,35400.0,1838627400.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),144.81,144.81,144.81,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,32.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,46200.0,1838638200.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,35400.0,1838627400.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),236.28,236.28,236.28,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,33.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,50029.0,1838642029.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,35400.0,1838627400.0,4.063611111111111,HOURS,4.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),181.79,181.79,181.79,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,34.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,53472.0,1838645472.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,35400.0,1838627400.0,5.02,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),153.96,153.96,153.96,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,35.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,57000.0,1838649000.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,35400.0,1838627400.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),90.97,90.97,90.97,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,36.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,64200.0,1838656200.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,35400.0,1838627400.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),63.33,63.33,63.33,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,37.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,78600.0,1838670600.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,35400.0,1838627400.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.9,18.90,18.90,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,38.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,85800.0,1838677800.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,35400.0,1838627400.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.81,10.81,10.81,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001031,103001031,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35400.0,1837417800.0,21280.0,35400.0,1838627400.0,39.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,35400.0,1838713800.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,35400.0,1838627400.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.48,3.48,3.48,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,1.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,33660.0,1837416060.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,35460.0,1837417860.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,2.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,37260.0,1837419660.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,35460.0,1837417860.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),241.06,241.06,241.06,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,3.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,39060.0,1837421460.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,35460.0,1837417860.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),201.93,201.93,201.93,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,4.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,40860.0,1837423260.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,35460.0,1837417860.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),136.96,136.96,136.96,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,5.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,42660.0,1837425060.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,35460.0,1837417860.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),136.92,136.92,136.92,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,6.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,46260.0,1837428660.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,35460.0,1837417860.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),104.12,104.12,104.12,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,7.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,49860.0,1837432260.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,35460.0,1837417860.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),78.81,78.81,78.81,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,8.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,53460.0,1837435860.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,35460.0,1837417860.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.77,61.77,61.77,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,9.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,57060.0,1837439460.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,35460.0,1837417860.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.07,61.07,61.07,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,10.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,64260.0,1837446660.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,35460.0,1837417860.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),39.42,39.42,39.42,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,11.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,78660.0,1837461060.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,35460.0,1837417860.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.78,20.78,20.78,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,12.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,85951.0,1837468351.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,35460.0,1837417860.0,14.025277777777777,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),16.05,16.05,16.05,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,13.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,35460.0,1837504260.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,35460.0,1837417860.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.06,6.06,6.06,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,14.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,33660.0,1838020860.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,35460.0,1838022660.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,15.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,37260.0,1838024460.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,35460.0,1838022660.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),338.98,338.98,338.98,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,16.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,39060.0,1838026260.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,35460.0,1838022660.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),269.05,269.05,269.05,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,17.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,40860.0,1838028060.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,35460.0,1838022660.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),174.77,174.77,174.77,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,18.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,42660.0,1838029860.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,35460.0,1838022660.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),169.13,169.13,169.13,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,19.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,46260.0,1838033460.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,35460.0,1838022660.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),110.01,110.01,110.01,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,20.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,49860.0,1838037060.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,35460.0,1838022660.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),79.95,79.95,79.95,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,21.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,53460.0,1838040660.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,35460.0,1838022660.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),63.03,63.03,63.03,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,22.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,57060.0,1838044260.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,35460.0,1838022660.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),39.56,39.56,39.56,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,23.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,64260.0,1838051460.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,35460.0,1838022660.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),31.79,31.79,31.79,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,24.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,78660.0,1838065860.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,35460.0,1838022660.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.15,14.15,14.15,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,25.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,85860.0,1838073060.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,35460.0,1838022660.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.93,10.93,10.93,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,26.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,35460.0,1838109060.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,35460.0,1838022660.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.13,4.13,4.13,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,27.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,33660.0,1838625660.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,35460.0,1838627460.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,28.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,37260.0,1838629260.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,35460.0,1838627460.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),318.98,318.98,318.98,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,29.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,39060.0,1838631060.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,35460.0,1838627460.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),495.75,495.75,495.75,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,30.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,40860.0,1838632860.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,35460.0,1838627460.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),286.57,286.57,286.57,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,31.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,42660.0,1838634660.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,35460.0,1838627460.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),220.43,220.43,220.43,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,32.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,46260.0,1838638260.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,35460.0,1838627460.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),153.12,153.12,153.12,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,33.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,49860.0,1838641860.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,35460.0,1838627460.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),104.84,104.84,104.84,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,34.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,53460.0,1838645460.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,35460.0,1838627460.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),86.12,86.12,86.12,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,35.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,57060.0,1838649060.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,35460.0,1838627460.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),60.15,60.15,60.15,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,36.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,64260.0,1838656260.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,35460.0,1838627460.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),38.47,38.47,38.47,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,37.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,78660.0,1838670660.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,35460.0,1838627460.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.71,15.71,15.71,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,38.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,85860.0,1838677860.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,35460.0,1838627460.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.08,12.08,12.08,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001032,103001032,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,35460.0,1837417860.0,21280.0,35460.0,1838627460.0,39.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,35460.0,1838713860.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,35460.0,1838627460.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.93,3.93,3.93,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,32640.0,1837415040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,34472.0,1837416872.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,36240.0,1837418640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,34472.0,1837416872.0,0.4911111111111111,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),68.31,68.31,68.31,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,38040.0,1837420440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,34472.0,1837416872.0,0.9911111111111112,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),557.99,557.99,557.99,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,39840.0,1837422240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,34472.0,1837416872.0,1.491111111111111,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),454.67,454.67,454.67,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,41640.0,1837424040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,34472.0,1837416872.0,1.991111111111111,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),345.75,345.75,345.75,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,45240.0,1837427640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,34472.0,1837416872.0,2.991111111111111,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),260.1,260.10,260.10,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,48840.0,1837431240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,34472.0,1837416872.0,3.991111111111111,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),218.64,218.64,218.64,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,52440.0,1837434840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,34472.0,1837416872.0,4.9911111111111115,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),181.72,181.72,181.72,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,56040.0,1837438440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,34472.0,1837416872.0,5.9911111111111115,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),132.7,132.70,132.70,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,63240.0,1837445640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,34472.0,1837416872.0,7.9911111111111115,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),96.37,96.37,96.37,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,77640.0,1837460040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,34472.0,1837416872.0,11.991111111111111,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),49.98,49.98,49.98,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,84840.0,1837467240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,34472.0,1837416872.0,13.991111111111111,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),35.77,35.77,35.77,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,34440.0,1837503240.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,34472.0,1837416872.0,23.99111111111111,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.5,12.50,12.50,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,14.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,32640.0,1838019840.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,34440.0,1838021640.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,15.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,36240.0,1838023440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,34440.0,1838021640.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),137.36,137.36,137.36,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,16.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,38040.0,1838025240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,34440.0,1838021640.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),543.34,543.34,543.34,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,17.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,39840.0,1838027040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,34440.0,1838021640.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),358.42,358.42,358.42,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,18.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,41640.0,1838028840.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,34440.0,1838021640.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),314.03,314.03,314.03,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,19.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,45240.0,1838032440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,34440.0,1838021640.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),252.58,252.58,252.58,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,20.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,48840.0,1838036040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,34440.0,1838021640.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),200.21,200.21,200.21,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,21.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,52440.0,1838039640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,34440.0,1838021640.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),139.97,139.97,139.97,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,22.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,56040.0,1838043240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,34440.0,1838021640.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),114.2,114.20,114.20,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,23.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,63240.0,1838050440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,34440.0,1838021640.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),64.91,64.91,64.91,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,24.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,77640.0,1838064840.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,34440.0,1838021640.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),27.46,27.46,27.46,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,25.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,84840.0,1838072040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,34440.0,1838021640.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.59,20.59,20.59,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,26.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21274.0,34440.0,1838108040.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,34440.0,1838021640.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.32,6.32,6.32,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,27.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,32640.0,1838624640.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,34440.0,1838626440.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,28.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,36240.0,1838628240.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,34440.0,1838626440.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),120.48,120.48,120.48,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,29.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,38040.0,1838630040.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,34440.0,1838626440.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),532.92,532.92,532.92,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,30.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,39840.0,1838631840.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,34440.0,1838626440.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),357.92,357.92,357.92,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,31.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,41814.0,1838633814.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,34440.0,1838626440.0,2.0483333333333333,HOURS,3.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),319.22,319.22,319.22,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,32.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,45240.0,1838637240.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,34440.0,1838626440.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),225.6,225.60,225.60,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,33.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,48840.0,1838640840.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,34440.0,1838626440.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),167.71,167.71,167.71,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,34.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,52440.0,1838644440.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,34440.0,1838626440.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),116.68,116.68,116.68,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,35.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,56040.0,1838648040.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,34440.0,1838626440.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),94.23,94.23,94.23,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,36.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,63240.0,1838655240.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,34440.0,1838626440.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.04,61.04,61.04,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,37.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,77640.0,1838669640.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,34440.0,1838626440.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),27.87,27.87,27.87,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,38.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,84840.0,1838676840.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,34440.0,1838626440.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.97,20.97,20.97,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001034,103001034,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,34472.0,1837416872.0,21280.0,34440.0,1838626440.0,39.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,34440.0,1838712840.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,34440.0,1838626440.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.55,6.55,6.55,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,34680.0,1837417080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,36480.0,1837418880.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,38280.0,1837420680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,36480.0,1837418880.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),303.92,303.92,303.92,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,40080.0,1837422480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,36480.0,1837418880.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),355.97,355.97,355.97,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,41947.0,1837424347.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,36480.0,1837418880.0,1.5186111111111111,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),314.69,314.69,314.69,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,43680.0,1837426080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,36480.0,1837418880.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),273.1,273.10,273.10,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,47280.0,1837429680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,36480.0,1837418880.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),150.04,150.04,150.04,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,50880.0,1837433280.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,36480.0,1837418880.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),108.8,108.80,108.80,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,54480.0,1837436880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,36480.0,1837418880.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),74.62,74.62,74.62,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,58080.0,1837440480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,36480.0,1837418880.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),50.73,50.73,50.73,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,65280.0,1837447680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,36480.0,1837418880.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),27.25,27.25,27.25,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,79680.0,1837462080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,36480.0,1837418880.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.32,7.32,7.32,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,480.0,1837469280.0,2.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,36480.0,1837418880.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.0,5.00,5.00,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,36480.0,1837505280.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,36480.0,1837418880.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.77,1.77,1.77,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,14.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,34680.0,1838021880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,36480.0,1838023680.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,15.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,38280.0,1838025480.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,36480.0,1838023680.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),308.65,308.65,308.65,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,16.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,40080.0,1838027280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,36480.0,1838023680.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),449.04,449.04,449.04,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,17.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,41880.0,1838029080.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,36480.0,1838023680.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),383.15,383.15,383.15,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,18.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,43680.0,1838030880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,36480.0,1838023680.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),310.23,310.23,310.23,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,19.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,47280.0,1838034480.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,36480.0,1838023680.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),198.19,198.19,198.19,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,20.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,50880.0,1838038080.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,36480.0,1838023680.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),129.55,129.55,129.55,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,21.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,54480.0,1838041680.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,36480.0,1838023680.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),90.89,90.89,90.89,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,22.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,58080.0,1838045280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,36480.0,1838023680.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),65.61,65.61,65.61,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,23.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,65280.0,1838052480.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,36480.0,1838023680.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),33.14,33.14,33.14,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,24.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,79680.0,1838066880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,36480.0,1838023680.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.44,9.44,9.44,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,25.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,480.0,1838074080.0,9.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,36480.0,1838023680.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.88,5.88,5.88,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,26.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,36480.0,1838110080.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,36480.0,1838023680.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.3,2.30,2.30,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,27.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,34680.0,1838626680.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,36480.0,1838628480.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,28.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,38280.0,1838630280.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,36480.0,1838628480.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),112.27,112.27,112.27,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,29.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,40080.0,1838632080.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,36480.0,1838628480.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),364.59,364.59,364.59,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,30.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,41880.0,1838633880.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,36480.0,1838628480.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),453.57,453.57,453.57,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,31.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,43680.0,1838635680.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,36480.0,1838628480.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),381.34,381.34,381.34,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,32.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,47280.0,1838639280.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,36480.0,1838628480.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),204.63,204.63,204.63,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,33.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,50880.0,1838642880.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,36480.0,1838628480.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),132.29,132.29,132.29,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,34.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,54480.0,1838646480.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,36480.0,1838628480.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),83.67,83.67,83.67,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,35.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,58080.0,1838650080.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,36480.0,1838628480.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),58.53,58.53,58.53,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,36.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,65280.0,1838657280.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,36480.0,1838628480.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),25.58,25.58,25.58,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,37.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,79680.0,1838671680.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,36480.0,1838628480.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.26,7.26,7.26,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,38.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,480.0,1838678880.0,16.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,36480.0,1838628480.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.3,5.30,5.30,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001035,103001035,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36480.0,1837418880.0,21280.0,36480.0,1838628480.0,39.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,36480.0,1838714880.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,36480.0,1838628480.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.05,2.05,2.05,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,33120.0,1837415520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,34920.0,1837417320.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,36720.0,1837419120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,34920.0,1837417320.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),165.68,165.68,165.68,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,38520.0,1837420920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,34920.0,1837417320.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),573.61,573.61,573.61,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,40320.0,1837422720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,34920.0,1837417320.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),360.01,360.01,360.01,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,42120.0,1837424520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,34920.0,1837417320.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),265.15,265.15,265.15,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,45720.0,1837428120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,34920.0,1837417320.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),187.1,187.10,187.10,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,49320.0,1837431720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,34920.0,1837417320.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),142.63,142.63,142.63,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,52920.0,1837435320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,34920.0,1837417320.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),99.83,99.83,99.83,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,56520.0,1837438920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,34920.0,1837417320.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),76.14,76.14,76.14,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,63720.0,1837446120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,34920.0,1837417320.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),44.12,44.12,44.12,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,11.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,78120.0,1837460520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,34920.0,1837417320.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.98,15.98,15.98,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,12.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,85320.0,1837467720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,34920.0,1837417320.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.26,9.26,9.26,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,13.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,34920.0,1837503720.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,34920.0,1837417320.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.77,2.77,2.77,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,14.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,33120.0,1838020320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,34920.0,1838022120.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,15.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,36720.0,1838023920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,34920.0,1838022120.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),59.37,59.37,59.37,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,16.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,38520.0,1838025720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,34920.0,1838022120.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),453.39,453.39,453.39,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,17.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,40320.0,1838027520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,34920.0,1838022120.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),391.45,391.45,391.45,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,18.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,42120.0,1838029320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,34920.0,1838022120.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),339.05,339.05,339.05,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,19.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,45720.0,1838032920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,34920.0,1838022120.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),187.35,187.35,187.35,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,20.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,49320.0,1838036520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,34920.0,1838022120.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),133.77,133.77,133.77,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,21.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,52920.0,1838040120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,34920.0,1838022120.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),88.97,88.97,88.97,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,22.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,56520.0,1838043720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,34920.0,1838022120.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),65.21,65.21,65.21,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,23.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,63720.0,1838050920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,34920.0,1838022120.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),39.81,39.81,39.81,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,24.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,78120.0,1838065320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,34920.0,1838022120.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.62,13.62,13.62,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,25.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,85320.0,1838072520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,34920.0,1838022120.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.65,8.65,8.65,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,26.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21274.0,34920.0,1838108520.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,34920.0,1838022120.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.38,2.38,2.38,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,27.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,33120.0,1838625120.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,34920.0,1838626920.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,28.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,36720.0,1838628720.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,34920.0,1838626920.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),395.77,395.77,395.77,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,29.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,38520.0,1838630520.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,34920.0,1838626920.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),406.24,406.24,406.24,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,30.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,40320.0,1838632320.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,34920.0,1838626920.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),259.12,259.12,259.12,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,31.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,42120.0,1838634120.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,34920.0,1838626920.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),226.48,226.48,226.48,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,32.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,45720.0,1838637720.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,34920.0,1838626920.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),149.49,149.49,149.49,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,33.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,49320.0,1838641320.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,34920.0,1838626920.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),110.54,110.54,110.54,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,34.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,52920.0,1838644920.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,34920.0,1838626920.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),77.05,77.05,77.05,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,35.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,56520.0,1838648520.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,34920.0,1838626920.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),62.58,62.58,62.58,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,36.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,63720.0,1838655720.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,34920.0,1838626920.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),37.19,37.19,37.19,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,37.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,78120.0,1838670120.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,34920.0,1838626920.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),16.95,16.95,16.95,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,38.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,85320.0,1838677320.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,34920.0,1838626920.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.72,10.72,10.72,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001037,103001037,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34920.0,1837417320.0,21280.0,34920.0,1838626920.0,39.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,34920.0,1838713320.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,34920.0,1838626920.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.77,3.77,3.77,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,34002.0,1837416402.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,35520.0,1837417920.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,37381.0,1837419781.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,35520.0,1837417920.0,0.5169444444444444,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),379.26,379.26,379.26,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,39120.0,1837421520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,35520.0,1837417920.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),902.08,902.08,902.08,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,40920.0,1837423320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,35520.0,1837417920.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),466.69,466.69,466.69,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,42720.0,1837425120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,35520.0,1837417920.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),369.72,369.72,369.72,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,46320.0,1837428720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,35520.0,1837417920.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),225.52,225.52,225.52,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,49920.0,1837432320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,35520.0,1837417920.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),170.32,170.32,170.32,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,53745.0,1837436145.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,35520.0,1837417920.0,5.0625,HOURS,4.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),120.17,120.17,120.17,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,57120.0,1837439520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,35520.0,1837417920.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),83.74,83.74,83.74,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,65107.0,1837447507.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,35520.0,1837417920.0,8.21861111111111,HOURS,13.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),37.69,37.69,37.69,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,78720.0,1837461120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,35520.0,1837417920.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.09,18.09,18.09,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,86312.0,1837468712.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,35520.0,1837417920.0,14.108888888888888,HOURS,7.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.24,10.24,10.24,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,35520.0,1837504320.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,35520.0,1837417920.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.97,3.97,3.97,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,14.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,33720.0,1838020920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,35520.0,1838022720.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,15.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,37510.0,1838024710.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,35520.0,1838022720.0,0.5527777777777778,HOURS,3.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),290.88,290.88,290.88,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,16.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,39120.0,1838026320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,35520.0,1838022720.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),426.74,426.74,426.74,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,17.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,41026.0,1838028226.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,35520.0,1838022720.0,1.5294444444444444,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),368.45,368.45,368.45,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,18.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,42720.0,1838029920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,35520.0,1838022720.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),299.81,299.81,299.81,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,19.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,46320.0,1838033520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,35520.0,1838022720.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),197.92,197.92,197.92,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,20.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,49920.0,1838037120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,35520.0,1838022720.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),157.8,157.80,157.80,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,21.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,53580.0,1838040780.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,35520.0,1838022720.0,5.016666666666667,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),118.42,118.42,118.42,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,22.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,57120.0,1838044320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,35520.0,1838022720.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),83.8,83.80,83.80,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,23.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,64320.0,1838051520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,35520.0,1838022720.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),45.81,45.81,45.81,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,24.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,78720.0,1838065920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,35520.0,1838022720.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.92,18.92,18.92,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,25.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,85920.0,1838073120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,35520.0,1838022720.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.41,12.41,12.41,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,26.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21274.0,35626.0,1838109226.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,35520.0,1838022720.0,24.029444444444444,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.84,4.84,4.84,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,27.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,33720.0,1838625720.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,35520.0,1838627520.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,28.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,37465.0,1838629465.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,35520.0,1838627520.0,0.5402777777777777,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),190.46,190.46,190.46,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,29.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,39120.0,1838631120.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,35520.0,1838627520.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),475.21,475.21,475.21,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,30.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,40920.0,1838632920.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,35520.0,1838627520.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),370.78,370.78,370.78,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,31.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,42720.0,1838634720.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,35520.0,1838627520.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),328.33,328.33,328.33,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,32.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,46394.0,1838638394.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,35520.0,1838627520.0,3.0205555555555557,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),238.92,238.92,238.92,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,33.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,49920.0,1838641920.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,35520.0,1838627520.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),156.94,156.94,156.94,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,34.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,53520.0,1838645520.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,35520.0,1838627520.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),126.73,126.73,126.73,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,35.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,57120.0,1838649120.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,35520.0,1838627520.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),96.79,96.79,96.79,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,36.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,64320.0,1838656320.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,35520.0,1838627520.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),50.66,50.66,50.66,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,37.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,78720.0,1838670720.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,35520.0,1838627520.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.99,18.99,18.99,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,38.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,85920.0,1838677920.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,35520.0,1838627520.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.43,11.43,11.43,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001038,103001038,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35520.0,1837417920.0,21280.0,35520.0,1838627520.0,39.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,35520.0,1838713920.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,35520.0,1838627520.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.52,3.52,3.52,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,34200.0,1837416600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,36000.0,1837418400.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,37800.0,1837420200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,36000.0,1837418400.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),176.03,176.03,176.03,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,39600.0,1837422000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,36000.0,1837418400.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),393.44,393.44,393.44,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,41400.0,1837423800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,36000.0,1837418400.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),254.04,254.04,254.04,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,43200.0,1837425600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,36000.0,1837418400.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),210.07,210.07,210.07,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,46800.0,1837429200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,36000.0,1837418400.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),128.27,128.27,128.27,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,50400.0,1837432800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,36000.0,1837418400.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),93.54,93.54,93.54,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,54000.0,1837436400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,36000.0,1837418400.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),68.6,68.60,68.60,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,57600.0,1837440000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,36000.0,1837418400.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),47.83,47.83,47.83,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,64800.0,1837447200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,36000.0,1837418400.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),38.28,38.28,38.28,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,11.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,79200.0,1837461600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,36000.0,1837418400.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.6,14.60,14.60,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,12.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,0.0,1837468800.0,2.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,36000.0,1837418400.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.67,10.67,10.67,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,13.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,36000.0,1837504800.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,36000.0,1837418400.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.61,6.61,6.61,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,14.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,34200.0,1838021400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,36000.0,1838023200.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,15.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,37800.0,1838025000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,36000.0,1838023200.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),73.24,73.24,73.24,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,16.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,39600.0,1838026800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,36000.0,1838023200.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),262.07,262.07,262.07,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,17.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,41400.0,1838028600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,36000.0,1838023200.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),407.23,407.23,407.23,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,18.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,43200.0,1838030400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,36000.0,1838023200.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),381.7,381.70,381.70,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,19.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,46800.0,1838034000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,36000.0,1838023200.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),200.52,200.52,200.52,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,20.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,50400.0,1838037600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,36000.0,1838023200.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),136.02,136.02,136.02,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,21.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,54000.0,1838041200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,36000.0,1838023200.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),116.89,116.89,116.89,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,22.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,57600.0,1838044800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,36000.0,1838023200.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),89.75,89.75,89.75,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,23.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,64800.0,1838052000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,36000.0,1838023200.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),51.8,51.80,51.80,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,24.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,79200.0,1838066400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,36000.0,1838023200.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),21.64,21.64,21.64,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,25.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21274.0,0.0,1838073600.0,9.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,36000.0,1838023200.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.05,14.05,14.05,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,26.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21274.0,36000.0,1838109600.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,36000.0,1838023200.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.28,4.28,4.28,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,27.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,34200.0,1838626200.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,36000.0,1838628000.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,28.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,37800.0,1838629800.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,36000.0,1838628000.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),187.58,187.58,187.58,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,29.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,39600.0,1838631600.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,36000.0,1838628000.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),378.95,378.95,378.95,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,30.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,41400.0,1838633400.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,36000.0,1838628000.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),316.52,316.52,316.52,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,31.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,43200.0,1838635200.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,36000.0,1838628000.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),273.67,273.67,273.67,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,32.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,46800.0,1838638800.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,36000.0,1838628000.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),164.26,164.26,164.26,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,33.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,50400.0,1838642400.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,36000.0,1838628000.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),119.44,119.44,119.44,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,34.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,54000.0,1838646000.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,36000.0,1838628000.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),89.79,89.79,89.79,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,35.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,57600.0,1838649600.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,36000.0,1838628000.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),56.26,56.26,56.26,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,36.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,64800.0,1838656800.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,36000.0,1838628000.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),41.77,41.77,41.77,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,37.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,79200.0,1838671200.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,36000.0,1838628000.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.88,18.88,18.88,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,38.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,0.0,1838678400.0,16.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,36000.0,1838628000.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.48,13.48,13.48,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001044,103001044,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,36000.0,1837418400.0,21280.0,36000.0,1838628000.0,39.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,36000.0,1838714400.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,36000.0,1838628000.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.87,4.87,4.87,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,1.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,32700.0,1837415100.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,34500.0,1837416900.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,2.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,36300.0,1837418700.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,34500.0,1837416900.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),88.18,88.18,88.18,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,3.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,38100.0,1837420500.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,34500.0,1837416900.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),322.68,322.68,322.68,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,4.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,39900.0,1837422300.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,34500.0,1837416900.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),283.35,283.35,283.35,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,5.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,41700.0,1837424100.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,34500.0,1837416900.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),186.18,186.18,186.18,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,6.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,45300.0,1837427700.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,34500.0,1837416900.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),111.15,111.15,111.15,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,7.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,48900.0,1837431300.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,34500.0,1837416900.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),94.66,94.66,94.66,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,8.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,52500.0,1837434900.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,34500.0,1837416900.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.8,61.80,61.80,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,9.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,56100.0,1837438500.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,34500.0,1837416900.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),38.23,38.23,38.23,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,10.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,63300.0,1837445700.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,34500.0,1837416900.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),28.47,28.47,28.47,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,11.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,77700.0,1837460100.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,34500.0,1837416900.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.15,10.15,10.15,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,12.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,84900.0,1837467300.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,34500.0,1837416900.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.03,6.03,6.03,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,13.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,34500.0,1837503300.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,34500.0,1837416900.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.25,1.25,1.25,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,14.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,32700.0,1838019900.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,34500.0,1838021700.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,15.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,36300.0,1838023500.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,34500.0,1838021700.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),123.6,123.60,123.60,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,16.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,38100.0,1838025300.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,34500.0,1838021700.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),324.69,324.69,324.69,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,17.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,39900.0,1838027100.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,34500.0,1838021700.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),283.05,283.05,283.05,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,18.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,41700.0,1838028900.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,34500.0,1838021700.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),269.91,269.91,269.91,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,19.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,45300.0,1838032500.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,34500.0,1838021700.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),146.38,146.38,146.38,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,20.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,48900.0,1838036100.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,34500.0,1838021700.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),97.36,97.36,97.36,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,21.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,52500.0,1838039700.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,34500.0,1838021700.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),71.96,71.96,71.96,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,22.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,56100.0,1838043300.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,34500.0,1838021700.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),54.86,54.86,54.86,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,23.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,63300.0,1838050500.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,34500.0,1838021700.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),30.64,30.64,30.64,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,24.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,77700.0,1838064900.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,34500.0,1838021700.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.54,12.54,12.54,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,25.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,84900.0,1838072100.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,34500.0,1838021700.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.49,7.49,7.49,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,26.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,34567.0,1838108167.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,34500.0,1838021700.0,24.01861111111111,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.09,1.09,1.09,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,27.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,32700.0,1838624700.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,34500.0,1838626500.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,28.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,36300.0,1838628300.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,34500.0,1838626500.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),114.85,114.85,114.85,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,29.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,38100.0,1838630100.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,34500.0,1838626500.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),314.69,314.69,314.69,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,30.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,39900.0,1838631900.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,34500.0,1838626500.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),255.35,255.35,255.35,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,31.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,41700.0,1838633700.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,34500.0,1838626500.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),184.71,184.71,184.71,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,32.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,45300.0,1838637300.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,34500.0,1838626500.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),109.16,109.16,109.16,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,33.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,48900.0,1838640900.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,34500.0,1838626500.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),91.55,91.55,91.55,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,34.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,52500.0,1838644500.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,34500.0,1838626500.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),57.77,57.77,57.77,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,35.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,56100.0,1838648100.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,34500.0,1838626500.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),49.26,49.26,49.26,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,36.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,63300.0,1838655300.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,34500.0,1838626500.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),28.22,28.22,28.22,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,37.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,77700.0,1838669700.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,34500.0,1838626500.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.4,9.40,9.40,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,38.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,84900.0,1838676900.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,34500.0,1838626500.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.79,5.79,5.79,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001048,103001048,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34500.0,1837416900.0,21280.0,34500.0,1838626500.0,39.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,34500.0,1838712900.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,34500.0,1838626500.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,32760.0,1837415160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,34560.0,1837416960.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,36360.0,1837418760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,34560.0,1837416960.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),122.72,122.72,122.72,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,38160.0,1837420560.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,34560.0,1837416960.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),275.25,275.25,275.25,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,39960.0,1837422360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,34560.0,1837416960.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),174.2,174.20,174.20,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,41760.0,1837424160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,34560.0,1837416960.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),143.93,143.93,143.93,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,45360.0,1837427760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,34560.0,1837416960.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),124.62,124.62,124.62,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,48960.0,1837431360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,34560.0,1837416960.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),104.64,104.64,104.64,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,52560.0,1837434960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,34560.0,1837416960.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),83.35,83.35,83.35,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,56160.0,1837438560.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,34560.0,1837416960.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.51,61.51,61.51,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,63360.0,1837445760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,34560.0,1837416960.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),35.24,35.24,35.24,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,11.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,77760.0,1837460160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,34560.0,1837416960.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),16.03,16.03,16.03,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,12.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,84960.0,1837467360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,34560.0,1837416960.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.97,8.97,8.97,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,13.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,34560.0,1837503360.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,34560.0,1837416960.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.29,2.29,2.29,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,14.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,32760.0,1838019960.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,34560.0,1838021760.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,15.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,36360.0,1838023560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,34560.0,1838021760.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),185.25,185.25,185.25,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,16.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,38160.0,1838025360.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,34560.0,1838021760.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),320.27,320.27,320.27,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,17.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,39960.0,1838027160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,34560.0,1838021760.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),246.84,246.84,246.84,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,18.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,41760.0,1838028960.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,34560.0,1838021760.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),249.62,249.62,249.62,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,19.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,45360.0,1838032560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,34560.0,1838021760.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),169.09,169.09,169.09,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,20.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,48960.0,1838036160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,34560.0,1838021760.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),126.2,126.20,126.20,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,21.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,52560.0,1838039760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,34560.0,1838021760.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),110.84,110.84,110.84,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,22.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,56160.0,1838043360.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,34560.0,1838021760.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),83.52,83.52,83.52,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,23.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,63360.0,1838050560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,34560.0,1838021760.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),54.4,54.40,54.40,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,24.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,77760.0,1838064960.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,34560.0,1838021760.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.81,17.81,17.81,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,25.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,84960.0,1838072160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,34560.0,1838021760.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.25,11.25,11.25,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,26.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,34560.0,1838108160.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,34560.0,1838021760.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.68,3.68,3.68,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,27.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,32760.0,1838624760.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,34560.0,1838626560.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,28.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,36360.0,1838628360.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,34560.0,1838626560.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),155.25,155.25,155.25,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,29.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,38160.0,1838630160.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,34560.0,1838626560.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),317.72,317.72,317.72,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,30.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,39960.0,1838631960.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,34560.0,1838626560.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),241.77,241.77,241.77,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,31.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,41760.0,1838633760.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,34560.0,1838626560.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),197.68,197.68,197.68,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,32.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,45360.0,1838637360.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,34560.0,1838626560.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),236.79,236.79,236.79,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,33.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,48960.0,1838640960.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,34560.0,1838626560.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),158.13,158.13,158.13,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,34.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,52560.0,1838644560.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,34560.0,1838626560.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),144.32,144.32,144.32,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,35.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,56160.0,1838648160.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,34560.0,1838626560.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),100.12,100.12,100.12,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,36.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,63360.0,1838655360.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,34560.0,1838626560.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),60.2,60.20,60.20,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,37.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,77760.0,1838669760.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,34560.0,1838626560.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),22.06,22.06,22.06,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,38.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,84960.0,1838676960.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,34560.0,1838626560.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.08,14.08,14.08,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001052,103001052,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,34560.0,1837416960.0,21280.0,34560.0,1838626560.0,39.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,34560.0,1838712960.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,34560.0,1838626560.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.64,3.64,3.64,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,32820.0,1837415220.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,34620.0,1837417020.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,36420.0,1837418820.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,34620.0,1837417020.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),55.16,55.16,55.16,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,38220.0,1837420620.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,34620.0,1837417020.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),174.31,174.31,174.31,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,40020.0,1837422420.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,34620.0,1837417020.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),218.53,218.53,218.53,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,41820.0,1837424220.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,34620.0,1837417020.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),351.18,351.18,351.18,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,45420.0,1837427820.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,34620.0,1837417020.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),165.35,165.35,165.35,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,49020.0,1837431420.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,34620.0,1837417020.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),120.52,120.52,120.52,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,52620.0,1837435020.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,34620.0,1837417020.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),79.92,79.92,79.92,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,56220.0,1837438620.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,34620.0,1837417020.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),60.69,60.69,60.69,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,63420.0,1837445820.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,34620.0,1837417020.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),31.79,31.79,31.79,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,77820.0,1837460220.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,34620.0,1837417020.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.15,10.15,10.15,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,85020.0,1837467420.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,34620.0,1837417020.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.58,7.58,7.58,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,34620.0,1837503420.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,34620.0,1837417020.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.96,1.96,1.96,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,14.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,32820.0,1838020020.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,34620.0,1838021820.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,15.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,36420.0,1838023620.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,34620.0,1838021820.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),168.34,168.34,168.34,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,16.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,38220.0,1838025420.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,34620.0,1838021820.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),299.49,299.49,299.49,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,17.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,40020.0,1838027220.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,34620.0,1838021820.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),218.9,218.90,218.90,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,18.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,41820.0,1838029020.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,34620.0,1838021820.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),189.41,189.41,189.41,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,19.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,45420.0,1838032620.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,34620.0,1838021820.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),126.28,126.28,126.28,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,20.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,49020.0,1838036220.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,34620.0,1838021820.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),86.88,86.88,86.88,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,21.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,52620.0,1838039820.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,34620.0,1838021820.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),67.53,67.53,67.53,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,22.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,56220.0,1838043420.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,34620.0,1838021820.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),51.28,51.28,51.28,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,23.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,63420.0,1838050620.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,34620.0,1838021820.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),34.56,34.56,34.56,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,24.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,77820.0,1838065020.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,34620.0,1838021820.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.2,11.20,11.20,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,25.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,85020.0,1838072220.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,34620.0,1838021820.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.21,7.21,7.21,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,26.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,34620.0,1838108220.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,34620.0,1838021820.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.81,2.81,2.81,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,27.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,32820.0,1838624820.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,34620.0,1838626620.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,28.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,36420.0,1838628420.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,34620.0,1838626620.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),136.44,136.44,136.44,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,29.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,38220.0,1838630220.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,34620.0,1838626620.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),199.41,199.41,199.41,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,30.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,40020.0,1838632020.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,34620.0,1838626620.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),212.49,212.49,212.49,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,31.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,41820.0,1838633820.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,34620.0,1838626620.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),171.63,171.63,171.63,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,32.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,45420.0,1838637420.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,34620.0,1838626620.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),118.58,118.58,118.58,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,33.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,49020.0,1838641020.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,34620.0,1838626620.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),82.62,82.62,82.62,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,34.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,52620.0,1838644620.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,34620.0,1838626620.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),64.12,64.12,64.12,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,35.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,56220.0,1838648220.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,34620.0,1838626620.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),58.79,58.79,58.79,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,36.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,63420.0,1838655420.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,34620.0,1838626620.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),35.31,35.31,35.31,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,37.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,77820.0,1838669820.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,34620.0,1838626620.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.65,11.65,11.65,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,38.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,85020.0,1838677020.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,34620.0,1838626620.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.42,7.42,7.42,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001054,103001054,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34620.0,1837417020.0,21280.0,34620.0,1838626620.0,39.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,34620.0,1838713020.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,34620.0,1838626620.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.97,1.97,1.97,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,33420.0,1837415820.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,35220.0,1837417620.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,nan,nan,nan,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,35220.0,1837417620.0,nan,,nan,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),107.56,107.56,107.56,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,38820.0,1837421220.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,35220.0,1837417620.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),123.22,123.22,123.22,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,40620.0,1837423020.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,35220.0,1837417620.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),141.01,141.01,141.01,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,42420.0,1837424820.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,35220.0,1837417620.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),135.01,135.01,135.01,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,46020.0,1837428420.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,35220.0,1837417620.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),86.13,86.13,86.13,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,49620.0,1837432020.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,35220.0,1837417620.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.74,61.74,61.74,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,53220.0,1837435620.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,35220.0,1837417620.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),42.16,42.16,42.16,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,56820.0,1837439220.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,35220.0,1837417620.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),29.92,29.92,29.92,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,64020.0,1837446420.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,35220.0,1837417620.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.15,17.15,17.15,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,11.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,78420.0,1837460820.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,35220.0,1837417620.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.61,7.61,7.61,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,12.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,85620.0,1837468020.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,35220.0,1837417620.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.74,4.74,4.74,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,13.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,35220.0,1837504020.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,35220.0,1837417620.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.9,1.90,1.90,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,14.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,33420.0,1838020620.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,35220.0,1838022420.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,15.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,37020.0,1838024220.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,35220.0,1838022420.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),69.91,69.91,69.91,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,16.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,38864.0,1838026064.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,35220.0,1838022420.0,1.0122222222222221,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),143.43,143.43,143.43,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,17.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,40620.0,1838027820.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,35220.0,1838022420.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),93.69,93.69,93.69,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,18.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,42420.0,1838029620.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,35220.0,1838022420.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),97.27,97.27,97.27,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,19.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,46020.0,1838033220.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,35220.0,1838022420.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),81.22,81.22,81.22,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,20.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,49620.0,1838036820.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,35220.0,1838022420.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),66.59,66.59,66.59,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,21.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,53220.0,1838040420.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,35220.0,1838022420.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),47.84,47.84,47.84,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,22.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,56820.0,1838044020.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,35220.0,1838022420.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),34.99,34.99,34.99,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,23.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,64020.0,1838051220.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,35220.0,1838022420.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.63,18.63,18.63,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,24.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,78420.0,1838065620.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,35220.0,1838022420.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.28,7.28,7.28,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,25.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,85620.0,1838072820.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,35220.0,1838022420.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.14,4.14,4.14,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,26.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,35220.0,1838108820.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,35220.0,1838022420.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.48,1.48,1.48,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,27.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,33420.0,1838625420.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,35220.0,1838627220.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,28.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,37020.0,1838629020.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,35220.0,1838627220.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),95.65,95.65,95.65,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,29.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,38820.0,1838630820.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,35220.0,1838627220.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),112.44,112.44,112.44,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,30.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,40620.0,1838632620.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,35220.0,1838627220.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),85.4,85.40,85.40,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,31.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,42420.0,1838634420.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,35220.0,1838627220.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),111.31,111.31,111.31,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,32.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,46020.0,1838638020.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,35220.0,1838627220.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),85.58,85.58,85.58,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,33.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,49620.0,1838641620.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,35220.0,1838627220.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.3,61.30,61.30,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,34.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,53220.0,1838645220.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,35220.0,1838627220.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),47.09,47.09,47.09,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,35.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,56820.0,1838648820.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,35220.0,1838627220.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),37.06,37.06,37.06,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,36.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,64020.0,1838656020.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,35220.0,1838627220.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),23.62,23.62,23.62,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,37.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,78420.0,1838670420.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,35220.0,1838627220.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.78,7.78,7.78,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,38.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,85752.0,1838677752.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,35220.0,1838627220.0,14.036666666666667,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.37,5.37,5.37,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001057,103001057,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35220.0,1837417620.0,21280.0,35220.0,1838627220.0,39.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,35220.0,1838713620.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,35220.0,1838627220.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.45,1.45,1.45,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001058,103001058,001,Part A,1.0,Y,1.0,N,0.0,5: CAB,5.0,5: CAB,5.0,21266.0,34980.0,1837417380.0,21266.0,34980.0,1837417380.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,33254.0,1837415654.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,34980.0,1837417380.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001058,103001058,001,Part A,1.0,Y,1.0,N,0.0,5: CAB,5.0,5: CAB,5.0,21266.0,34980.0,1837417380.0,21266.0,34980.0,1837417380.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,36841.0,1837419241.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,34980.0,1837417380.0,0.5169444444444444,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),94.23,94.23,94.23,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001058,103001058,001,Part A,1.0,Y,1.0,N,0.0,5: CAB,5.0,5: CAB,5.0,21266.0,34980.0,1837417380.0,21266.0,34980.0,1837417380.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,38652.0,1837421052.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,34980.0,1837417380.0,1.02,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),194.43,194.43,194.43,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001058,103001058,001,Part A,1.0,Y,1.0,N,0.0,5: CAB,5.0,5: CAB,5.0,21266.0,34980.0,1837417380.0,21266.0,34980.0,1837417380.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,40380.0,1837422780.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,34980.0,1837417380.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),195.46,195.46,195.46,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001058,103001058,001,Part A,1.0,Y,1.0,N,0.0,5: CAB,5.0,5: CAB,5.0,21266.0,34980.0,1837417380.0,21266.0,34980.0,1837417380.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,42253.0,1837424653.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,34980.0,1837417380.0,2.020277777777778,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),262.3,262.30,262.30,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001058,103001058,001,Part A,1.0,Y,1.0,N,0.0,5: CAB,5.0,5: CAB,5.0,21266.0,34980.0,1837417380.0,21266.0,34980.0,1837417380.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,45780.0,1837428180.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,34980.0,1837417380.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),147.94,147.94,147.94,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001058,103001058,001,Part A,1.0,Y,1.0,N,0.0,5: CAB,5.0,5: CAB,5.0,21266.0,34980.0,1837417380.0,21266.0,34980.0,1837417380.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,49380.0,1837431780.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,34980.0,1837417380.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),104.47,104.47,104.47,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001058,103001058,001,Part A,1.0,Y,1.0,N,0.0,5: CAB,5.0,5: CAB,5.0,21266.0,34980.0,1837417380.0,21266.0,34980.0,1837417380.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,52980.0,1837435380.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,34980.0,1837417380.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),72.44,72.44,72.44,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001058,103001058,001,Part A,1.0,Y,1.0,N,0.0,5: CAB,5.0,5: CAB,5.0,21266.0,34980.0,1837417380.0,21266.0,34980.0,1837417380.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,56580.0,1837438980.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,34980.0,1837417380.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),58.23,58.23,58.23,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001058,103001058,001,Part A,1.0,Y,1.0,N,0.0,5: CAB,5.0,5: CAB,5.0,21266.0,34980.0,1837417380.0,21266.0,34980.0,1837417380.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,63780.0,1837446180.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,34980.0,1837417380.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),37.1,37.10,37.10,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001058,103001058,001,Part A,1.0,Y,1.0,N,0.0,5: CAB,5.0,5: CAB,5.0,21266.0,34980.0,1837417380.0,21266.0,34980.0,1837417380.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,78180.0,1837460580.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,34980.0,1837417380.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.57,14.57,14.57,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001058,103001058,001,Part A,1.0,Y,1.0,N,0.0,5: CAB,5.0,5: CAB,5.0,21266.0,34980.0,1837417380.0,21266.0,34980.0,1837417380.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,85380.0,1837467780.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,34980.0,1837417380.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.89,7.89,7.89,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001058,103001058,001,Part A,1.0,Y,1.0,N,0.0,5: CAB,5.0,5: CAB,5.0,21266.0,34980.0,1837417380.0,21266.0,34980.0,1837417380.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,34980.0,1837503780.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,34980.0,1837417380.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.57,2.57,2.57,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001059,103001059,001,Part A,1.0,Y,1.0,N,0.0,1: ABC,1.0,1: ABC,1.0,21266.0,36540.0,1837418940.0,21266.0,36540.0,1837418940.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,34740.0,1837417140.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,36540.0,1837418940.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001059,103001059,001,Part A,1.0,Y,1.0,N,0.0,1: ABC,1.0,1: ABC,1.0,21266.0,36540.0,1837418940.0,21266.0,36540.0,1837418940.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,38340.0,1837420740.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,36540.0,1837418940.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),211.83,211.83,211.83,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001059,103001059,001,Part A,1.0,Y,1.0,N,0.0,1: ABC,1.0,1: ABC,1.0,21266.0,36540.0,1837418940.0,21266.0,36540.0,1837418940.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,40140.0,1837422540.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,36540.0,1837418940.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),309.11,309.11,309.11,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001059,103001059,001,Part A,1.0,Y,1.0,N,0.0,1: ABC,1.0,1: ABC,1.0,21266.0,36540.0,1837418940.0,21266.0,36540.0,1837418940.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,41940.0,1837424340.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,36540.0,1837418940.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),407.55,407.55,407.55,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001059,103001059,001,Part A,1.0,Y,1.0,N,0.0,1: ABC,1.0,1: ABC,1.0,21266.0,36540.0,1837418940.0,21266.0,36540.0,1837418940.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,43740.0,1837426140.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,36540.0,1837418940.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),313.42,313.42,313.42,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001059,103001059,001,Part A,1.0,Y,1.0,N,0.0,1: ABC,1.0,1: ABC,1.0,21266.0,36540.0,1837418940.0,21266.0,36540.0,1837418940.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,47345.0,1837429745.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,36540.0,1837418940.0,3.001388888888889,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),145.37,145.37,145.37,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001059,103001059,001,Part A,1.0,Y,1.0,N,0.0,1: ABC,1.0,1: ABC,1.0,21266.0,36540.0,1837418940.0,21266.0,36540.0,1837418940.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,50940.0,1837433340.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,36540.0,1837418940.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),97.15,97.15,97.15,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001059,103001059,001,Part A,1.0,Y,1.0,N,0.0,1: ABC,1.0,1: ABC,1.0,21266.0,36540.0,1837418940.0,21266.0,36540.0,1837418940.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,54540.0,1837436940.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,36540.0,1837418940.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),60.21,60.21,60.21,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001059,103001059,001,Part A,1.0,Y,1.0,N,0.0,1: ABC,1.0,1: ABC,1.0,21266.0,36540.0,1837418940.0,21266.0,36540.0,1837418940.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,58140.0,1837440540.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,36540.0,1837418940.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),44.73,44.73,44.73,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001059,103001059,001,Part A,1.0,Y,1.0,N,0.0,1: ABC,1.0,1: ABC,1.0,21266.0,36540.0,1837418940.0,21266.0,36540.0,1837418940.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,nan,nan,nan,nan,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,36540.0,1837418940.0,nan,,nan,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),nan,,Subject Was An Early Term,ng/mL,nan,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,33780.0,1837416180.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,35580.0,1837417980.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,37380.0,1837419780.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,35580.0,1837417980.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.81,6.81,6.81,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,39180.0,1837421580.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,35580.0,1837417980.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),95.14,95.14,95.14,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,40980.0,1837423380.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,35580.0,1837417980.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),193.57,193.57,193.57,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,42780.0,1837425180.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,35580.0,1837417980.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),279.3,279.30,279.30,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,46380.0,1837428780.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,35580.0,1837417980.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),472.93,472.93,472.93,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,49980.0,1837432380.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,35580.0,1837417980.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),237.54,237.54,237.54,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,53580.0,1837435980.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,35580.0,1837417980.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),142.0,142.00,142.00,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,57180.0,1837439580.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,35580.0,1837417980.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),119.38,119.38,119.38,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,64380.0,1837446780.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,35580.0,1837417980.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.57,61.57,61.57,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,11.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,78856.0,1837461256.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,35580.0,1837417980.0,12.02111111111111,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),23.31,23.31,23.31,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,12.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,85980.0,1837468380.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,35580.0,1837417980.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.18,15.18,15.18,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,13.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,35580.0,1837504380.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,35580.0,1837417980.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.09,5.09,5.09,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,14.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,33780.0,1838020980.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,35580.0,1838022780.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,15.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,37380.0,1838024580.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,35580.0,1838022780.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),41.2,41.20,41.20,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,16.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,39180.0,1838026380.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,35580.0,1838022780.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),233.87,233.87,233.87,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,17.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,40980.0,1838028180.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,35580.0,1838022780.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),411.96,411.96,411.96,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,18.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,42780.0,1838029980.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,35580.0,1838022780.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),358.94,358.94,358.94,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,19.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,46380.0,1838033580.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,35580.0,1838022780.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),219.73,219.73,219.73,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,20.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,49980.0,1838037180.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,35580.0,1838022780.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),144.48,144.48,144.48,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,21.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,53580.0,1838040780.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,35580.0,1838022780.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),114.22,114.22,114.22,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,22.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,57292.0,1838044492.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,35580.0,1838022780.0,6.0311111111111115,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),98.3,98.30,98.30,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,23.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,64380.0,1838051580.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,35580.0,1838022780.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),48.09,48.09,48.09,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,24.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,78780.0,1838065980.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,35580.0,1838022780.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),19.37,19.37,19.37,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,25.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,85980.0,1838073180.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,35580.0,1838022780.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.54,14.54,14.54,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,26.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21274.0,35781.0,1838109381.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,35580.0,1838022780.0,24.055833333333332,HOURS,3.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.2,6.20,6.20,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,27.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,33780.0,1838625780.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,35580.0,1838627580.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,28.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,37380.0,1838629380.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,35580.0,1838627580.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.53,4.53,4.53,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,29.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,39180.0,1838631180.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,35580.0,1838627580.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),140.41,140.41,140.41,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,30.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,40980.0,1838632980.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,35580.0,1838627580.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),183.35,183.35,183.35,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,31.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,42780.0,1838634780.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,35580.0,1838627580.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),241.08,241.08,241.08,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,32.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,46380.0,1838638380.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,35580.0,1838627580.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),205.89,205.89,205.89,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,33.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,49980.0,1838641980.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,35580.0,1838627580.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),141.02,141.02,141.02,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,34.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,53580.0,1838645580.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,35580.0,1838627580.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),95.3,95.30,95.30,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,35.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,57180.0,1838649180.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,35580.0,1838627580.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),75.84,75.84,75.84,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,36.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,64380.0,1838656380.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,35580.0,1838627580.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),41.71,41.71,41.71,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,37.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,78780.0,1838670780.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,35580.0,1838627580.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.43,18.43,18.43,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,38.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,85980.0,1838677980.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,35580.0,1838627580.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.88,10.88,10.88,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001066,103001066,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35580.0,1837417980.0,21280.0,35580.0,1838627580.0,39.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,35580.0,1838713980.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,35580.0,1838627580.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.19,4.19,4.19,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,33840.0,1837416240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,35640.0,1837418040.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,37440.0,1837419840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,35640.0,1837418040.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),101.38,101.38,101.38,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,39240.0,1837421640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,35640.0,1837418040.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),610.07,610.07,610.07,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,41040.0,1837423440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,35640.0,1837418040.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),467.39,467.39,467.39,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,42840.0,1837425240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,35640.0,1837418040.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),373.27,373.27,373.27,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,46440.0,1837428840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,35640.0,1837418040.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),261.28,261.28,261.28,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,50040.0,1837432440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,35640.0,1837418040.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),223.22,223.22,223.22,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,53640.0,1837436040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,35640.0,1837418040.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),186.32,186.32,186.32,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,57240.0,1837439640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,35640.0,1837418040.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),121.92,121.92,121.92,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,64440.0,1837446840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,35640.0,1837418040.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),79.76,79.76,79.76,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,11.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,78840.0,1837461240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,35640.0,1837418040.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),26.44,26.44,26.44,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,12.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,86040.0,1837468440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,35640.0,1837418040.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.23,15.23,15.23,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,13.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,35640.0,1837504440.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,35640.0,1837418040.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.46,3.46,3.46,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,14.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,33840.0,1838021040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,35640.0,1838022840.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,15.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,37440.0,1838024640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,35640.0,1838022840.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),138.21,138.21,138.21,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,16.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,39240.0,1838026440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,35640.0,1838022840.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),450.25,450.25,450.25,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,17.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,41040.0,1838028240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,35640.0,1838022840.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),422.35,422.35,422.35,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,18.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,42840.0,1838030040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,35640.0,1838022840.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),333.35,333.35,333.35,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,19.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,46440.0,1838033640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,35640.0,1838022840.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),235.05,235.05,235.05,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,20.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,50040.0,1838037240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,35640.0,1838022840.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),196.79,196.79,196.79,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,21.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,53640.0,1838040840.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,35640.0,1838022840.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),134.97,134.97,134.97,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,22.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,57240.0,1838044440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,35640.0,1838022840.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),108.34,108.34,108.34,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,23.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,64440.0,1838051640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,35640.0,1838022840.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),59.7,59.70,59.70,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,24.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,78840.0,1838066040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,35640.0,1838022840.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.87,20.87,20.87,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,25.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,86040.0,1838073240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,35640.0,1838022840.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.39,10.39,10.39,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,26.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21274.0,35640.0,1838109240.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,35640.0,1838022840.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.57,2.57,2.57,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,27.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,33840.0,1838625840.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,35640.0,1838627640.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,28.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,37440.0,1838629440.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,35640.0,1838627640.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),154.14,154.14,154.14,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,29.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,39240.0,1838631240.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,35640.0,1838627640.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),371.6,371.60,371.60,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,30.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,41040.0,1838633040.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,35640.0,1838627640.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),287.71,287.71,287.71,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,31.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,42840.0,1838634840.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,35640.0,1838627640.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),241.31,241.31,241.31,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,32.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,46440.0,1838638440.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,35640.0,1838627640.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),181.1,181.10,181.10,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,33.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,50040.0,1838642040.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,35640.0,1838627640.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),153.54,153.54,153.54,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,34.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,53640.0,1838645640.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,35640.0,1838627640.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),105.88,105.88,105.88,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,35.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,57240.0,1838649240.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,35640.0,1838627640.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),76.22,76.22,76.22,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,36.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,64440.0,1838656440.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,35640.0,1838627640.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),50.89,50.89,50.89,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,37.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,78840.0,1838670840.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,35640.0,1838627640.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.15,18.15,18.15,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,38.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,86040.0,1838678040.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,35640.0,1838627640.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.44,11.44,11.44,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001067,103001067,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,35640.0,1837418040.0,21280.0,35640.0,1838627640.0,39.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,35640.0,1838714040.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,35640.0,1838627640.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.65,2.65,2.65,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,1.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,34920.0,1837417320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,36720.0,1837419120.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,2.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,38520.0,1837420920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,36720.0,1837419120.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),111.16,111.16,111.16,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,3.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,40320.0,1837422720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,36720.0,1837419120.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),342.36,342.36,342.36,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,4.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,42120.0,1837424520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,36720.0,1837419120.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),265.08,265.08,265.08,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,5.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,43920.0,1837426320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,36720.0,1837419120.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),232.33,232.33,232.33,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,6.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,47520.0,1837429920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,36720.0,1837419120.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),149.72,149.72,149.72,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,7.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,51280.0,1837433680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,36720.0,1837419120.0,4.044444444444444,HOURS,3.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),118.67,118.67,118.67,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,8.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,54720.0,1837437120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,36720.0,1837419120.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),88.83,88.83,88.83,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,9.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,58320.0,1837440720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,36720.0,1837419120.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),64.86,64.86,64.86,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,10.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,65520.0,1837447920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,36720.0,1837419120.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),32.11,32.11,32.11,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,11.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,79920.0,1837462320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,36720.0,1837419120.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.94,12.94,12.94,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,12.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,720.0,1837469520.0,2.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,36720.0,1837419120.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.52,8.52,8.52,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,13.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,36720.0,1837505520.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,36720.0,1837419120.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.62,1.62,1.62,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,14.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,34920.0,1838022120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,36720.0,1838023920.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,15.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,38520.0,1838025720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,36720.0,1838023920.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),101.9,101.90,101.90,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,16.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,40320.0,1838027520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,36720.0,1838023920.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),265.61,265.61,265.61,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,17.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,42120.0,1838029320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,36720.0,1838023920.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),221.26,221.26,221.26,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,18.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,43920.0,1838031120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,36720.0,1838023920.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),251.46,251.46,251.46,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,19.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,47520.0,1838034720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,36720.0,1838023920.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),205.29,205.29,205.29,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,20.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,51120.0,1838038320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,36720.0,1838023920.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),185.27,185.27,185.27,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,21.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,54720.0,1838041920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,36720.0,1838023920.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),138.43,138.43,138.43,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,22.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,58320.0,1838045520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,36720.0,1838023920.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),104.76,104.76,104.76,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,23.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,65686.0,1838052886.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,36720.0,1838023920.0,8.046111111111111,HOURS,3.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),76.58,76.58,76.58,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,24.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,79920.0,1838067120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,36720.0,1838023920.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),28.71,28.71,28.71,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,25.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,720.0,1838074320.0,9.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,36720.0,1838023920.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),19.22,19.22,19.22,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,26.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,36720.0,1838110320.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,36720.0,1838023920.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.11,3.11,3.11,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,27.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,34920.0,1838626920.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,36720.0,1838628720.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,28.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,38520.0,1838630520.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,36720.0,1838628720.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),65.08,65.08,65.08,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,29.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,40320.0,1838632320.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,36720.0,1838628720.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),349.21,349.21,349.21,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,30.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,42120.0,1838634120.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,36720.0,1838628720.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),268.15,268.15,268.15,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,31.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,43920.0,1838635920.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,36720.0,1838628720.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),268.87,268.87,268.87,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,32.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,47520.0,1838639520.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,36720.0,1838628720.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),213.03,213.03,213.03,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,33.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,51120.0,1838643120.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,36720.0,1838628720.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),181.73,181.73,181.73,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,34.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,54720.0,1838646720.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,36720.0,1838628720.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),125.94,125.94,125.94,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,35.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,58320.0,1838650320.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,36720.0,1838628720.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),100.86,100.86,100.86,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,36.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,65520.0,1838657520.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,36720.0,1838628720.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),56.33,56.33,56.33,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,37.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,79920.0,1838671920.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,36720.0,1838628720.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),19.8,19.80,19.80,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,38.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,720.0,1838679120.0,16.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,36720.0,1838628720.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.5,13.50,13.50,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001074,103001074,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36720.0,1837419120.0,21280.0,36720.0,1838628720.0,39.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,36720.0,1838715120.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,36720.0,1838628720.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.87,2.87,2.87,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,33900.0,1837416300.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,35700.0,1837418100.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,37500.0,1837419900.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,35700.0,1837418100.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.11,61.11,61.11,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,39300.0,1837421700.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,35700.0,1837418100.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),153.72,153.72,153.72,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,41100.0,1837423500.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,35700.0,1837418100.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),184.25,184.25,184.25,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,42900.0,1837425300.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,35700.0,1837418100.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),321.19,321.19,321.19,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,46500.0,1837428900.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,35700.0,1837418100.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),213.46,213.46,213.46,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,50100.0,1837432500.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,35700.0,1837418100.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),189.92,189.92,189.92,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,53700.0,1837436100.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,35700.0,1837418100.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),151.93,151.93,151.93,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,57300.0,1837439700.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,35700.0,1837418100.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),107.71,107.71,107.71,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,64500.0,1837446900.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,35700.0,1837418100.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),51.66,51.66,51.66,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,78900.0,1837461300.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,35700.0,1837418100.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.96,20.96,20.96,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,86230.0,1837468630.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,35700.0,1837418100.0,14.036111111111111,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.74,13.74,13.74,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,35700.0,1837504500.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,35700.0,1837418100.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.37,4.37,4.37,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,14.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,33900.0,1838021100.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,35758.0,1838022958.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,15.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,37500.0,1838024700.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,35758.0,1838022958.0,0.48388888888888887,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),105.69,105.69,105.69,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,16.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,39300.0,1838026500.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,35758.0,1838022958.0,0.9838888888888889,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),220.78,220.78,220.78,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,17.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,41100.0,1838028300.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,35758.0,1838022958.0,1.4838888888888888,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),341.7,341.70,341.70,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,18.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,42900.0,1838030100.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,35758.0,1838022958.0,1.9838888888888888,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),354.4,354.40,354.40,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,19.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,46500.0,1838033700.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,35758.0,1838022958.0,2.983888888888889,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),211.57,211.57,211.57,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,20.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,50100.0,1838037300.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,35758.0,1838022958.0,3.983888888888889,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),154.64,154.64,154.64,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,21.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,53700.0,1838040900.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,35758.0,1838022958.0,4.983888888888889,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),129.92,129.92,129.92,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,22.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,57300.0,1838044500.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,35758.0,1838022958.0,5.983888888888889,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),84.47,84.47,84.47,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,23.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,64500.0,1838051700.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,35758.0,1838022958.0,7.983888888888889,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),50.03,50.03,50.03,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,24.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,78900.0,1838066100.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,35758.0,1838022958.0,11.983888888888888,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.87,20.87,20.87,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,25.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,86100.0,1838073300.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,35758.0,1838022958.0,13.983888888888888,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.52,15.52,15.52,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,26.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,35700.0,1838109300.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,35758.0,1838022958.0,23.983888888888888,HOURS,-1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.68,4.68,4.68,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,27.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,33900.0,1838625900.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,35700.0,1838627700.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,28.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,37500.0,1838629500.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,35700.0,1838627700.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),149.98,149.98,149.98,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,29.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,39300.0,1838631300.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,35700.0,1838627700.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),450.54,450.54,450.54,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,30.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,41100.0,1838633100.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,35700.0,1838627700.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),306.42,306.42,306.42,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,31.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,42900.0,1838634900.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,35700.0,1838627700.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),443.24,443.24,443.24,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,32.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,46500.0,1838638500.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,35700.0,1838627700.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),253.81,253.81,253.81,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,33.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,50100.0,1838642100.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,35700.0,1838627700.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),196.88,196.88,196.88,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,34.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,53700.0,1838645700.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,35700.0,1838627700.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),160.73,160.73,160.73,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,35.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,57300.0,1838649300.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,35700.0,1838627700.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),110.51,110.51,110.51,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,36.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,64500.0,1838656500.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,35700.0,1838627700.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),81.15,81.15,81.15,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,37.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,78900.0,1838670900.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,35700.0,1838627700.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),27.5,27.50,27.50,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,38.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,86100.0,1838678100.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,35700.0,1838627700.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.65,15.65,15.65,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001079,103001079,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,35700.0,1837418100.0,21280.0,35700.0,1838627700.0,39.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,35700.0,1838714100.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,35700.0,1838627700.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.11,4.11,4.11,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,1.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,34980.0,1837417380.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,36780.0,1837419180.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,2.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,38580.0,1837420980.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,36780.0,1837419180.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),94.79,94.79,94.79,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,3.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,40380.0,1837422780.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,36780.0,1837419180.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),213.4,213.40,213.40,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,4.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,42180.0,1837424580.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,36780.0,1837419180.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),275.5,275.50,275.50,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,5.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,43980.0,1837426380.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,36780.0,1837419180.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),408.09,408.09,408.09,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,6.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,47580.0,1837429980.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,36780.0,1837419180.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),266.63,266.63,266.63,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,7.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,51180.0,1837433580.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,36780.0,1837419180.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),181.59,181.59,181.59,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,8.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,54780.0,1837437180.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,36780.0,1837419180.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),149.82,149.82,149.82,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,9.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,58380.0,1837440780.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,36780.0,1837419180.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),112.65,112.65,112.65,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,10.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,65580.0,1837447980.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,36780.0,1837419180.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),62.7,62.70,62.70,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,11.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,79980.0,1837462380.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,36780.0,1837419180.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),24.43,24.43,24.43,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,12.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,780.0,1837469580.0,2.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,36780.0,1837419180.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),16.49,16.49,16.49,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,13.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,36780.0,1837505580.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,36780.0,1837419180.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.12,3.12,3.12,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,14.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,34980.0,1838022180.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,36780.0,1838023980.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,15.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,38580.0,1838025780.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,36780.0,1838023980.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),49.53,49.53,49.53,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,16.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,40380.0,1838027580.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,36780.0,1838023980.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),230.46,230.46,230.46,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,17.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,42180.0,1838029380.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,36780.0,1838023980.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),308.57,308.57,308.57,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,18.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,43980.0,1838031180.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,36780.0,1838023980.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),276.93,276.93,276.93,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,19.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,47580.0,1838034780.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,36780.0,1838023980.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),194.56,194.56,194.56,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,20.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,51180.0,1838038380.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,36780.0,1838023980.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),162.34,162.34,162.34,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,21.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,54780.0,1838041980.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,36780.0,1838023980.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),110.52,110.52,110.52,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,22.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,58460.0,1838045660.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,36780.0,1838023980.0,6.022222222222222,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),79.64,79.64,79.64,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,23.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,65580.0,1838052780.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,36780.0,1838023980.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),50.04,50.04,50.04,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,24.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,79980.0,1838067180.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,36780.0,1838023980.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.3,17.30,17.30,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,25.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,780.0,1838074380.0,9.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,36780.0,1838023980.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.96,10.96,10.96,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,26.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,36780.0,1838110380.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,36780.0,1838023980.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.7,2.70,2.70,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,27.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,34980.0,1838626980.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,36780.0,1838628780.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,28.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,38580.0,1838630580.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,36780.0,1838628780.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),50.48,50.48,50.48,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,29.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,40380.0,1838632380.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,36780.0,1838628780.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),184.37,184.37,184.37,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,30.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,42180.0,1838634180.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,36780.0,1838628780.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),274.59,274.59,274.59,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,31.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,43980.0,1838635980.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,36780.0,1838628780.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),376.28,376.28,376.28,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,32.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,47580.0,1838639580.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,36780.0,1838628780.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),309.17,309.17,309.17,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,33.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,51180.0,1838643180.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,36780.0,1838628780.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),232.89,232.89,232.89,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,34.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,54780.0,1838646780.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,36780.0,1838628780.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),173.08,173.08,173.08,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,35.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,58380.0,1838650380.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,36780.0,1838628780.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),113.56,113.56,113.56,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,36.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,65580.0,1838657580.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,36780.0,1838628780.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),70.97,70.97,70.97,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,37.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,79980.0,1838671980.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,36780.0,1838628780.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),26.33,26.33,26.33,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,38.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,780.0,1838679180.0,16.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,36780.0,1838628780.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.06,15.06,15.06,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001089,103001089,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36780.0,1837419180.0,21280.0,36780.0,1838628780.0,39.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,36780.0,1838715180.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,36780.0,1838628780.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.04,3.04,3.04,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,33300.0,1837415700.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,35100.0,1837417500.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,36900.0,1837419300.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,35100.0,1837417500.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),80.6,80.60,80.60,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,38762.0,1837421162.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,35100.0,1837417500.0,1.0172222222222222,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),182.21,182.21,182.21,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,40500.0,1837422900.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,35100.0,1837417500.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),134.66,134.66,134.66,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,42300.0,1837424700.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,35100.0,1837417500.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),134.36,134.36,134.36,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,45900.0,1837428300.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,35100.0,1837417500.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),108.05,108.05,108.05,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,49500.0,1837431900.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,35100.0,1837417500.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),82.91,82.91,82.91,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,53100.0,1837435500.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,35100.0,1837417500.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),64.28,64.28,64.28,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,56700.0,1837439100.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,35100.0,1837417500.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),43.81,43.81,43.81,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,63900.0,1837446300.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,35100.0,1837417500.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),31.65,31.65,31.65,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,78300.0,1837460700.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,35100.0,1837417500.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.28,13.28,13.28,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,85500.0,1837467900.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,35100.0,1837417500.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.08,9.08,9.08,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,35100.0,1837503900.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,35100.0,1837417500.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.41,2.41,2.41,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,14.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,33300.0,1838020500.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,35100.0,1838022300.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,15.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,36980.0,1838024180.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,35100.0,1838022300.0,0.5222222222222223,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),91.93,91.93,91.93,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,16.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,38700.0,1838025900.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,35100.0,1838022300.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),136.54,136.54,136.54,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,17.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,40500.0,1838027700.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,35100.0,1838022300.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),149.89,149.89,149.89,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,18.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,42300.0,1838029500.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,35100.0,1838022300.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),142.85,142.85,142.85,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,19.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,45981.0,1838033181.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,35100.0,1838022300.0,3.0225,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),91.75,91.75,91.75,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,20.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,49500.0,1838036700.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,35100.0,1838022300.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),90.75,90.75,90.75,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,21.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,53100.0,1838040300.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,35100.0,1838022300.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),77.12,77.12,77.12,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,22.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,56700.0,1838043900.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,35100.0,1838022300.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),62.09,62.09,62.09,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,23.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,63900.0,1838051100.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,35100.0,1838022300.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),29.52,29.52,29.52,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,24.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,78300.0,1838065500.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,35100.0,1838022300.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.34,12.34,12.34,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,25.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,85500.0,1838072700.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,35100.0,1838022300.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.41,8.41,8.41,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,26.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21274.0,35100.0,1838108700.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,35100.0,1838022300.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.58,2.58,2.58,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,27.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,33300.0,1838625300.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,35100.0,1838627100.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,28.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,36900.0,1838628900.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,35100.0,1838627100.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.08,11.08,11.08,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,29.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,38700.0,1838630700.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,35100.0,1838627100.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),21.41,21.41,21.41,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,30.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,40500.0,1838632500.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,35100.0,1838627100.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),45.28,45.28,45.28,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,31.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,42300.0,1838634300.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,35100.0,1838627100.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),51.02,51.02,51.02,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,32.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,45900.0,1838637900.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,35100.0,1838627100.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),216.47,216.47,216.47,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,33.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,49500.0,1838641500.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,35100.0,1838627100.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),139.77,139.77,139.77,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,34.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,53100.0,1838645100.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,35100.0,1838627100.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),98.13,98.13,98.13,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,35.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,56700.0,1838648700.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,35100.0,1838627100.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),62.38,62.38,62.38,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,36.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,63900.0,1838655900.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,35100.0,1838627100.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),43.46,43.46,43.46,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,37.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,78300.0,1838670300.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,35100.0,1838627100.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.83,17.83,17.83,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,38.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,85500.0,1838677500.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,35100.0,1838627100.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.25,12.25,12.25,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001092,103001092,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35100.0,1837417500.0,21280.0,35100.0,1838627100.0,39.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,35162.0,1838713562.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,35100.0,1838627100.0,24.017222222222223,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.47,2.47,2.47,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,34140.0,1837416540.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,35940.0,1837418340.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,37740.0,1837420140.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,35940.0,1837418340.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),278.11,278.11,278.11,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,39540.0,1837421940.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,35940.0,1837418340.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),613.87,613.87,613.87,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,41402.0,1837423802.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,35940.0,1837418340.0,1.5172222222222222,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),470.34,470.34,470.34,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,43140.0,1837425540.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,35940.0,1837418340.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),306.07,306.07,306.07,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,46740.0,1837429140.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,35940.0,1837418340.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),237.18,237.18,237.18,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,50340.0,1837432740.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,35940.0,1837418340.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),165.7,165.70,165.70,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,53940.0,1837436340.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,35940.0,1837418340.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),143.63,143.63,143.63,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,57540.0,1837439940.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,35940.0,1837418340.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),90.33,90.33,90.33,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,64740.0,1837447140.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,35940.0,1837418340.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),60.23,60.23,60.23,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,79140.0,1837461540.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,35940.0,1837418340.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),23.71,23.71,23.71,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,86340.0,1837468740.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,35940.0,1837418340.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),16.83,16.83,16.83,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,35940.0,1837504740.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,35940.0,1837418340.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.9,3.90,3.90,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,14.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,34140.0,1838021340.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,35940.0,1838023140.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,15.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,37740.0,1838024940.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,35940.0,1838023140.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),187.48,187.48,187.48,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,16.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,39540.0,1838026740.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,35940.0,1838023140.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),580.63,580.63,580.63,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,17.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,41340.0,1838028540.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,35940.0,1838023140.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),393.2,393.20,393.20,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,18.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,43140.0,1838030340.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,35940.0,1838023140.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),279.71,279.71,279.71,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,19.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,46740.0,1838033940.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,35940.0,1838023140.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),174.52,174.52,174.52,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,20.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,50340.0,1838037540.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,35940.0,1838023140.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),131.1,131.10,131.10,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,21.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,53940.0,1838041140.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,35940.0,1838023140.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),113.04,113.04,113.04,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,22.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,57540.0,1838044740.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,35940.0,1838023140.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),78.18,78.18,78.18,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,23.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,64740.0,1838051940.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,35940.0,1838023140.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),51.32,51.32,51.32,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,24.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,79140.0,1838066340.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,35940.0,1838023140.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.81,18.81,18.81,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,25.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,86340.0,1838073540.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,35940.0,1838023140.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.07,14.07,14.07,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,26.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21274.0,35940.0,1838109540.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,35940.0,1838023140.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.4,2.40,2.40,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,27.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,34140.0,1838626140.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,35940.0,1838627940.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,28.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,37740.0,1838629740.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,35940.0,1838627940.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),138.99,138.99,138.99,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,29.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,39540.0,1838631540.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,35940.0,1838627940.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),555.95,555.95,555.95,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,30.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,41340.0,1838633340.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,35940.0,1838627940.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),340.72,340.72,340.72,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,31.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,43140.0,1838635140.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,35940.0,1838627940.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),293.06,293.06,293.06,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,32.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,46740.0,1838638740.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,35940.0,1838627940.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),171.98,171.98,171.98,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,33.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,50340.0,1838642340.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,35940.0,1838627940.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),143.51,143.51,143.51,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,34.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,53940.0,1838645940.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,35940.0,1838627940.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),118.52,118.52,118.52,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,35.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,57540.0,1838649540.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,35940.0,1838627940.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),82.82,82.82,82.82,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,36.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,64740.0,1838656740.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,35940.0,1838627940.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),65.46,65.46,65.46,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,37.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,79140.0,1838671140.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,35940.0,1838627940.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),22.74,22.74,22.74,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,38.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,86340.0,1838678340.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,35940.0,1838627940.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.95,13.95,13.95,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001096,103001096,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,35940.0,1837418340.0,21280.0,35940.0,1838627940.0,39.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,35940.0,1838714340.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,35940.0,1838627940.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.19,3.19,3.19,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,34320.0,1837416720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,36120.0,1837418520.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,37920.0,1837420320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,36120.0,1837418520.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),92.79,92.79,92.79,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,39720.0,1837422120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,36120.0,1837418520.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),428.26,428.26,428.26,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,41520.0,1837423920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,36120.0,1837418520.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),536.45,536.45,536.45,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,43320.0,1837425720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,36120.0,1837418520.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),399.66,399.66,399.66,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,46920.0,1837429320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,36120.0,1837418520.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),297.51,297.51,297.51,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,50520.0,1837432920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,36120.0,1837418520.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),238.64,238.64,238.64,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,54120.0,1837436520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,36120.0,1837418520.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),157.65,157.65,157.65,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,57720.0,1837440120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,36120.0,1837418520.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),109.96,109.96,109.96,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,65046.0,1837447446.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,36120.0,1837418520.0,8.035,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),54.44,54.44,54.44,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,79320.0,1837461720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,36120.0,1837418520.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.52,20.52,20.52,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,120.0,1837468920.0,2.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,36120.0,1837418520.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.33,13.33,13.33,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,36120.0,1837504920.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,36120.0,1837418520.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.87,3.87,3.87,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,14.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,34320.0,1838021520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,36120.0,1838023320.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,15.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,37920.0,1838025120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,36120.0,1838023320.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.87,7.87,7.87,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,16.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,39720.0,1838026920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,36120.0,1838023320.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.29,20.29,20.29,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,17.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,41520.0,1838028720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,36120.0,1838023320.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),89.96,89.96,89.96,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,18.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,43320.0,1838030520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,36120.0,1838023320.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),195.82,195.82,195.82,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,19.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,46920.0,1838034120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,36120.0,1838023320.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),177.57,177.57,177.57,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,20.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,50520.0,1838037720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,36120.0,1838023320.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),274.84,274.84,274.84,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,21.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,54120.0,1838041320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,36120.0,1838023320.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),279.44,279.44,279.44,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,22.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,57720.0,1838044920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,36120.0,1838023320.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),219.53,219.53,219.53,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,23.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,64920.0,1838052120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,36120.0,1838023320.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),130.84,130.84,130.84,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,24.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,79320.0,1838066520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,36120.0,1838023320.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),30.46,30.46,30.46,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,25.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,120.0,1838073720.0,9.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,36120.0,1838023320.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),24.38,24.38,24.38,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,26.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,36120.0,1838109720.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,36120.0,1838023320.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.15,6.15,6.15,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,27.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,34320.0,1838626320.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,36120.0,1838628120.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,28.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,37920.0,1838629920.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,36120.0,1838628120.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.55,20.55,20.55,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,29.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,39720.0,1838631720.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,36120.0,1838628120.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),163.52,163.52,163.52,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,30.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,41520.0,1838633520.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,36120.0,1838628120.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),196.49,196.49,196.49,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,31.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,43320.0,1838635320.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,36120.0,1838628120.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),240.88,240.88,240.88,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,32.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,46920.0,1838638920.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,36120.0,1838628120.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),313.69,313.69,313.69,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,33.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,50520.0,1838642520.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,36120.0,1838628120.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),260.29,260.29,260.29,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,34.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,54120.0,1838646120.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,36120.0,1838628120.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),202.08,202.08,202.08,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,35.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,57720.0,1838649720.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,36120.0,1838628120.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),152.33,152.33,152.33,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,36.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,64920.0,1838656920.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,36120.0,1838628120.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),74.05,74.05,74.05,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,37.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,79320.0,1838671320.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,36120.0,1838628120.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),27.54,27.54,27.54,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,38.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,120.0,1838678520.0,16.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,36120.0,1838628120.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.0,20.00,20.00,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001098,103001098,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,36120.0,1837418520.0,21280.0,36120.0,1838628120.0,39.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,36120.0,1838714520.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,36120.0,1838628120.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.08,5.08,5.08,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,34020.0,1837416420.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,35820.0,1837418220.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,37620.0,1837420020.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,35820.0,1837418220.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),180.57,180.57,180.57,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,39420.0,1837421820.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,35820.0,1837418220.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),606.16,606.16,606.16,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,41220.0,1837423620.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,35820.0,1837418220.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),499.19,499.19,499.19,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,43020.0,1837425420.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,35820.0,1837418220.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),532.76,532.76,532.76,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,46620.0,1837429020.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,35820.0,1837418220.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),388.56,388.56,388.56,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,50220.0,1837432620.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,35820.0,1837418220.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),298.09,298.09,298.09,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,53820.0,1837436220.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,35820.0,1837418220.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),220.34,220.34,220.34,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,57420.0,1837439820.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,35820.0,1837418220.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),169.87,169.87,169.87,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,64620.0,1837447020.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,35820.0,1837418220.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),102.97,102.97,102.97,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,11.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,79020.0,1837461420.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,35820.0,1837418220.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),35.62,35.62,35.62,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,12.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,86220.0,1837468620.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,35820.0,1837418220.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),24.08,24.08,24.08,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,13.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,35820.0,1837504620.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,35820.0,1837418220.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.01,5.01,5.01,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,14.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,34020.0,1838021220.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,35820.0,1838023020.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,15.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,37620.0,1838024820.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,35820.0,1838023020.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.59,15.59,15.59,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,16.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,39420.0,1838026620.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,35820.0,1838023020.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),176.47,176.47,176.47,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,17.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,41220.0,1838028420.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,35820.0,1838023020.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),263.25,263.25,263.25,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,18.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,43178.0,1838030378.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,35820.0,1838023020.0,2.043888888888889,HOURS,3.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),437.07,437.07,437.07,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,19.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,46620.0,1838033820.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,35820.0,1838023020.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),407.54,407.54,407.54,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,20.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,50220.0,1838037420.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,35820.0,1838023020.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),300.88,300.88,300.88,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,21.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,53820.0,1838041020.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,35820.0,1838023020.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),215.66,215.66,215.66,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,22.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,57420.0,1838044620.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,35820.0,1838023020.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),170.71,170.71,170.71,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,23.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,64620.0,1838051820.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,35820.0,1838023020.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),106.85,106.85,106.85,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,24.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,79020.0,1838066220.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,35820.0,1838023020.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),37.08,37.08,37.08,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,25.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,86220.0,1838073420.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,35820.0,1838023020.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),22.85,22.85,22.85,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001105,103001105,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,35820.0,1837418220.0,21273.0,35820.0,1838023020.0,26.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,35820.0,1838109420.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,35820.0,1838023020.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.49,5.49,5.49,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,1.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,32880.0,1837415280.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,34680.0,1837417080.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,2.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,36480.0,1837418880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,34680.0,1837417080.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.91,15.91,15.91,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,3.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,38280.0,1837420680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,34680.0,1837417080.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),205.13,205.13,205.13,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,4.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,40080.0,1837422480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,34680.0,1837417080.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),229.79,229.79,229.79,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,5.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,41880.0,1837424280.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,34680.0,1837417080.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),248.16,248.16,248.16,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,6.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,45480.0,1837427880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,34680.0,1837417080.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),166.57,166.57,166.57,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,7.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,49080.0,1837431480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,34680.0,1837417080.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),136.69,136.69,136.69,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,8.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,52680.0,1837435080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,34680.0,1837417080.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),109.36,109.36,109.36,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,9.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,56280.0,1837438680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,34680.0,1837417080.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),75.0,75.00,75.00,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,10.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,63480.0,1837445880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,34680.0,1837417080.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),46.07,46.07,46.07,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,11.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,77880.0,1837460280.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,34680.0,1837417080.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.1,18.10,18.10,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,12.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,85080.0,1837467480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,34680.0,1837417080.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.94,11.94,11.94,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,13.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,34680.0,1837503480.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,34680.0,1837417080.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.39,3.39,3.39,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,14.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,32880.0,1838020080.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,34680.0,1838021880.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,15.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,36480.0,1838023680.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,34680.0,1838021880.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),43.31,43.31,43.31,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,16.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,38280.0,1838025480.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,34680.0,1838021880.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),275.81,275.81,275.81,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,17.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,40080.0,1838027280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,34680.0,1838021880.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),220.69,220.69,220.69,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,18.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,41880.0,1838029080.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,34680.0,1838021880.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),247.14,247.14,247.14,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,19.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,45480.0,1838032680.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,34680.0,1838021880.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),161.58,161.58,161.58,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,20.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,49080.0,1838036280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,34680.0,1838021880.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),117.95,117.95,117.95,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,21.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,52680.0,1838039880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,34680.0,1838021880.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),88.4,88.40,88.40,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,22.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,56280.0,1838043480.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,34680.0,1838021880.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),70.8,70.80,70.80,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,23.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,63480.0,1838050680.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,34680.0,1838021880.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),40.92,40.92,40.92,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,24.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,77880.0,1838065080.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,34680.0,1838021880.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),16.13,16.13,16.13,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,25.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,85080.0,1838072280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,34680.0,1838021880.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.56,9.56,9.56,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,26.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,34680.0,1838108280.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,34680.0,1838021880.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.27,2.27,2.27,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,27.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,32880.0,1838624880.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,34680.0,1838626680.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,28.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,36480.0,1838628480.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,34680.0,1838626680.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.73,10.73,10.73,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,29.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,38280.0,1838630280.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,34680.0,1838626680.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),49.83,49.83,49.83,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,30.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,40080.0,1838632080.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,34680.0,1838626680.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),91.92,91.92,91.92,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,31.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,41880.0,1838633880.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,34680.0,1838626680.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),192.83,192.83,192.83,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,32.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,45480.0,1838637480.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,34680.0,1838626680.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),202.26,202.26,202.26,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,33.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,49080.0,1838641080.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,34680.0,1838626680.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),218.7,218.70,218.70,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,34.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,52680.0,1838644680.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,34680.0,1838626680.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),169.04,169.04,169.04,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,35.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,56280.0,1838648280.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,34680.0,1838626680.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),127.62,127.62,127.62,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,36.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,63480.0,1838655480.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,34680.0,1838626680.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),60.56,60.56,60.56,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,37.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,77880.0,1838669880.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,34680.0,1838626680.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),27.92,27.92,27.92,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,38.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,85080.0,1838677080.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,34680.0,1838626680.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.06,18.06,18.06,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001107,103001107,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,34680.0,1837417080.0,21280.0,34680.0,1838626680.0,39.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,34680.0,1838713080.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,34680.0,1838626680.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.63,2.63,2.63,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,1.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,34800.0,1837417200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,36600.0,1837419000.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,2.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,38400.0,1837420800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,36600.0,1837419000.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),214.96,214.96,214.96,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,3.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,40200.0,1837422600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,36600.0,1837419000.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),497.23,497.23,497.23,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,4.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,42010.0,1837424410.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,36600.0,1837419000.0,1.5027777777777778,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),307.66,307.66,307.66,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,5.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,43800.0,1837426200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,36600.0,1837419000.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),214.33,214.33,214.33,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,6.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,47473.0,1837429873.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,36600.0,1837419000.0,3.020277777777778,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),129.97,129.97,129.97,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,7.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,51000.0,1837433400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,36600.0,1837419000.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),105.82,105.82,105.82,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,8.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,54600.0,1837437000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,36600.0,1837419000.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),75.11,75.11,75.11,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,9.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,58200.0,1837440600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,36600.0,1837419000.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),57.32,57.32,57.32,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,10.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,65400.0,1837447800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,36600.0,1837419000.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),31.52,31.52,31.52,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,11.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,79800.0,1837462200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,36600.0,1837419000.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.29,13.29,13.29,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,12.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,600.0,1837469400.0,2.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,36600.0,1837419000.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.24,8.24,8.24,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,13.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,36600.0,1837505400.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,36600.0,1837419000.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.3,2.30,2.30,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,14.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,34800.0,1838022000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,36600.0,1838023800.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,15.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,38400.0,1838025600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,36600.0,1838023800.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),169.55,169.55,169.55,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,16.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,40200.0,1838027400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,36600.0,1838023800.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),394.81,394.81,394.81,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,17.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,42000.0,1838029200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,36600.0,1838023800.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),289.0,289.00,289.00,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,18.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,43800.0,1838031000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,36600.0,1838023800.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),215.34,215.34,215.34,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,19.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,47400.0,1838034600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,36600.0,1838023800.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),144.5,144.50,144.50,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,20.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,51000.0,1838038200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,36600.0,1838023800.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),97.69,97.69,97.69,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,21.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,54600.0,1838041800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,36600.0,1838023800.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),80.72,80.72,80.72,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,22.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,58200.0,1838045400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,36600.0,1838023800.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),65.45,65.45,65.45,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,23.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,65400.0,1838052600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,36600.0,1838023800.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),42.78,42.78,42.78,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,24.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,79800.0,1838067000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,36600.0,1838023800.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.38,20.38,20.38,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,25.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,600.0,1838074200.0,9.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,36600.0,1838023800.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.07,15.07,15.07,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,26.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,36600.0,1838110200.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,36600.0,1838023800.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.06,4.06,4.06,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,27.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21287.0,34800.0,1839231600.0,22.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21287.0,36600.0,1839233400.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,28.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21287.0,38400.0,1839235200.0,22.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21287.0,36600.0,1839233400.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),126.42,126.42,126.42,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,29.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21287.0,40200.0,1839237000.0,22.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21287.0,36600.0,1839233400.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),354.26,354.26,354.26,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,30.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21287.0,42000.0,1839238800.0,22.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21287.0,36600.0,1839233400.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),304.95,304.95,304.95,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,31.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21287.0,43800.0,1839240600.0,22.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21287.0,36600.0,1839233400.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),290.82,290.82,290.82,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,32.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21287.0,47400.0,1839244200.0,22.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21287.0,36600.0,1839233400.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),170.2,170.20,170.20,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,33.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21287.0,51000.0,1839247800.0,22.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21287.0,36600.0,1839233400.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),126.05,126.05,126.05,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,34.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21287.0,54600.0,1839251400.0,22.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21287.0,36600.0,1839233400.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),91.71,91.71,91.71,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,35.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21287.0,58200.0,1839255000.0,22.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21287.0,36600.0,1839233400.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),74.75,74.75,74.75,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,36.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21287.0,65400.0,1839262200.0,22.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21287.0,36600.0,1839233400.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),42.06,42.06,42.06,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,37.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21287.0,79800.0,1839276600.0,22.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21287.0,36600.0,1839233400.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.92,14.92,14.92,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,38.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21288.0,600.0,1839283800.0,23.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21287.0,36600.0,1839233400.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.53,9.53,9.53,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001111,103001111,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36600.0,1837419000.0,21287.0,36600.0,1839233400.0,39.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21288.0,36600.0,1839319800.0,23.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21287.0,36600.0,1839233400.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.45,2.45,2.45,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,32940.0,1837415340.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,34740.0,1837417140.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,36540.0,1837418940.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,34740.0,1837417140.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),194.1,194.10,194.10,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,38340.0,1837420740.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,34740.0,1837417140.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),257.23,257.23,257.23,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,40140.0,1837422540.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,34740.0,1837417140.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),170.42,170.42,170.42,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,42099.0,1837424499.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,34740.0,1837417140.0,2.0441666666666665,HOURS,3.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),140.73,140.73,140.73,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,45540.0,1837427940.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,34740.0,1837417140.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),103.12,103.12,103.12,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,49140.0,1837431540.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,34740.0,1837417140.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),76.17,76.17,76.17,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,52740.0,1837435140.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,34740.0,1837417140.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.9,61.90,61.90,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,56428.0,1837438828.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,34740.0,1837417140.0,6.024444444444445,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),43.6,43.60,43.60,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,63783.0,1837446183.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,34740.0,1837417140.0,8.0675,HOURS,4.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),26.61,26.61,26.61,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,11.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,78016.0,1837460416.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,34740.0,1837417140.0,12.02111111111111,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.0,10.00,10.00,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,12.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,85140.0,1837467540.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,34740.0,1837417140.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.71,6.71,6.71,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,13.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,34740.0,1837503540.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,34740.0,1837417140.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.36,1.36,1.36,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,14.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,32940.0,1838020140.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,34740.0,1838021940.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,15.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,36540.0,1838023740.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,34740.0,1838021940.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),118.52,118.52,118.52,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,16.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,38340.0,1838025540.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,34740.0,1838021940.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),282.42,282.42,282.42,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,17.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,40140.0,1838027340.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,34740.0,1838021940.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),222.41,222.41,222.41,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,18.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,41940.0,1838029140.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,34740.0,1838021940.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),194.51,194.51,194.51,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,19.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,45540.0,1838032740.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,34740.0,1838021940.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),174.25,174.25,174.25,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,20.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,49140.0,1838036340.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,34740.0,1838021940.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),115.57,115.57,115.57,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,21.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,52740.0,1838039940.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,34740.0,1838021940.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),69.14,69.14,69.14,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,22.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,56340.0,1838043540.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,34740.0,1838021940.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),55.31,55.31,55.31,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,23.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,63540.0,1838050740.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,34740.0,1838021940.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),31.54,31.54,31.54,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,24.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,77940.0,1838065140.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,34740.0,1838021940.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.25,12.25,12.25,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,25.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,85140.0,1838072340.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,34740.0,1838021940.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.98,5.98,5.98,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,26.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21274.0,34740.0,1838108340.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,34740.0,1838021940.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.02,1.02,1.02,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,27.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,32940.0,1838624940.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,34740.0,1838626740.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,28.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,36540.0,1838628540.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,34740.0,1838626740.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),24.59,24.59,24.59,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,29.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,38340.0,1838630340.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,34740.0,1838626740.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),81.41,81.41,81.41,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,30.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,40140.0,1838632140.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,34740.0,1838626740.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),161.51,161.51,161.51,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,31.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,41940.0,1838633940.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,34740.0,1838626740.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),158.53,158.53,158.53,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,32.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,45540.0,1838637540.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,34740.0,1838626740.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),210.45,210.45,210.45,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,33.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,49140.0,1838641140.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,34740.0,1838626740.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),144.54,144.54,144.54,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,34.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,52810.0,1838644810.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,34740.0,1838626740.0,5.019444444444445,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),86.11,86.11,86.11,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,35.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,56340.0,1838648340.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,34740.0,1838626740.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),56.29,56.29,56.29,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,36.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,63540.0,1838655540.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,34740.0,1838626740.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),32.53,32.53,32.53,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,37.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,77940.0,1838669940.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,34740.0,1838626740.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.79,10.79,10.79,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,38.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,85140.0,1838677140.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,34740.0,1838626740.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.14,7.14,7.14,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001114,103001114,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21266.0,34740.0,1837417140.0,21280.0,34740.0,1838626740.0,39.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,34951.0,1838713351.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,34740.0,1838626740.0,24.058611111111112,HOURS,4.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.71,1.71,1.71,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,1.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,34500.0,1837416900.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,36300.0,1837418700.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,2.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,38100.0,1837420500.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,36300.0,1837418700.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.72,61.72,61.72,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,3.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,39900.0,1837422300.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,36300.0,1837418700.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),219.33,219.33,219.33,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,4.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,41700.0,1837424100.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,36300.0,1837418700.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),266.99,266.99,266.99,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,5.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,43500.0,1837425900.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,36300.0,1837418700.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),222.94,222.94,222.94,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,6.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,47100.0,1837429500.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,36300.0,1837418700.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),154.47,154.47,154.47,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,7.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,50700.0,1837433100.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,36300.0,1837418700.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),126.15,126.15,126.15,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,8.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,54300.0,1837436700.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,36300.0,1837418700.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),79.92,79.92,79.92,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,9.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,57900.0,1837440300.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,36300.0,1837418700.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.33,61.33,61.33,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,10.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,65100.0,1837447500.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,36300.0,1837418700.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),29.24,29.24,29.24,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,11.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,79500.0,1837461900.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,36300.0,1837418700.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.34,7.34,7.34,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,12.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,300.0,1837469100.0,2.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,36300.0,1837418700.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.16,4.16,4.16,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,13.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,36300.0,1837505100.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,36300.0,1837418700.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.44,1.44,1.44,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,14.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,34500.0,1838021700.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,36300.0,1838023500.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,15.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,38100.0,1838025300.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,36300.0,1838023500.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),177.93,177.93,177.93,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,16.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,39900.0,1838027100.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,36300.0,1838023500.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),387.62,387.62,387.62,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,17.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,41700.0,1838028900.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,36300.0,1838023500.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),294.31,294.31,294.31,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,18.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,43500.0,1838030700.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,36300.0,1838023500.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),286.66,286.66,286.66,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,19.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,47100.0,1838034300.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,36300.0,1838023500.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),187.5,187.50,187.50,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,20.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,50700.0,1838037900.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,36300.0,1838023500.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),122.95,122.95,122.95,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,21.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,54300.0,1838041500.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,36300.0,1838023500.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),89.32,89.32,89.32,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,22.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,57900.0,1838045100.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,36300.0,1838023500.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),64.32,64.32,64.32,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,23.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,65100.0,1838052300.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,36300.0,1838023500.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),38.26,38.26,38.26,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,24.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,79500.0,1838066700.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,36300.0,1838023500.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.85,9.85,9.85,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,25.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,300.0,1838073900.0,9.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,36300.0,1838023500.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.81,5.81,5.81,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,26.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,36300.0,1838109900.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,36300.0,1838023500.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.75,1.75,1.75,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,27.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,34500.0,1838626500.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,36300.0,1838628300.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,28.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,38100.0,1838630100.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,36300.0,1838628300.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),149.56,149.56,149.56,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,29.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,39900.0,1838631900.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,36300.0,1838628300.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),326.46,326.46,326.46,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,30.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,41700.0,1838633700.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,36300.0,1838628300.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),294.46,294.46,294.46,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,31.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,43500.0,1838635500.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,36300.0,1838628300.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),225.22,225.22,225.22,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,32.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,47100.0,1838639100.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,36300.0,1838628300.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),148.1,148.10,148.10,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,33.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,50700.0,1838642700.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,36300.0,1838628300.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),104.15,104.15,104.15,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,34.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,54300.0,1838646300.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,36300.0,1838628300.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),86.49,86.49,86.49,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,35.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,57900.0,1838649900.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,36300.0,1838628300.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),63.63,63.63,63.63,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,36.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,65100.0,1838657100.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,36300.0,1838628300.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),33.96,33.96,33.96,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,37.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21280.0,79500.0,1838671500.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,36300.0,1838628300.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.0,10.00,10.00,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,38.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,300.0,1838678700.0,16.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,36300.0,1838628300.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.65,4.65,4.65,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001129,103001129,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21266.0,36300.0,1837418700.0,21280.0,36300.0,1838628300.0,39.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21281.0,36300.0,1838714700.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,36300.0,1838628300.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.65,1.65,1.65,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,1.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,33360.0,1837415760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,35160.0,1837417560.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,2.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,36960.0,1837419360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,35160.0,1837417560.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),152.32,152.32,152.32,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,3.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,38760.0,1837421160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,35160.0,1837417560.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),468.96,468.96,468.96,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,4.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,40560.0,1837422960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,35160.0,1837417560.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),411.9,411.90,411.90,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,5.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,42360.0,1837424760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,35160.0,1837417560.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),410.37,410.37,410.37,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,6.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,45960.0,1837428360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,35160.0,1837417560.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),242.17,242.17,242.17,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,7.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,49560.0,1837431960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,35160.0,1837417560.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),174.1,174.10,174.10,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,8.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,53160.0,1837435560.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,35160.0,1837417560.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),132.79,132.79,132.79,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,9.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,56760.0,1837439160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,35160.0,1837417560.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),96.53,96.53,96.53,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,10.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,63960.0,1837446360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,35160.0,1837417560.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),62.0,62.00,62.00,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,11.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,78360.0,1837460760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,35160.0,1837417560.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.05,17.05,17.05,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,12.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,85560.0,1837467960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,35160.0,1837417560.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.67,10.67,10.67,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,13.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,35160.0,1837503960.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,35160.0,1837417560.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.55,2.55,2.55,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,14.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,33360.0,1838020560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,35160.0,1838022360.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,15.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,36960.0,1838024160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,35160.0,1838022360.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),70.34,70.34,70.34,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,16.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,38760.0,1838025960.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,35160.0,1838022360.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),341.91,341.91,341.91,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,17.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,40560.0,1838027760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,35160.0,1838022360.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),313.37,313.37,313.37,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,18.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,42360.0,1838029560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,35160.0,1838022360.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),265.26,265.26,265.26,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,19.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,45960.0,1838033160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,35160.0,1838022360.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),216.59,216.59,216.59,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,20.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,49560.0,1838036760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,35160.0,1838022360.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),185.92,185.92,185.92,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,21.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,53160.0,1838040360.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,35160.0,1838022360.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),118.75,118.75,118.75,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,22.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,56760.0,1838043960.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,35160.0,1838022360.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),87.5,87.50,87.50,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,23.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,63960.0,1838051160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,35160.0,1838022360.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),57.1,57.10,57.10,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,24.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,78360.0,1838065560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,35160.0,1838022360.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),16.52,16.52,16.52,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,25.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,85560.0,1838072760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,35160.0,1838022360.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.8,10.80,10.80,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,26.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,35160.0,1838108760.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,35160.0,1838022360.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.1,2.10,2.10,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,27.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,33360.0,1838625360.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,35160.0,1838627160.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,28.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,36960.0,1838628960.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,35160.0,1838627160.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),200.29,200.29,200.29,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,29.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,38760.0,1838630760.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,35160.0,1838627160.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),673.91,673.91,673.91,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,30.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,40560.0,1838632560.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,35160.0,1838627160.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),415.47,415.47,415.47,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,31.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,42360.0,1838634360.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,35160.0,1838627160.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),343.77,343.77,343.77,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,32.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,45960.0,1838637960.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,35160.0,1838627160.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),274.23,274.23,274.23,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,33.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,49560.0,1838641560.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,35160.0,1838627160.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),223.28,223.28,223.28,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,34.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,53160.0,1838645160.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,35160.0,1838627160.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),156.91,156.91,156.91,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,35.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,56760.0,1838648760.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,35160.0,1838627160.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),112.67,112.67,112.67,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,36.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,63960.0,1838655960.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,35160.0,1838627160.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),75.34,75.34,75.34,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,37.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,78360.0,1838670360.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,35160.0,1838627160.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.45,20.45,20.45,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,38.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,85560.0,1838677560.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,35160.0,1838627160.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.36,12.36,12.36,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001136,103001136,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,35160.0,1837417560.0,21280.0,35160.0,1838627160.0,39.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,35160.0,1838713560.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,35160.0,1838627160.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.69,2.69,2.69,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,1.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,33000.0,1837415400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,34800.0,1837417200.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,2.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,36600.0,1837419000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,34800.0,1837417200.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),46.92,46.92,46.92,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,3.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,38400.0,1837420800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,34800.0,1837417200.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),232.5,232.50,232.50,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,4.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,40200.0,1837422600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,34800.0,1837417200.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),212.84,212.84,212.84,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,5.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,42000.0,1837424400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,34800.0,1837417200.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),208.72,208.72,208.72,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,6.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,45600.0,1837428000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,34800.0,1837417200.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),132.49,132.49,132.49,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,7.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,49200.0,1837431600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,34800.0,1837417200.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),147.75,147.75,147.75,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,8.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,52800.0,1837435200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,34800.0,1837417200.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),114.56,114.56,114.56,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,9.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,56400.0,1837438800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,34800.0,1837417200.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),76.69,76.69,76.69,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,10.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,63600.0,1837446000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,34800.0,1837417200.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),41.11,41.11,41.11,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,11.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,78000.0,1837460400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,34800.0,1837417200.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.03,18.03,18.03,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,12.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,85200.0,1837467600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,34800.0,1837417200.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.44,11.44,11.44,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,13.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,34800.0,1837503600.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,34800.0,1837417200.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.9,3.90,3.90,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,14.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,33000.0,1838020200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,34800.0,1838022000.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,15.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,36600.0,1838023800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,34800.0,1838022000.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),19.12,19.12,19.12,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,16.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,38400.0,1838025600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,34800.0,1838022000.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),121.54,121.54,121.54,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,17.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,40200.0,1838027400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,34800.0,1838022000.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),138.8,138.80,138.80,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,18.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,42000.0,1838029200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,34800.0,1838022000.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),113.85,113.85,113.85,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,19.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,45600.0,1838032800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,34800.0,1838022000.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),104.56,104.56,104.56,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,20.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,49200.0,1838036400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,34800.0,1838022000.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),93.7,93.70,93.70,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,21.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,52800.0,1838040000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,34800.0,1838022000.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),81.24,81.24,81.24,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,22.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,56400.0,1838043600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,34800.0,1838022000.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),53.17,53.17,53.17,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,23.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,63600.0,1838050800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,34800.0,1838022000.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),33.16,33.16,33.16,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,24.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,78000.0,1838065200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,34800.0,1838022000.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.64,12.64,12.64,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,25.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,85200.0,1838072400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,34800.0,1838022000.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.42,8.42,8.42,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,26.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,34800.0,1838108400.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,34800.0,1838022000.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.89,3.89,3.89,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,27.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,33000.0,1838625000.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,34800.0,1838626800.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,28.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,36600.0,1838628600.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,34800.0,1838626800.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),35.29,35.29,35.29,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,29.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,38400.0,1838630400.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,34800.0,1838626800.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),146.41,146.41,146.41,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,30.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,40200.0,1838632200.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,34800.0,1838626800.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),192.84,192.84,192.84,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,31.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,42000.0,1838634000.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,34800.0,1838626800.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),195.97,195.97,195.97,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,32.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,45600.0,1838637600.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,34800.0,1838626800.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),159.12,159.12,159.12,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,33.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,49200.0,1838641200.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,34800.0,1838626800.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),119.78,119.78,119.78,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,34.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,52800.0,1838644800.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,34800.0,1838626800.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),95.05,95.05,95.05,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,35.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,56400.0,1838648400.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,34800.0,1838626800.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),68.74,68.74,68.74,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,36.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,63600.0,1838655600.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,34800.0,1838626800.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),34.94,34.94,34.94,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,37.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,78000.0,1838670000.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,34800.0,1838626800.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.03,14.03,14.03,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,38.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,85200.0,1838677200.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,34800.0,1838626800.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.77,8.77,8.77,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001141,103001141,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34800.0,1837417200.0,21280.0,34800.0,1838626800.0,39.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,34800.0,1838713200.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,34800.0,1838626800.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.21,3.21,3.21,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,34260.0,1837416660.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,36060.0,1837418460.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,37860.0,1837420260.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,36060.0,1837418460.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),366.19,366.19,366.19,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,39660.0,1837422060.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,36060.0,1837418460.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),657.94,657.94,657.94,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,41460.0,1837423860.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,36060.0,1837418460.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),416.16,416.16,416.16,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,43260.0,1837425660.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,36060.0,1837418460.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),330.05,330.05,330.05,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,46860.0,1837429260.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,36060.0,1837418460.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),233.47,233.47,233.47,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,50460.0,1837432860.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,36060.0,1837418460.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),146.37,146.37,146.37,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,54060.0,1837436460.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,36060.0,1837418460.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),127.74,127.74,127.74,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,57660.0,1837440060.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,36060.0,1837418460.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),99.03,99.03,99.03,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,64860.0,1837447260.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,36060.0,1837418460.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),56.79,56.79,56.79,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,79260.0,1837461660.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,36060.0,1837418460.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.94,17.94,17.94,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,60.0,1837468860.0,2.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,36060.0,1837418460.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.23,11.23,11.23,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,36060.0,1837504860.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,36060.0,1837418460.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.8,1.80,1.80,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,14.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,34260.0,1838021460.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,36060.0,1838023260.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,15.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,37860.0,1838025060.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,36060.0,1838023260.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),123.59,123.59,123.59,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,16.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,39660.0,1838026860.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,36060.0,1838023260.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),293.13,293.13,293.13,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,17.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,41460.0,1838028660.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,36060.0,1838023260.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),553.93,553.93,553.93,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,18.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,43260.0,1838030460.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,36060.0,1838023260.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),429.91,429.91,429.91,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,19.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,46860.0,1838034060.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,36060.0,1838023260.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),275.1,275.10,275.10,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,20.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,50460.0,1838037660.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,36060.0,1838023260.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),205.78,205.78,205.78,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,21.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,54060.0,1838041260.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,36060.0,1838023260.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),139.31,139.31,139.31,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,22.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,57660.0,1838044860.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,36060.0,1838023260.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),116.86,116.86,116.86,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,23.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,64860.0,1838052060.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,36060.0,1838023260.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),59.4,59.40,59.40,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,24.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,79260.0,1838066460.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,36060.0,1838023260.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),22.54,22.54,22.54,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,25.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21274.0,60.0,1838073660.0,9.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,36060.0,1838023260.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.42,12.42,12.42,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,26.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21274.0,36060.0,1838109660.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,36060.0,1838023260.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.67,2.67,2.67,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,27.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,34260.0,1838626260.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,36060.0,1838628060.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,28.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,37860.0,1838629860.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,36060.0,1838628060.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),436.08,436.08,436.08,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,29.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,39660.0,1838631660.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,36060.0,1838628060.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),436.62,436.62,436.62,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,30.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,41460.0,1838633460.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,36060.0,1838628060.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),405.87,405.87,405.87,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,31.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,43260.0,1838635260.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,36060.0,1838628060.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),329.96,329.96,329.96,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,32.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,46860.0,1838638860.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,36060.0,1838628060.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),219.49,219.49,219.49,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,33.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,50460.0,1838642460.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,36060.0,1838628060.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),174.7,174.70,174.70,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,34.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,54060.0,1838646060.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,36060.0,1838628060.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),110.91,110.91,110.91,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,35.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,57660.0,1838649660.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,36060.0,1838628060.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),89.37,89.37,89.37,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,36.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,64860.0,1838656860.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,36060.0,1838628060.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),51.12,51.12,51.12,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,37.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,79260.0,1838671260.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,36060.0,1838628060.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.48,15.48,15.48,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,38.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,60.0,1838678460.0,16.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,36060.0,1838628060.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.07,11.07,11.07,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001149,103001149,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36060.0,1837418460.0,21280.0,36060.0,1838628060.0,39.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,36060.0,1838714460.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,36060.0,1838628060.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.24,2.24,2.24,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,34860.0,1837417260.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,36660.0,1837419060.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,38460.0,1837420860.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,36660.0,1837419060.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),91.25,91.25,91.25,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,40260.0,1837422660.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,36660.0,1837419060.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),497.51,497.51,497.51,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,42060.0,1837424460.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,36660.0,1837419060.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),410.19,410.19,410.19,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,43860.0,1837426260.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,36660.0,1837419060.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),318.33,318.33,318.33,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,47460.0,1837429860.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,36660.0,1837419060.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),212.31,212.31,212.31,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,51060.0,1837433460.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,36660.0,1837419060.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),135.26,135.26,135.26,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,54660.0,1837437060.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,36660.0,1837419060.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),101.26,101.26,101.26,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,58260.0,1837440660.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,36660.0,1837419060.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),66.47,66.47,66.47,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,65460.0,1837447860.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,36660.0,1837419060.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),36.86,36.86,36.86,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,79860.0,1837462260.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,36660.0,1837419060.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.12,13.12,13.12,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,660.0,1837469460.0,2.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,36660.0,1837419060.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.74,8.74,8.74,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,36660.0,1837505460.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,36660.0,1837419060.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.85,2.85,2.85,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,14.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,34860.0,1838022060.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,36660.0,1838023860.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,15.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,38460.0,1838025660.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,36660.0,1838023860.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),45.04,45.04,45.04,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,16.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,40260.0,1838027460.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,36660.0,1838023860.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),454.93,454.93,454.93,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,17.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,42060.0,1838029260.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,36660.0,1838023860.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),377.5,377.50,377.50,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,18.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,43908.0,1838031108.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,36660.0,1838023860.0,2.013333333333333,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),293.67,293.67,293.67,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,19.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,47460.0,1838034660.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,36660.0,1838023860.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),299.33,299.33,299.33,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,20.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,51060.0,1838038260.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,36660.0,1838023860.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),179.23,179.23,179.23,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,21.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,54660.0,1838041860.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,36660.0,1838023860.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),104.66,104.66,104.66,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,22.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,58260.0,1838045460.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,36660.0,1838023860.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),95.74,95.74,95.74,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,23.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,65460.0,1838052660.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,36660.0,1838023860.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),37.7,37.70,37.70,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,24.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21273.0,79860.0,1838067060.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,36660.0,1838023860.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.28,13.28,13.28,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,25.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21274.0,660.0,1838074260.0,9.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,36660.0,1838023860.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.95,7.95,7.95,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,26.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21274.0,36660.0,1838110260.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,36660.0,1838023860.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.39,4.39,4.39,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,27.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,34860.0,1838626860.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,36660.0,1838628660.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,28.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,38460.0,1838630460.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,36660.0,1838628660.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),38.67,38.67,38.67,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,29.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,40260.0,1838632260.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,36660.0,1838628660.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),289.21,289.21,289.21,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,30.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,42060.0,1838634060.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,36660.0,1838628660.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),237.31,237.31,237.31,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,31.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,43860.0,1838635860.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,36660.0,1838628660.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),309.33,309.33,309.33,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,32.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,47460.0,1838639460.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,36660.0,1838628660.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),215.46,215.46,215.46,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,33.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,51060.0,1838643060.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,36660.0,1838628660.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),165.64,165.64,165.64,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,34.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,54660.0,1838646660.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,36660.0,1838628660.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),129.32,129.32,129.32,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,35.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,58260.0,1838650260.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,36660.0,1838628660.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),85.26,85.26,85.26,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,36.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,65460.0,1838657460.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,36660.0,1838628660.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),53.89,53.89,53.89,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,37.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,79860.0,1838671860.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,36660.0,1838628660.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.87,11.87,11.87,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,38.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,660.0,1838679060.0,16.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,36660.0,1838628660.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.62,5.62,5.62,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001150,103001150,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21266.0,36660.0,1837419060.0,21280.0,36660.0,1838628660.0,39.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,36660.0,1838715060.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,36660.0,1838628660.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.63,2.63,2.63,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,1.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,34440.0,1837416840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,36240.0,1837418640.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,2.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,38040.0,1837420440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,36240.0,1837418640.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),93.49,93.49,93.49,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,3.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,39840.0,1837422240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,36240.0,1837418640.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),252.68,252.68,252.68,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,4.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,41640.0,1837424040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,36240.0,1837418640.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),365.56,365.56,365.56,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,5.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,43440.0,1837425840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,36240.0,1837418640.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),425.93,425.93,425.93,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,6.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,47040.0,1837429440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,36240.0,1837418640.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),264.72,264.72,264.72,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,7.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,50640.0,1837433040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,36240.0,1837418640.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),177.8,177.80,177.80,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,8.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,54328.0,1837436728.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,36240.0,1837418640.0,5.024444444444445,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),111.98,111.98,111.98,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,9.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,57840.0,1837440240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,36240.0,1837418640.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),74.98,74.98,74.98,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,10.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,65233.0,1837447633.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,36240.0,1837418640.0,8.053611111111111,HOURS,3.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),32.6,32.60,32.60,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,11.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,79440.0,1837461840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,36240.0,1837418640.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.51,8.51,8.51,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,12.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,240.0,1837469040.0,2.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,36240.0,1837418640.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.87,5.87,5.87,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,13.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,36240.0,1837505040.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,36240.0,1837418640.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,14.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,34440.0,1838021640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,36240.0,1838023440.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,15.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,38040.0,1838025240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,36240.0,1838023440.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.58,15.58,15.58,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,16.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,39840.0,1838027040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,36240.0,1838023440.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),118.77,118.77,118.77,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,17.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,42038.0,1838029238.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,36240.0,1838023440.0,1.6105555555555555,HOURS,7.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),191.27,191.27,191.27,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,18.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,43440.0,1838030640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,36240.0,1838023440.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),250.32,250.32,250.32,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,19.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,47040.0,1838034240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,36240.0,1838023440.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),193.02,193.02,193.02,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,20.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,50706.0,1838037906.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,36240.0,1838023440.0,4.0183333333333335,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),173.9,173.90,173.90,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,21.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,54240.0,1838041440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,36240.0,1838023440.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),194.49,194.49,194.49,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,22.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,57840.0,1838045040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,36240.0,1838023440.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),124.46,124.46,124.46,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,23.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,65040.0,1838052240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,36240.0,1838023440.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),65.44,65.44,65.44,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,24.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,79440.0,1838066640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,36240.0,1838023440.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.13,13.13,13.13,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,25.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,345.0,1838073945.0,9.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,36240.0,1838023440.0,14.029166666666667,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.38,7.38,7.38,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,26.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,36240.0,1838109840.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,36240.0,1838023440.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.69,1.69,1.69,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,27.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,34440.0,1838626440.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,36240.0,1838628240.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,28.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,38040.0,1838630040.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,36240.0,1838628240.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),64.92,64.92,64.92,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,29.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,39840.0,1838631840.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,36240.0,1838628240.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),268.0,268.00,268.00,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,30.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,41640.0,1838633640.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,36240.0,1838628240.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),454.35,454.35,454.35,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,31.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,43440.0,1838635440.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,36240.0,1838628240.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),480.19,480.19,480.19,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,32.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,47040.0,1838639040.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,36240.0,1838628240.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),240.77,240.77,240.77,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,33.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,50640.0,1838642640.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,36240.0,1838628240.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),182.43,182.43,182.43,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,34.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,54380.0,1838646380.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,36240.0,1838628240.0,5.038888888888889,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),105.77,105.77,105.77,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,35.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,57840.0,1838649840.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,36240.0,1838628240.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),77.73,77.73,77.73,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,36.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,65040.0,1838657040.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,36240.0,1838628240.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),34.38,34.38,34.38,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,37.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,79440.0,1838671440.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,36240.0,1838628240.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.21,10.21,10.21,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,38.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,240.0,1838678640.0,16.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,36240.0,1838628240.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.62,5.62,5.62,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001155,103001155,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,36240.0,1837418640.0,21280.0,36240.0,1838628240.0,39.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,36240.0,1838714640.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,36240.0,1838628240.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.05,1.05,1.05,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001156,103001156,001,Part A,1.0,Y,1.0,N,0.0,3: BAC,3.0,3: BAC,3.0,21266.0,35880.0,1837418280.0,21266.0,35880.0,1837418280.0,1.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,34080.0,1837416480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,35880.0,1837418280.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001156,103001156,001,Part A,1.0,Y,1.0,N,0.0,3: BAC,3.0,3: BAC,3.0,21266.0,35880.0,1837418280.0,21266.0,35880.0,1837418280.0,2.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,37680.0,1837420080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,35880.0,1837418280.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.49,20.49,20.49,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001156,103001156,001,Part A,1.0,Y,1.0,N,0.0,3: BAC,3.0,3: BAC,3.0,21266.0,35880.0,1837418280.0,21266.0,35880.0,1837418280.0,3.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,39480.0,1837421880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,35880.0,1837418280.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),118.43,118.43,118.43,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001156,103001156,001,Part A,1.0,Y,1.0,N,0.0,3: BAC,3.0,3: BAC,3.0,21266.0,35880.0,1837418280.0,21266.0,35880.0,1837418280.0,4.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,41280.0,1837423680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,35880.0,1837418280.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),99.06,99.06,99.06,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001156,103001156,001,Part A,1.0,Y,1.0,N,0.0,3: BAC,3.0,3: BAC,3.0,21266.0,35880.0,1837418280.0,21266.0,35880.0,1837418280.0,5.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,43080.0,1837425480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,35880.0,1837418280.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),240.2,240.20,240.20,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001156,103001156,001,Part A,1.0,Y,1.0,N,0.0,3: BAC,3.0,3: BAC,3.0,21266.0,35880.0,1837418280.0,21266.0,35880.0,1837418280.0,6.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,46680.0,1837429080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,35880.0,1837418280.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),234.78,234.78,234.78,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001156,103001156,001,Part A,1.0,Y,1.0,N,0.0,3: BAC,3.0,3: BAC,3.0,21266.0,35880.0,1837418280.0,21266.0,35880.0,1837418280.0,7.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,50280.0,1837432680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,35880.0,1837418280.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),140.64,140.64,140.64,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001156,103001156,001,Part A,1.0,Y,1.0,N,0.0,3: BAC,3.0,3: BAC,3.0,21266.0,35880.0,1837418280.0,21266.0,35880.0,1837418280.0,8.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,53880.0,1837436280.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,35880.0,1837418280.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),100.53,100.53,100.53,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001156,103001156,001,Part A,1.0,Y,1.0,N,0.0,3: BAC,3.0,3: BAC,3.0,21266.0,35880.0,1837418280.0,21266.0,35880.0,1837418280.0,9.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,57480.0,1837439880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,35880.0,1837418280.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),75.56,75.56,75.56,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001156,103001156,001,Part A,1.0,Y,1.0,N,0.0,3: BAC,3.0,3: BAC,3.0,21266.0,35880.0,1837418280.0,21266.0,35880.0,1837418280.0,10.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,64680.0,1837447080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,35880.0,1837418280.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),46.51,46.51,46.51,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001156,103001156,001,Part A,1.0,Y,1.0,N,0.0,3: BAC,3.0,3: BAC,3.0,21266.0,35880.0,1837418280.0,21266.0,35880.0,1837418280.0,11.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,79080.0,1837461480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,35880.0,1837418280.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),19.21,19.21,19.21,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001156,103001156,001,Part A,1.0,Y,1.0,N,0.0,3: BAC,3.0,3: BAC,3.0,21266.0,35880.0,1837418280.0,21266.0,35880.0,1837418280.0,12.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,86280.0,1837468680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,35880.0,1837418280.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.53,12.53,12.53,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001156,103001156,001,Part A,1.0,Y,1.0,N,0.0,3: BAC,3.0,3: BAC,3.0,21266.0,35880.0,1837418280.0,21266.0,35880.0,1837418280.0,13.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,35880.0,1837504680.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,35880.0,1837418280.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.25,5.25,5.25,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,34380.0,1837416780.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,36180.0,1837418580.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,37980.0,1837420380.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,36180.0,1837418580.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),153.82,153.82,153.82,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,39780.0,1837422180.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,36180.0,1837418580.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),482.13,482.13,482.13,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,41580.0,1837423980.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,36180.0,1837418580.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),490.38,490.38,490.38,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,43380.0,1837425780.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,36180.0,1837418580.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),439.76,439.76,439.76,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,46980.0,1837429380.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,36180.0,1837418580.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),334.83,334.83,334.83,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,50580.0,1837432980.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,36180.0,1837418580.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),247.52,247.52,247.52,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,54180.0,1837436580.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,36180.0,1837418580.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),169.99,169.99,169.99,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,57780.0,1837440180.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,36180.0,1837418580.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),119.59,119.59,119.59,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,64980.0,1837447380.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,36180.0,1837418580.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),67.79,67.79,67.79,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,11.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21266.0,79380.0,1837461780.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,36180.0,1837418580.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),16.32,16.32,16.32,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,12.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,180.0,1837468980.0,2.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,36180.0,1837418580.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.98,12.98,12.98,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,13.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21267.0,36180.0,1837504980.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,36180.0,1837418580.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.17,3.17,3.17,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,14.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,34380.0,1838021580.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,36180.0,1838023380.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,15.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,37980.0,1838025180.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,36180.0,1838023380.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),42.18,42.18,42.18,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,16.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,39780.0,1838026980.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,36180.0,1838023380.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),161.76,161.76,161.76,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,17.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,41580.0,1838028780.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,36180.0,1838023380.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),245.15,245.15,245.15,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,18.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,43380.0,1838030580.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,36180.0,1838023380.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),599.78,599.78,599.78,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,19.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,46980.0,1838034180.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,36180.0,1838023380.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),527.94,527.94,527.94,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,20.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,50580.0,1838037780.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,36180.0,1838023380.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),418.58,418.58,418.58,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,21.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,54180.0,1838041380.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,36180.0,1838023380.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),276.86,276.86,276.86,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,22.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,57780.0,1838044980.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,36180.0,1838023380.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),231.18,231.18,231.18,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,23.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,64980.0,1838052180.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,36180.0,1838023380.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),119.21,119.21,119.21,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,24.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,79380.0,1838066580.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,36180.0,1838023380.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),41.98,41.98,41.98,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,25.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,180.0,1838073780.0,9.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,36180.0,1838023380.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.09,17.09,17.09,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,26.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,36248.0,1838109848.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,36180.0,1838023380.0,24.01888888888889,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.8,5.80,5.80,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,27.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,34380.0,1838626380.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,36180.0,1838628180.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,28.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,37980.0,1838629980.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,36180.0,1838628180.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),125.94,125.94,125.94,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,29.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,39780.0,1838631780.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,36180.0,1838628180.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),408.77,408.77,408.77,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,30.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,41580.0,1838633580.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,36180.0,1838628180.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),374.0,374.00,374.00,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,31.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,43380.0,1838635380.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,36180.0,1838628180.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),559.32,559.32,559.32,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,32.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,46980.0,1838638980.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,36180.0,1838628180.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),402.77,402.77,402.77,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,33.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,50580.0,1838642580.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,36180.0,1838628180.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),274.66,274.66,274.66,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,34.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,54180.0,1838646180.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,36180.0,1838628180.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),206.83,206.83,206.83,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,35.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,57780.0,1838649780.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,36180.0,1838628180.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),142.04,142.04,142.04,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,36.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,64980.0,1838656980.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,36180.0,1838628180.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),82.98,82.98,82.98,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,37.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,79380.0,1838671380.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,36180.0,1838628180.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),27.59,27.59,27.59,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,38.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,180.0,1838678580.0,16.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,36180.0,1838628180.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.33,17.33,17.33,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001193,103001193,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21266.0,36180.0,1837418580.0,21280.0,36180.0,1838628180.0,39.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,36180.0,1838714580.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,36180.0,1838628180.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.83,3.83,3.83,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,32400.0,1837414800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,34200.0,1837416600.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,36000.0,1837418400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,34200.0,1837416600.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.2,5.20,5.20,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,37800.0,1837420200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,34200.0,1837416600.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),101.35,101.35,101.35,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,39600.0,1837422000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,34200.0,1837416600.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),191.01,191.01,191.01,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,41400.0,1837423800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,34200.0,1837416600.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),269.48,269.48,269.48,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,45000.0,1837427400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,34200.0,1837416600.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),210.39,210.39,210.39,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,48600.0,1837431000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,34200.0,1837416600.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),131.78,131.78,131.78,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,52200.0,1837434600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,34200.0,1837416600.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),85.88,85.88,85.88,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,55800.0,1837438200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,34200.0,1837416600.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.58,61.58,61.58,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,63000.0,1837445400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,34200.0,1837416600.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),33.82,33.82,33.82,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,77400.0,1837459800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,34200.0,1837416600.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.47,12.47,12.47,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21266.0,84600.0,1837467000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,34200.0,1837416600.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.34,8.34,8.34,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21267.0,34200.0,1837503000.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,34200.0,1837416600.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.66,5.66,5.66,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,14.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,32400.0,1838019600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,34200.0,1838021400.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,15.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,36000.0,1838023200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,34200.0,1838021400.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.39,20.39,20.39,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,16.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,37800.0,1838025000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,34200.0,1838021400.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),117.63,117.63,117.63,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,17.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,39600.0,1838026800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,34200.0,1838021400.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),133.76,133.76,133.76,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,18.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,41400.0,1838028600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,34200.0,1838021400.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),192.72,192.72,192.72,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,19.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,45000.0,1838032200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,34200.0,1838021400.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),196.32,196.32,196.32,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,20.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,48600.0,1838035800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,34200.0,1838021400.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),146.02,146.02,146.02,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,21.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,52200.0,1838039400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,34200.0,1838021400.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),98.0,98.00,98.00,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,22.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,55800.0,1838043000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,34200.0,1838021400.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),70.68,70.68,70.68,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,23.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,63000.0,1838050200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,34200.0,1838021400.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),39.49,39.49,39.49,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,24.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,77400.0,1838064600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,34200.0,1838021400.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.86,12.86,12.86,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,25.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21273.0,84600.0,1838071800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,34200.0,1838021400.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.18,9.18,9.18,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,26.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21274.0,34200.0,1838107800.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,34200.0,1838021400.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.95,3.95,3.95,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,27.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,32400.0,1838624400.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,34200.0,1838626200.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,28.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,36000.0,1838628000.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,34200.0,1838626200.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.3,10.30,10.30,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,29.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,37800.0,1838629800.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,34200.0,1838626200.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.26,12.26,12.26,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,30.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,39600.0,1838631600.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,34200.0,1838626200.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),21.83,21.83,21.83,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,31.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,41400.0,1838633400.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,34200.0,1838626200.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),49.62,49.62,49.62,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,32.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,45000.0,1838637000.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,34200.0,1838626200.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),48.44,48.44,48.44,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,33.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,48600.0,1838640600.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,34200.0,1838626200.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),38.65,38.65,38.65,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,34.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,52200.0,1838644200.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,34200.0,1838626200.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),39.1,39.10,39.10,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,35.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,55800.0,1838647800.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,34200.0,1838626200.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),29.57,29.57,29.57,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,36.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,63000.0,1838655000.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,34200.0,1838626200.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),19.33,19.33,19.33,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,37.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,77400.0,1838669400.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,34200.0,1838626200.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.96,8.96,8.96,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,38.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21280.0,84600.0,1838676600.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,34200.0,1838626200.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.23,7.23,7.23,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001201,103001201,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21266.0,34200.0,1837416600.0,21280.0,34200.0,1838626200.0,39.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21281.0,34200.0,1838712600.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,34200.0,1838626200.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.74,5.74,5.74,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,1.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,32460.0,1837414860.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21266.0,34260.0,1837416660.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,2.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,36060.0,1837418460.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21266.0,34260.0,1837416660.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),133.7,133.70,133.70,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,3.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,37860.0,1837420260.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21266.0,34260.0,1837416660.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),332.67,332.67,332.67,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,4.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,39660.0,1837422060.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21266.0,34260.0,1837416660.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),236.97,236.97,236.97,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,5.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,41460.0,1837423860.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21266.0,34260.0,1837416660.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),234.27,234.27,234.27,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,6.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,45060.0,1837427460.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21266.0,34260.0,1837416660.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),176.23,176.23,176.23,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,7.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,48660.0,1837431060.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21266.0,34260.0,1837416660.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),151.09,151.09,151.09,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,8.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,52260.0,1837434660.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21266.0,34260.0,1837416660.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),107.03,107.03,107.03,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,9.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,55860.0,1837438260.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21266.0,34260.0,1837416660.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),81.2,81.20,81.20,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,10.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,63060.0,1837445460.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21266.0,34260.0,1837416660.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),54.05,54.05,54.05,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,11.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,77460.0,1837459860.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21266.0,34260.0,1837416660.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.41,18.41,18.41,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,12.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21266.0,84660.0,1837467060.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21266.0,34260.0,1837416660.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.39,12.39,12.39,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,13.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21267.0,34260.0,1837503060.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21266.0,34260.0,1837416660.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.03,3.03,3.03,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,14.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,32460.0,1838019660.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21273.0,34260.0,1838021460.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,15.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,36060.0,1838023260.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21273.0,34260.0,1838021460.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),50.7,50.70,50.70,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,16.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,37860.0,1838025060.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21273.0,34260.0,1838021460.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),94.24,94.24,94.24,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,17.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,39660.0,1838026860.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21273.0,34260.0,1838021460.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),140.24,140.24,140.24,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,18.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,41460.0,1838028660.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21273.0,34260.0,1838021460.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),281.57,281.57,281.57,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,19.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,45060.0,1838032260.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21273.0,34260.0,1838021460.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),158.74,158.74,158.74,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,20.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,48660.0,1838035860.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21273.0,34260.0,1838021460.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),150.97,150.97,150.97,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,21.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,52260.0,1838039460.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21273.0,34260.0,1838021460.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),146.71,146.71,146.71,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,22.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,55860.0,1838043060.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21273.0,34260.0,1838021460.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),101.23,101.23,101.23,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,23.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,63060.0,1838050260.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21273.0,34260.0,1838021460.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),54.69,54.69,54.69,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,24.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,77460.0,1838064660.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21273.0,34260.0,1838021460.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),19.41,19.41,19.41,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,25.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21273.0,84660.0,1838071860.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21273.0,34260.0,1838021460.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.42,12.42,12.42,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,26.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21274.0,34260.0,1838107860.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21273.0,34260.0,1838021460.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.05,3.05,3.05,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,27.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,32460.0,1838624460.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21280.0,34260.0,1838626260.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,28.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,36060.0,1838628060.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21280.0,34260.0,1838626260.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),221.83,221.83,221.83,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,29.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,37860.0,1838629860.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21280.0,34260.0,1838626260.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),366.95,366.95,366.95,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,30.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,39660.0,1838631660.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21280.0,34260.0,1838626260.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),232.5,232.50,232.50,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,31.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,41460.0,1838633460.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21280.0,34260.0,1838626260.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),219.59,219.59,219.59,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,32.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,45060.0,1838637060.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21280.0,34260.0,1838626260.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),194.84,194.84,194.84,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,33.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,48660.0,1838640660.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21280.0,34260.0,1838626260.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),154.34,154.34,154.34,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,34.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,52260.0,1838644260.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21280.0,34260.0,1838626260.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),103.7,103.70,103.70,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,35.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,55860.0,1838647860.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21280.0,34260.0,1838626260.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),80.71,80.71,80.71,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,36.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,63060.0,1838655060.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21280.0,34260.0,1838626260.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),45.83,45.83,45.83,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,37.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,77460.0,1838669460.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21280.0,34260.0,1838626260.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),16.74,16.74,16.74,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,38.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21280.0,84660.0,1838676660.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21280.0,34260.0,1838626260.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.17,11.17,11.17,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001211,103001211,001,Part A,1.0,Y,1.0,Y,1.0,4: BCA,4.0,4: BCA,4.0,21266.0,34260.0,1837416660.0,21280.0,34260.0,1838626260.0,39.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21281.0,34260.0,1838712660.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21280.0,34260.0,1838626260.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.23,2.23,2.23,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,27540.0,1839656340.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21292.0,29880.0,1839658680.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,31680.0,1839660480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21292.0,29880.0,1839658680.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),252.04,252.04,252.04,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,33480.0,1839662280.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21292.0,29880.0,1839658680.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),315.13,315.13,315.13,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,35280.0,1839664080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21292.0,29880.0,1839658680.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),303.14,303.14,303.14,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,37080.0,1839665880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21292.0,29880.0,1839658680.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),252.37,252.37,252.37,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,40680.0,1839669480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21292.0,29880.0,1839658680.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),123.75,123.75,123.75,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,44280.0,1839673080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21292.0,29880.0,1839658680.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),96.65,96.65,96.65,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,47880.0,1839676680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21292.0,29880.0,1839658680.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),62.88,62.88,62.88,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,51480.0,1839680280.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21292.0,29880.0,1839658680.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),46.9,46.90,46.90,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,58680.0,1839687480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21292.0,29880.0,1839658680.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),25.84,25.84,25.84,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,73080.0,1839701880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21292.0,29880.0,1839658680.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.16,10.16,10.16,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,80280.0,1839709080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21292.0,29880.0,1839658680.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.02,8.02,8.02,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21293.0,29880.0,1839745080.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21292.0,29880.0,1839658680.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.45,4.45,4.45,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,14.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,27600.0,1840261200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21299.0,29880.0,1840263480.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,15.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,31680.0,1840265280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21299.0,29880.0,1840263480.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),224.51,224.51,224.51,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,16.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,33480.0,1840267080.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21299.0,29880.0,1840263480.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),313.52,313.52,313.52,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,17.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,35280.0,1840268880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21299.0,29880.0,1840263480.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),228.77,228.77,228.77,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,18.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,37080.0,1840270680.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21299.0,29880.0,1840263480.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),185.11,185.11,185.11,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,19.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,40680.0,1840274280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21299.0,29880.0,1840263480.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),122.76,122.76,122.76,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,20.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,44280.0,1840277880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21299.0,29880.0,1840263480.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),86.42,86.42,86.42,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,21.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,47880.0,1840281480.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21299.0,29880.0,1840263480.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),62.16,62.16,62.16,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,22.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,51480.0,1840285080.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21299.0,29880.0,1840263480.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),45.39,45.39,45.39,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,23.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,58680.0,1840292280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21299.0,29880.0,1840263480.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),22.49,22.49,22.49,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,24.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,73080.0,1840306680.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21299.0,29880.0,1840263480.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.91,7.91,7.91,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,25.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,80280.0,1840313880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21299.0,29880.0,1840263480.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.34,5.34,5.34,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,26.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21300.0,29880.0,1840349880.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21299.0,29880.0,1840263480.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.31,2.31,2.31,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,27.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,28080.0,1840866480.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21306.0,29880.0,1840868280.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,28.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,31680.0,1840870080.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21306.0,29880.0,1840868280.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),127.89,127.89,127.89,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,29.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,33480.0,1840871880.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21306.0,29880.0,1840868280.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),378.47,378.47,378.47,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,30.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,35280.0,1840873680.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21306.0,29880.0,1840868280.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),253.73,253.73,253.73,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,31.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,37080.0,1840875480.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21306.0,29880.0,1840868280.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),227.04,227.04,227.04,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,32.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,40680.0,1840879080.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21306.0,29880.0,1840868280.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),124.79,124.79,124.79,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,33.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,44280.0,1840882680.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21306.0,29880.0,1840868280.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),68.91,68.91,68.91,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,34.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,47880.0,1840886280.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21306.0,29880.0,1840868280.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),53.81,53.81,53.81,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,35.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,51480.0,1840889880.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21306.0,29880.0,1840868280.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),42.41,42.41,42.41,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,36.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,58680.0,1840897080.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21306.0,29880.0,1840868280.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),26.22,26.22,26.22,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,37.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,73080.0,1840911480.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21306.0,29880.0,1840868280.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.32,7.32,7.32,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,38.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,80280.0,1840918680.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21306.0,29880.0,1840868280.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.6,4.60,4.60,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001218,103001218,001,Part A,1.0,Y,1.0,Y,1.0,5: CAB,5.0,5: CAB,5.0,21292.0,29880.0,1839658680.0,21306.0,29880.0,1840868280.0,39.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21307.0,29880.0,1840954680.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21306.0,29880.0,1840868280.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.4,1.40,1.40,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,27600.0,1839656400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21292.0,30000.0,1839658800.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,31854.0,1839660654.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21292.0,30000.0,1839658800.0,0.515,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),347.23,347.23,347.23,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,33600.0,1839662400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21292.0,30000.0,1839658800.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),505.13,505.13,505.13,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,35400.0,1839664200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21292.0,30000.0,1839658800.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),285.7,285.70,285.70,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,37200.0,1839666000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21292.0,30000.0,1839658800.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),236.92,236.92,236.92,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,40800.0,1839669600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21292.0,30000.0,1839658800.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),184.9,184.90,184.90,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,44400.0,1839673200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21292.0,30000.0,1839658800.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),153.97,153.97,153.97,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,48000.0,1839676800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21292.0,30000.0,1839658800.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),95.99,95.99,95.99,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,51600.0,1839680400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21292.0,30000.0,1839658800.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),93.78,93.78,93.78,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,58800.0,1839687600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21292.0,30000.0,1839658800.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),48.4,48.40,48.40,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,11.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,73200.0,1839702000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21292.0,30000.0,1839658800.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.75,17.75,17.75,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,12.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,80400.0,1839709200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21292.0,30000.0,1839658800.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.06,11.06,11.06,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,13.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21293.0,30000.0,1839745200.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21292.0,30000.0,1839658800.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.92,2.92,2.92,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,14.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21299.0,27720.0,1840261320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21299.0,30000.0,1840263600.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,15.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21299.0,31800.0,1840265400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21299.0,30000.0,1840263600.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),60.86,60.86,60.86,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,16.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21299.0,33600.0,1840267200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21299.0,30000.0,1840263600.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),199.17,199.17,199.17,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,17.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21299.0,35400.0,1840269000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21299.0,30000.0,1840263600.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),162.14,162.14,162.14,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,18.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21299.0,37200.0,1840270800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21299.0,30000.0,1840263600.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),317.38,317.38,317.38,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,19.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21299.0,40803.0,1840274403.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21299.0,30000.0,1840263600.0,3.0008333333333335,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),247.91,247.91,247.91,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,20.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21299.0,44400.0,1840278000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21299.0,30000.0,1840263600.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),177.59,177.59,177.59,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,21.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21299.0,48000.0,1840281600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21299.0,30000.0,1840263600.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),135.86,135.86,135.86,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,22.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21299.0,51600.0,1840285200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21299.0,30000.0,1840263600.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),106.62,106.62,106.62,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,23.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21299.0,58800.0,1840292400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21299.0,30000.0,1840263600.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),64.31,64.31,64.31,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,24.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21299.0,73200.0,1840306800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21299.0,30000.0,1840263600.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.62,20.62,20.62,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,25.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21299.0,80400.0,1840314000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21299.0,30000.0,1840263600.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.0,11.00,11.00,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,26.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21300.0,30000.0,1840350000.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21299.0,30000.0,1840263600.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.16,3.16,3.16,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,27.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,28200.0,1840866600.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21306.0,30000.0,1840868400.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,28.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,31800.0,1840870200.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21306.0,30000.0,1840868400.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),53.33,53.33,53.33,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,29.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,33600.0,1840872000.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21306.0,30000.0,1840868400.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),227.74,227.74,227.74,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,30.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,35400.0,1840873800.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21306.0,30000.0,1840868400.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),235.42,235.42,235.42,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,31.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,37200.0,1840875600.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21306.0,30000.0,1840868400.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),371.46,371.46,371.46,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,32.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,40800.0,1840879200.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21306.0,30000.0,1840868400.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),229.49,229.49,229.49,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,33.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,44400.0,1840882800.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21306.0,30000.0,1840868400.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),156.95,156.95,156.95,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,34.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,48000.0,1840886400.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21306.0,30000.0,1840868400.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),116.06,116.06,116.06,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,35.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,51600.0,1840890000.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21306.0,30000.0,1840868400.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),91.59,91.59,91.59,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,36.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,58800.0,1840897200.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21306.0,30000.0,1840868400.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),39.43,39.43,39.43,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,37.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,73200.0,1840911600.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21306.0,30000.0,1840868400.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),16.33,16.33,16.33,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,38.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21306.0,80400.0,1840918800.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21306.0,30000.0,1840868400.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.16,9.16,9.16,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001220,103001220,001,Part A,1.0,Y,1.0,Y,1.0,2: ACB,2.0,2: ACB,2.0,21292.0,30000.0,1839658800.0,21306.0,30000.0,1840868400.0,39.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21307.0,30000.0,1840954800.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21306.0,30000.0,1840868400.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.62,2.62,2.62,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,1.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,27840.0,1839656640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21292.0,30240.0,1839659040.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,2.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,32040.0,1839660840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21292.0,30240.0,1839659040.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),55.72,55.72,55.72,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,3.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,33840.0,1839662640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21292.0,30240.0,1839659040.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),124.09,124.09,124.09,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,4.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,35640.0,1839664440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21292.0,30240.0,1839659040.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),279.76,279.76,279.76,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,5.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,37440.0,1839666240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21292.0,30240.0,1839659040.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),224.6,224.60,224.60,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,6.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,41040.0,1839669840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21292.0,30240.0,1839659040.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),181.78,181.78,181.78,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,7.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,44640.0,1839673440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21292.0,30240.0,1839659040.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),119.32,119.32,119.32,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,8.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,48240.0,1839677040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21292.0,30240.0,1839659040.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),84.54,84.54,84.54,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,9.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,51840.0,1839680640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21292.0,30240.0,1839659040.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.45,61.45,61.45,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,10.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,59040.0,1839687840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21292.0,30240.0,1839659040.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),40.53,40.53,40.53,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,11.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,73440.0,1839702240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21292.0,30240.0,1839659040.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.95,15.95,15.95,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,12.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21292.0,80640.0,1839709440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21292.0,30240.0,1839659040.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.69,10.69,10.69,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,13.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21293.0,30240.0,1839745440.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21292.0,30240.0,1839659040.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.3,2.30,2.30,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,14.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,27960.0,1840261560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21299.0,30240.0,1840263840.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,15.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,32040.0,1840265640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21299.0,30240.0,1840263840.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),169.67,169.67,169.67,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,16.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,33840.0,1840267440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21299.0,30240.0,1840263840.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),216.5,216.50,216.50,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,17.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,35640.0,1840269240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21299.0,30240.0,1840263840.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),202.24,202.24,202.24,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,18.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,37440.0,1840271040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21299.0,30240.0,1840263840.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),155.15,155.15,155.15,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,19.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,41040.0,1840274640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21299.0,30240.0,1840263840.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),97.58,97.58,97.58,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,20.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,44640.0,1840278240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21299.0,30240.0,1840263840.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),71.19,71.19,71.19,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,21.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,48240.0,1840281840.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21299.0,30240.0,1840263840.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),54.75,54.75,54.75,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,22.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,51840.0,1840285440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21299.0,30240.0,1840263840.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),36.65,36.65,36.65,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,23.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,59040.0,1840292640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21299.0,30240.0,1840263840.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),26.32,26.32,26.32,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,24.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,73440.0,1840307040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21299.0,30240.0,1840263840.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.12,12.12,12.12,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,25.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,80640.0,1840314240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21299.0,30240.0,1840263840.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.92,7.92,7.92,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,26.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21300.0,30240.0,1840350240.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21299.0,30240.0,1840263840.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.49,2.49,2.49,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,27.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,28440.0,1840866840.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21306.0,30240.0,1840868640.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,28.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,32040.0,1840870440.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21306.0,30240.0,1840868640.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),105.22,105.22,105.22,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,29.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,33840.0,1840872240.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21306.0,30240.0,1840868640.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),162.47,162.47,162.47,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,30.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,35640.0,1840874040.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21306.0,30240.0,1840868640.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),171.55,171.55,171.55,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,31.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,37440.0,1840875840.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21306.0,30240.0,1840868640.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),327.39,327.39,327.39,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,32.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,41040.0,1840879440.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21306.0,30240.0,1840868640.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),174.63,174.63,174.63,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,33.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,44640.0,1840883040.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21306.0,30240.0,1840868640.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),116.89,116.89,116.89,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,34.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,48240.0,1840886640.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21306.0,30240.0,1840868640.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),72.76,72.76,72.76,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,35.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,51840.0,1840890240.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21306.0,30240.0,1840868640.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),58.47,58.47,58.47,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,36.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,59040.0,1840897440.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21306.0,30240.0,1840868640.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),33.08,33.08,33.08,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,37.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,73440.0,1840911840.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21306.0,30240.0,1840868640.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.67,13.67,13.67,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,38.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,80640.0,1840919040.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21306.0,30240.0,1840868640.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.41,8.41,8.41,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001222,103001222,001,Part A,1.0,Y,1.0,Y,1.0,1: ABC,1.0,1: ABC,1.0,21292.0,30240.0,1839659040.0,21306.0,30240.0,1840868640.0,39.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21307.0,30240.0,1840955040.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21306.0,30240.0,1840868640.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.96,1.96,1.96,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,1.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,26764.0,1839655564.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21292.0,28920.0,1839657720.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,2.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,30720.0,1839659520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21292.0,28920.0,1839657720.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,3.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,32520.0,1839661320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21292.0,28920.0,1839657720.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),69.17,69.17,69.17,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,4.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,34320.0,1839663120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21292.0,28920.0,1839657720.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),138.38,138.38,138.38,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,5.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,36120.0,1839664920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21292.0,28920.0,1839657720.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),208.29,208.29,208.29,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,6.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,39720.0,1839668520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21292.0,28920.0,1839657720.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),310.92,310.92,310.92,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,7.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,43320.0,1839672120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21292.0,28920.0,1839657720.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),166.34,166.34,166.34,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,8.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,46920.0,1839675720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21292.0,28920.0,1839657720.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),113.37,113.37,113.37,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,9.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,50520.0,1839679320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21292.0,28920.0,1839657720.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),85.38,85.38,85.38,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,10.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,57720.0,1839686520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21292.0,28920.0,1839657720.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),46.9,46.90,46.90,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,11.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,72120.0,1839700920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21292.0,28920.0,1839657720.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.88,18.88,18.88,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,12.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,79320.0,1839708120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21292.0,28920.0,1839657720.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.52,10.52,10.52,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,13.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21293.0,28920.0,1839744120.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21292.0,28920.0,1839657720.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.55,2.55,2.55,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,14.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,26520.0,1840260120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21299.0,28920.0,1840262520.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,15.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,30720.0,1840264320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21299.0,28920.0,1840262520.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),97.08,97.08,97.08,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,16.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,32520.0,1840266120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21299.0,28920.0,1840262520.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),342.37,342.37,342.37,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,17.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,34320.0,1840267920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21299.0,28920.0,1840262520.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),239.36,239.36,239.36,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,18.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,36120.0,1840269720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21299.0,28920.0,1840262520.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),181.64,181.64,181.64,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,19.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,39720.0,1840273320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21299.0,28920.0,1840262520.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),122.1,122.10,122.10,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,20.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,43320.0,1840276920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21299.0,28920.0,1840262520.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),96.97,96.97,96.97,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,21.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,46920.0,1840280520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21299.0,28920.0,1840262520.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),72.98,72.98,72.98,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,22.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,50520.0,1840284120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21299.0,28920.0,1840262520.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),60.8,60.80,60.80,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,23.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,57720.0,1840291320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21299.0,28920.0,1840262520.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),41.4,41.40,41.40,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,24.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,72120.0,1840305720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21299.0,28920.0,1840262520.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.12,14.12,14.12,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,25.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,79320.0,1840312920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21299.0,28920.0,1840262520.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.38,8.38,8.38,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001225,103001225,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,28920.0,1839657720.0,21299.0,28920.0,1840262520.0,26.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21300.0,28920.0,1840348920.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21299.0,28920.0,1840262520.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.05,2.05,2.05,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,1.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,26824.0,1839655624.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21292.0,29040.0,1839657840.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,2.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,30840.0,1839659640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21292.0,29040.0,1839657840.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),379.4,379.40,379.40,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,3.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,32640.0,1839661440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21292.0,29040.0,1839657840.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),269.32,269.32,269.32,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,4.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,34440.0,1839663240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21292.0,29040.0,1839657840.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),317.05,317.05,317.05,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,5.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,36240.0,1839665040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21292.0,29040.0,1839657840.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),409.04,409.04,409.04,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,6.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,39840.0,1839668640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21292.0,29040.0,1839657840.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),255.11,255.11,255.11,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,7.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,43440.0,1839672240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21292.0,29040.0,1839657840.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),179.49,179.49,179.49,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,8.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,47040.0,1839675840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21292.0,29040.0,1839657840.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),126.61,126.61,126.61,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,9.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,50640.0,1839679440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21292.0,29040.0,1839657840.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),84.48,84.48,84.48,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,10.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,57840.0,1839686640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21292.0,29040.0,1839657840.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),54.23,54.23,54.23,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,11.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,72240.0,1839701040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21292.0,29040.0,1839657840.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.22,17.22,17.22,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,12.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,79440.0,1839708240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21292.0,29040.0,1839657840.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.96,9.96,9.96,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,13.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21293.0,29040.0,1839744240.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21292.0,29040.0,1839657840.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.49,4.49,4.49,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,14.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,26640.0,1840260240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21299.0,29040.0,1840262640.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,15.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,30840.0,1840264440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21299.0,29040.0,1840262640.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),726.53,726.53,726.53,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,16.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,32640.0,1840266240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21299.0,29040.0,1840262640.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),542.1,542.10,542.10,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,17.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,34440.0,1840268040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21299.0,29040.0,1840262640.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),304.93,304.93,304.93,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,18.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,36240.0,1840269840.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21299.0,29040.0,1840262640.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),265.65,265.65,265.65,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,19.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,39840.0,1840273440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21299.0,29040.0,1840262640.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),207.57,207.57,207.57,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,20.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,43440.0,1840277040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21299.0,29040.0,1840262640.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),140.04,140.04,140.04,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,21.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,47040.0,1840280640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21299.0,29040.0,1840262640.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),101.54,101.54,101.54,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,22.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,50640.0,1840284240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21299.0,29040.0,1840262640.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),72.1,72.10,72.10,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,23.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,57840.0,1840291440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21299.0,29040.0,1840262640.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),42.13,42.13,42.13,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,24.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,72240.0,1840305840.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21299.0,29040.0,1840262640.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.71,13.71,13.71,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,25.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,79440.0,1840313040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21299.0,29040.0,1840262640.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.1,9.10,9.10,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001233,103001233,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29040.0,1839657840.0,21299.0,29040.0,1840262640.0,26.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21300.0,29040.0,1840349040.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21299.0,29040.0,1840262640.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.25,2.25,2.25,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001234,103001234,001,Part B,2.0,Y,1.0,N,0.0,2: ED,8.0,2: ED,8.0,21292.0,29280.0,1839658080.0,21292.0,29280.0,1839658080.0,1.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,27020.0,1839655820.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21292.0,29280.0,1839658080.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001234,103001234,001,Part B,2.0,Y,1.0,N,0.0,2: ED,8.0,2: ED,8.0,21292.0,29280.0,1839658080.0,21292.0,29280.0,1839658080.0,2.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,31080.0,1839659880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21292.0,29280.0,1839658080.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),221.64,221.64,221.64,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001234,103001234,001,Part B,2.0,Y,1.0,N,0.0,2: ED,8.0,2: ED,8.0,21292.0,29280.0,1839658080.0,21292.0,29280.0,1839658080.0,3.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,32880.0,1839661680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21292.0,29280.0,1839658080.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),270.99,270.99,270.99,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001234,103001234,001,Part B,2.0,Y,1.0,N,0.0,2: ED,8.0,2: ED,8.0,21292.0,29280.0,1839658080.0,21292.0,29280.0,1839658080.0,4.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,34769.0,1839663569.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21292.0,29280.0,1839658080.0,1.5247222222222223,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),200.54,200.54,200.54,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001234,103001234,001,Part B,2.0,Y,1.0,N,0.0,2: ED,8.0,2: ED,8.0,21292.0,29280.0,1839658080.0,21292.0,29280.0,1839658080.0,5.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,36627.0,1839665427.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21292.0,29280.0,1839658080.0,2.0408333333333335,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),202.32,202.32,202.32,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001234,103001234,001,Part B,2.0,Y,1.0,N,0.0,2: ED,8.0,2: ED,8.0,21292.0,29280.0,1839658080.0,21292.0,29280.0,1839658080.0,6.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,40080.0,1839668880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21292.0,29280.0,1839658080.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),126.25,126.25,126.25,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001234,103001234,001,Part B,2.0,Y,1.0,N,0.0,2: ED,8.0,2: ED,8.0,21292.0,29280.0,1839658080.0,21292.0,29280.0,1839658080.0,7.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,43680.0,1839672480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21292.0,29280.0,1839658080.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),91.65,91.65,91.65,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001234,103001234,001,Part B,2.0,Y,1.0,N,0.0,2: ED,8.0,2: ED,8.0,21292.0,29280.0,1839658080.0,21292.0,29280.0,1839658080.0,8.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,47280.0,1839676080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21292.0,29280.0,1839658080.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),81.01,81.01,81.01,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001234,103001234,001,Part B,2.0,Y,1.0,N,0.0,2: ED,8.0,2: ED,8.0,21292.0,29280.0,1839658080.0,21292.0,29280.0,1839658080.0,9.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,50880.0,1839679680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21292.0,29280.0,1839658080.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),67.64,67.64,67.64,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001234,103001234,001,Part B,2.0,Y,1.0,N,0.0,2: ED,8.0,2: ED,8.0,21292.0,29280.0,1839658080.0,21292.0,29280.0,1839658080.0,10.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,58080.0,1839686880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21292.0,29280.0,1839658080.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),42.52,42.52,42.52,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001234,103001234,001,Part B,2.0,Y,1.0,N,0.0,2: ED,8.0,2: ED,8.0,21292.0,29280.0,1839658080.0,21292.0,29280.0,1839658080.0,11.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,72480.0,1839701280.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21292.0,29280.0,1839658080.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.59,10.59,10.59,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001234,103001234,001,Part B,2.0,Y,1.0,N,0.0,2: ED,8.0,2: ED,8.0,21292.0,29280.0,1839658080.0,21292.0,29280.0,1839658080.0,12.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,79680.0,1839708480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21292.0,29280.0,1839658080.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.89,11.89,11.89,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001234,103001234,001,Part B,2.0,Y,1.0,N,0.0,2: ED,8.0,2: ED,8.0,21292.0,29280.0,1839658080.0,21292.0,29280.0,1839658080.0,13.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21293.0,29280.0,1839744480.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21292.0,29280.0,1839658080.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.89,3.89,3.89,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,1.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,27240.0,1839656040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21292.0,29640.0,1839658440.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,2.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,31440.0,1839660240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21292.0,29640.0,1839658440.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),255.87,255.87,255.87,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,3.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,33240.0,1839662040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21292.0,29640.0,1839658440.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),317.62,317.62,317.62,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,4.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,35040.0,1839663840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21292.0,29640.0,1839658440.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),186.82,186.82,186.82,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,5.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,36840.0,1839665640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21292.0,29640.0,1839658440.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),164.36,164.36,164.36,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,6.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,40440.0,1839669240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21292.0,29640.0,1839658440.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),107.36,107.36,107.36,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,7.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,44040.0,1839672840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21292.0,29640.0,1839658440.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),84.14,84.14,84.14,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,8.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,47905.0,1839676705.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21292.0,29640.0,1839658440.0,5.073611111111111,HOURS,4.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),72.42,72.42,72.42,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,9.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,51240.0,1839680040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21292.0,29640.0,1839658440.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),57.02,57.02,57.02,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,10.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,58532.0,1839687332.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21292.0,29640.0,1839658440.0,8.025555555555556,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),31.82,31.82,31.82,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,11.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,73085.0,1839701885.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21292.0,29640.0,1839658440.0,12.068055555555556,HOURS,4.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),19.29,19.29,19.29,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,12.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,80040.0,1839708840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21292.0,29640.0,1839658440.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.5,7.50,7.50,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,13.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21293.0,29710.0,1839744910.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21292.0,29640.0,1839658440.0,24.019444444444446,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.49,1.49,1.49,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,14.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,27240.0,1840260840.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21299.0,29640.0,1840263240.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,15.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,31440.0,1840265040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21299.0,29640.0,1840263240.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.03,1.03,1.03,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,16.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,33240.0,1840266840.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21299.0,29640.0,1840263240.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.82,17.82,17.82,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,17.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,35040.0,1840268640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21299.0,29640.0,1840263240.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),39.43,39.43,39.43,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,18.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,36840.0,1840270440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21299.0,29640.0,1840263240.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),54.99,54.99,54.99,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,19.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,40581.0,1840274181.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21299.0,29640.0,1840263240.0,3.0391666666666666,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),87.37,87.37,87.37,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,20.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,44040.0,1840277640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21299.0,29640.0,1840263240.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),227.78,227.78,227.78,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,21.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,47815.0,1840281415.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21299.0,29640.0,1840263240.0,5.048611111111111,HOURS,3.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),193.64,193.64,193.64,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,22.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,51240.0,1840284840.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21299.0,29640.0,1840263240.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),127.85,127.85,127.85,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,23.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,58440.0,1840292040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21299.0,29640.0,1840263240.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),72.86,72.86,72.86,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,24.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,72840.0,1840306440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21299.0,29640.0,1840263240.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),24.26,24.26,24.26,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,25.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,80040.0,1840313640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21299.0,29640.0,1840263240.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),16.13,16.13,16.13,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001241,103001241,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,29640.0,1839658440.0,21299.0,29640.0,1840263240.0,26.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21300.0,29640.0,1840349640.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21299.0,29640.0,1840263240.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.47,3.47,3.47,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,1.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,26987.0,1839655787.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21292.0,29160.0,1839657960.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,2.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,30960.0,1839659760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21292.0,29160.0,1839657960.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.13,12.13,12.13,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,3.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,32760.0,1839661560.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21292.0,29160.0,1839657960.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),38.92,38.92,38.92,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,4.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,34560.0,1839663360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21292.0,29160.0,1839657960.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),74.53,74.53,74.53,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,5.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,36360.0,1839665160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21292.0,29160.0,1839657960.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),95.82,95.82,95.82,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,6.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,39960.0,1839668760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21292.0,29160.0,1839657960.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),118.27,118.27,118.27,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,7.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,43560.0,1839672360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21292.0,29160.0,1839657960.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),272.51,272.51,272.51,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,8.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,47160.0,1839675960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21292.0,29160.0,1839657960.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),183.98,183.98,183.98,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,9.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,50760.0,1839679560.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21292.0,29160.0,1839657960.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),113.89,113.89,113.89,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,10.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,57960.0,1839686760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21292.0,29160.0,1839657960.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),64.79,64.79,64.79,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,11.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,72360.0,1839701160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21292.0,29160.0,1839657960.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.37,20.37,20.37,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,12.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,79560.0,1839708360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21292.0,29160.0,1839657960.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.28,12.28,12.28,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,13.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21293.0,29160.0,1839744360.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21292.0,29160.0,1839657960.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.97,2.97,2.97,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,14.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,26760.0,1840260360.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21299.0,29160.0,1840262760.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,15.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,30960.0,1840264560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21299.0,29160.0,1840262760.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),82.77,82.77,82.77,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,16.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,32760.0,1840266360.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21299.0,29160.0,1840262760.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),335.85,335.85,335.85,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,17.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,34560.0,1840268160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21299.0,29160.0,1840262760.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),276.62,276.62,276.62,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,18.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,36360.0,1840269960.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21299.0,29160.0,1840262760.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),257.21,257.21,257.21,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,19.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,39960.0,1840273560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21299.0,29160.0,1840262760.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),138.08,138.08,138.08,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,20.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,43560.0,1840277160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21299.0,29160.0,1840262760.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),97.01,97.01,97.01,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,21.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,47160.0,1840280760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21299.0,29160.0,1840262760.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),76.34,76.34,76.34,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,22.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,50760.0,1840284360.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21299.0,29160.0,1840262760.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),57.84,57.84,57.84,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,23.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,57960.0,1840291560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21299.0,29160.0,1840262760.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),33.81,33.81,33.81,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,24.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,72360.0,1840305960.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21299.0,29160.0,1840262760.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.86,10.86,10.86,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,25.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,79560.0,1840313160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21299.0,29160.0,1840262760.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.98,6.98,6.98,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001248,103001248,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29160.0,1839657960.0,21299.0,29160.0,1840262760.0,26.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21300.0,29160.0,1840349160.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21299.0,29160.0,1840262760.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.84,1.84,1.84,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,1.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,27050.0,1839655850.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21292.0,29400.0,1839658200.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,2.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,31200.0,1839660000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21292.0,29400.0,1839658200.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.75,13.75,13.75,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,3.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,33000.0,1839661800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21292.0,29400.0,1839658200.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),23.04,23.04,23.04,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,4.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,34800.0,1839663600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21292.0,29400.0,1839658200.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),33.09,33.09,33.09,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,5.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,36600.0,1839665400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21292.0,29400.0,1839658200.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),77.81,77.81,77.81,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,6.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,40200.0,1839669000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21292.0,29400.0,1839658200.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),186.08,186.08,186.08,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,7.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,43800.0,1839672600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21292.0,29400.0,1839658200.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),203.22,203.22,203.22,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,8.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,47400.0,1839676200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21292.0,29400.0,1839658200.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),175.9,175.90,175.90,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,9.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,51000.0,1839679800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21292.0,29400.0,1839658200.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),135.24,135.24,135.24,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,10.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,58200.0,1839687000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21292.0,29400.0,1839658200.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),74.5,74.50,74.50,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,11.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,72600.0,1839701400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21292.0,29400.0,1839658200.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),25.05,25.05,25.05,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,12.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,79800.0,1839708600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21292.0,29400.0,1839658200.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.48,13.48,13.48,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,13.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21293.0,29400.0,1839744600.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21292.0,29400.0,1839658200.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.39,2.39,2.39,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,14.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,27000.0,1840260600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21299.0,29400.0,1840263000.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,15.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,31200.0,1840264800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21299.0,29400.0,1840263000.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),103.35,103.35,103.35,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,16.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,33000.0,1840266600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21299.0,29400.0,1840263000.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),474.03,474.03,474.03,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,17.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,34800.0,1840268400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21299.0,29400.0,1840263000.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),356.44,356.44,356.44,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,18.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,36600.0,1840270200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21299.0,29400.0,1840263000.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),291.62,291.62,291.62,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,19.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,40200.0,1840273800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21299.0,29400.0,1840263000.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),198.75,198.75,198.75,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,20.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,43800.0,1840277400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21299.0,29400.0,1840263000.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),150.79,150.79,150.79,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,21.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,47400.0,1840281000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21299.0,29400.0,1840263000.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),111.9,111.90,111.90,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,22.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,51000.0,1840284600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21299.0,29400.0,1840263000.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),72.87,72.87,72.87,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,23.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,58200.0,1840291800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21299.0,29400.0,1840263000.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),44.22,44.22,44.22,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,24.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,72600.0,1840306200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21299.0,29400.0,1840263000.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.44,11.44,11.44,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,25.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,79800.0,1840313400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21299.0,29400.0,1840263000.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.68,6.68,6.68,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001279,103001279,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29400.0,1839658200.0,21299.0,29400.0,1840263000.0,26.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21300.0,29400.0,1840349400.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21299.0,29400.0,1840263000.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.15,2.15,2.15,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,1.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,26717.0,1839655517.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21292.0,28800.0,1839657600.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,2.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,30600.0,1839659400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21292.0,28800.0,1839657600.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),34.22,34.22,34.22,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,3.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,32400.0,1839661200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21292.0,28800.0,1839657600.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),209.98,209.98,209.98,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,4.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,34200.0,1839663000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21292.0,28800.0,1839657600.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),390.6,390.60,390.60,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,5.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,36000.0,1839664800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21292.0,28800.0,1839657600.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),376.56,376.56,376.56,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,6.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,39600.0,1839668400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21292.0,28800.0,1839657600.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),386.36,386.36,386.36,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,7.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,43200.0,1839672000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21292.0,28800.0,1839657600.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),202.42,202.42,202.42,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,8.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,46800.0,1839675600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21292.0,28800.0,1839657600.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),226.85,226.85,226.85,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,9.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,50400.0,1839679200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21292.0,28800.0,1839657600.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),157.93,157.93,157.93,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,10.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,57600.0,1839686400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21292.0,28800.0,1839657600.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),64.42,64.42,64.42,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,11.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,72000.0,1839700800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21292.0,28800.0,1839657600.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),30.38,30.38,30.38,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,12.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21292.0,79200.0,1839708000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21292.0,28800.0,1839657600.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),13.65,13.65,13.65,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,13.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21293.0,28800.0,1839744000.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21292.0,28800.0,1839657600.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.43,7.43,7.43,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,14.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,26400.0,1840260000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21299.0,28800.0,1840262400.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,15.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,30600.0,1840264200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21299.0,28800.0,1840262400.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.21,4.21,4.21,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,16.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,32400.0,1840266000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21299.0,28800.0,1840262400.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),43.47,43.47,43.47,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,17.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,34200.0,1840267800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21299.0,28800.0,1840262400.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),205.87,205.87,205.87,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,18.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,36000.0,1840269600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21299.0,28800.0,1840262400.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),217.44,217.44,217.44,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,19.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,39600.0,1840273200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21299.0,28800.0,1840262400.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),195.04,195.04,195.04,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,20.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,43200.0,1840276800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21299.0,28800.0,1840262400.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),229.18,229.18,229.18,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,21.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,46879.0,1840280479.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21299.0,28800.0,1840262400.0,5.021944444444444,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),155.96,155.96,155.96,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,22.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,50400.0,1840284000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21299.0,28800.0,1840262400.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),151.25,151.25,151.25,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,23.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,57600.0,1840291200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21299.0,28800.0,1840262400.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),119.74,119.74,119.74,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,24.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,72000.0,1840305600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21299.0,28800.0,1840262400.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),42.4,42.40,42.40,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,25.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21299.0,79200.0,1840312800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21299.0,28800.0,1840262400.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),29.11,29.11,29.11,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001284,103001284,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21292.0,28800.0,1839657600.0,21299.0,28800.0,1840262400.0,26.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21300.0,28800.0,1840348800.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21299.0,28800.0,1840262400.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.37,9.37,9.37,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,1.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,27360.0,1839656160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21292.0,29760.0,1839658560.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,2.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,31560.0,1839660360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21292.0,29760.0,1839658560.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),134.67,134.67,134.67,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,3.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,33360.0,1839662160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21292.0,29760.0,1839658560.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),264.6,264.60,264.60,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,4.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,35160.0,1839663960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21292.0,29760.0,1839658560.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),190.85,190.85,190.85,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,5.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,36960.0,1839665760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21292.0,29760.0,1839658560.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),174.02,174.02,174.02,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,6.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,40560.0,1839669360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21292.0,29760.0,1839658560.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),108.78,108.78,108.78,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,7.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,44160.0,1839672960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21292.0,29760.0,1839658560.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),72.86,72.86,72.86,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,8.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,47760.0,1839676560.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21292.0,29760.0,1839658560.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),54.92,54.92,54.92,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,9.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,51360.0,1839680160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21292.0,29760.0,1839658560.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),38.62,38.62,38.62,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,10.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,58560.0,1839687360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21292.0,29760.0,1839658560.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),26.9,26.90,26.90,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,11.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,73036.0,1839701836.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21292.0,29760.0,1839658560.0,12.02111111111111,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.63,14.63,14.63,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,12.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21292.0,80160.0,1839708960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21292.0,29760.0,1839658560.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.7,8.70,8.70,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,13.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21293.0,29836.0,1839745036.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21292.0,29760.0,1839658560.0,24.02111111111111,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.3,5.30,5.30,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,14.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,27560.0,1840261160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21299.0,29760.0,1840263360.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,15.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,31560.0,1840265160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21299.0,29760.0,1840263360.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),201.8,201.80,201.80,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,16.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,33360.0,1840266960.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21299.0,29760.0,1840263360.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),441.23,441.23,441.23,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,17.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,35160.0,1840268760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21299.0,29760.0,1840263360.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),357.75,357.75,357.75,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,18.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,36960.0,1840270560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21299.0,29760.0,1840263360.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),300.06,300.06,300.06,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,19.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,40560.0,1840274160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21299.0,29760.0,1840263360.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),177.11,177.11,177.11,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,20.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,44160.0,1840277760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21299.0,29760.0,1840263360.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),115.53,115.53,115.53,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,21.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,47809.0,1840281409.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21299.0,29760.0,1840263360.0,5.0136111111111115,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),93.41,93.41,93.41,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,22.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,51360.0,1840284960.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21299.0,29760.0,1840263360.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),64.07,64.07,64.07,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,23.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,58560.0,1840292160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21299.0,29760.0,1840263360.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),45.33,45.33,45.33,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,24.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,72960.0,1840306560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21299.0,29760.0,1840263360.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),19.5,19.50,19.50,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,25.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21299.0,80160.0,1840313760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21299.0,29760.0,1840263360.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.23,14.23,14.23,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,26.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21300.0,29760.0,1840349760.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21299.0,29760.0,1840263360.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.93,4.93,4.93,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,27.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21306.0,27960.0,1840866360.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21306.0,29760.0,1840868160.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,28.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21306.0,31753.0,1840870153.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21306.0,29760.0,1840868160.0,0.5536111111111112,HOURS,3.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),388.41,388.41,388.41,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,29.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21306.0,33360.0,1840871760.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21306.0,29760.0,1840868160.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),474.83,474.83,474.83,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,30.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21306.0,35244.0,1840873644.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21306.0,29760.0,1840868160.0,1.5233333333333334,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),434.17,434.17,434.17,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,31.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21306.0,36960.0,1840875360.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21306.0,29760.0,1840868160.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),428.84,428.84,428.84,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,32.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21306.0,40560.0,1840878960.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21306.0,29760.0,1840868160.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),354.56,354.56,354.56,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,33.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21306.0,44160.0,1840882560.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21306.0,29760.0,1840868160.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),234.37,234.37,234.37,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,34.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21306.0,47760.0,1840886160.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21306.0,29760.0,1840868160.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),162.71,162.71,162.71,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,35.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21306.0,51360.0,1840889760.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21306.0,29760.0,1840868160.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),96.74,96.74,96.74,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,36.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21306.0,58560.0,1840896960.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21306.0,29760.0,1840868160.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),61.49,61.49,61.49,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,37.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21306.0,72960.0,1840911360.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21306.0,29760.0,1840868160.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.9,20.90,20.90,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,38.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21306.0,80160.0,1840918560.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21306.0,29760.0,1840868160.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.27,14.27,14.27,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001288,103001288,001,Part A,1.0,Y,1.0,Y,1.0,6: CBA,6.0,6: CBA,6.0,21292.0,29760.0,1839658560.0,21306.0,29760.0,1840868160.0,39.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21307.0,29825.0,1840954625.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21306.0,29760.0,1840868160.0,24.018055555555556,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.73,2.73,2.73,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,1.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21292.0,27720.0,1839656520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21292.0,30120.0,1839658920.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,2.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21292.0,31920.0,1839660720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21292.0,30120.0,1839658920.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),50.87,50.87,50.87,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,3.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21292.0,33720.0,1839662520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21292.0,30120.0,1839658920.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),147.33,147.33,147.33,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,4.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21292.0,35520.0,1839664320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21292.0,30120.0,1839658920.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),125.0,125.00,125.00,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,5.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21292.0,37320.0,1839666120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21292.0,30120.0,1839658920.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),270.63,270.63,270.63,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,6.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21292.0,40920.0,1839669720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21292.0,30120.0,1839658920.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),173.75,173.75,173.75,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,7.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21292.0,44520.0,1839673320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21292.0,30120.0,1839658920.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),114.78,114.78,114.78,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,8.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21292.0,48120.0,1839676920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21292.0,30120.0,1839658920.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),80.64,80.64,80.64,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,9.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21292.0,51720.0,1839680520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21292.0,30120.0,1839658920.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),68.03,68.03,68.03,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,10.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21292.0,58920.0,1839687720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21292.0,30120.0,1839658920.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),32.3,32.30,32.30,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,11.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21292.0,73320.0,1839702120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21292.0,30120.0,1839658920.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.38,15.38,15.38,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,12.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21292.0,80520.0,1839709320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21292.0,30120.0,1839658920.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.24,8.24,8.24,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,13.0,TREATMENT,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21293.0,30120.0,1839745320.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21292.0,30120.0,1839658920.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.98,1.98,1.98,ng/mL,1.0,Altasciences Company Inc.,B: TBM Ubrogepant 2 x 50 mg (Test 2),B
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,14.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,27840.0,1840261440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21299.0,30120.0,1840263720.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,15.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,31920.0,1840265520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21299.0,30120.0,1840263720.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.47,6.47,6.47,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,16.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,33720.0,1840267320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21299.0,30120.0,1840263720.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),50.86,50.86,50.86,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,17.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,35520.0,1840269120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21299.0,30120.0,1840263720.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),64.84,64.84,64.84,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,18.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,37320.0,1840270920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21299.0,30120.0,1840263720.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),104.88,104.88,104.88,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,19.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,40920.0,1840274520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21299.0,30120.0,1840263720.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),143.5,143.50,143.50,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,20.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,44520.0,1840278120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21299.0,30120.0,1840263720.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),234.64,234.64,234.64,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,21.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,48120.0,1840281720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21299.0,30120.0,1840263720.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),161.08,161.08,161.08,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,22.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,51720.0,1840285320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21299.0,30120.0,1840263720.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),89.92,89.92,89.92,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,23.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,58920.0,1840292520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21299.0,30120.0,1840263720.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),56.17,56.17,56.17,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,24.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,73320.0,1840306920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21299.0,30120.0,1840263720.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.08,20.08,20.08,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,25.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21299.0,80520.0,1840314120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21299.0,30120.0,1840263720.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.72,12.72,12.72,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,26.0,TREATMENT,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21300.0,30120.0,1840350120.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21299.0,30120.0,1840263720.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.38,2.38,2.38,ng/mL,1.0,Altasciences Company Inc.,A: TBM Ubrogepant 1 x 100 mg (Test 1),A
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,27.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,28320.0,1840866720.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,Predose,0.0,21306.0,30120.0,1840868520.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,28.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,31920.0,1840870320.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,0.5 h,0.5,21306.0,30120.0,1840868520.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),9.61,9.61,9.61,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,29.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,33720.0,1840872120.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1 h,1.0,21306.0,30120.0,1840868520.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),104.01,104.01,104.01,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,30.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,35520.0,1840873920.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,1.5 h,1.5,21306.0,30120.0,1840868520.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),136.28,136.28,136.28,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,31.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,37320.0,1840875720.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,2 h,2.0,21306.0,30120.0,1840868520.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),170.87,170.87,170.87,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,32.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,40920.0,1840879320.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,3 h,3.0,21306.0,30120.0,1840868520.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),118.86,118.86,118.86,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,33.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,44520.0,1840882920.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,4 h,4.0,21306.0,30120.0,1840868520.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),88.33,88.33,88.33,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,34.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,48120.0,1840886520.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,5 h,5.0,21306.0,30120.0,1840868520.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),67.99,67.99,67.99,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,35.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,51720.0,1840890120.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,6 h,6.0,21306.0,30120.0,1840868520.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),43.99,43.99,43.99,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,36.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,58920.0,1840897320.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,8 h,8.0,21306.0,30120.0,1840868520.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),30.77,30.77,30.77,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,37.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,73320.0,1840911720.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,12 h,12.0,21306.0,30120.0,1840868520.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.51,12.51,12.51,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,38.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21306.0,80520.0,1840918920.0,15.0,Period 3 Day 15,25.0,3.0,Period 3,14 h,14.0,21306.0,30120.0,1840868520.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.98,8.98,8.98,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001290,103001290,001,Part A,1.0,Y,1.0,Y,1.0,3: BAC,3.0,3: BAC,3.0,21292.0,30120.0,1839658920.0,21306.0,30120.0,1840868520.0,39.0,TREATMENT,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21307.0,30120.0,1840954920.0,16.0,Period 3 Day 16,26.0,3.0,Period 3,24 h,24.0,21306.0,30120.0,1840868520.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.57,2.57,2.57,ng/mL,1.0,Altasciences Company Inc.,C: CT Ubrogepant 2 x 50 mg (Reference 1),C
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,1.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,27137.0,1839655937.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21292.0,29520.0,1839658320.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,2.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,31320.0,1839660120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21292.0,29520.0,1839658320.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.2,1.20,1.20,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,3.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,33120.0,1839661920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21292.0,29520.0,1839658320.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.6,18.60,18.60,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,4.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,34920.0,1839663720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21292.0,29520.0,1839658320.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),87.22,87.22,87.22,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,5.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,36720.0,1839665520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21292.0,29520.0,1839658320.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),153.21,153.21,153.21,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,6.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,40320.0,1839669120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21292.0,29520.0,1839658320.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),154.93,154.93,154.93,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,7.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,43920.0,1839672720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21292.0,29520.0,1839658320.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),171.82,171.82,171.82,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,8.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,47520.0,1839676320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21292.0,29520.0,1839658320.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),114.47,114.47,114.47,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,9.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,51120.0,1839679920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21292.0,29520.0,1839658320.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),63.61,63.61,63.61,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,10.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,58320.0,1839687120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21292.0,29520.0,1839658320.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),34.78,34.78,34.78,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,11.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,72720.0,1839701520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21292.0,29520.0,1839658320.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.4,8.40,8.40,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,12.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21292.0,79920.0,1839708720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21292.0,29520.0,1839658320.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.36,4.36,4.36,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,13.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21293.0,29520.0,1839744720.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21292.0,29520.0,1839658320.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.32,1.32,1.32,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,14.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,27120.0,1840260720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21299.0,29520.0,1840263120.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,15.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,31320.0,1840264920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21299.0,29520.0,1840263120.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),88.24,88.24,88.24,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,16.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,33120.0,1840266720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21299.0,29520.0,1840263120.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),272.93,272.93,272.93,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,17.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,34920.0,1840268520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21299.0,29520.0,1840263120.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),161.1,161.10,161.10,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,18.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,36720.0,1840270320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21299.0,29520.0,1840263120.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),172.34,172.34,172.34,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,19.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,40320.0,1840273920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21299.0,29520.0,1840263120.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),120.68,120.68,120.68,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,20.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,43920.0,1840277520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21299.0,29520.0,1840263120.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),97.21,97.21,97.21,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,21.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,47520.0,1840281120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21299.0,29520.0,1840263120.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),63.92,63.92,63.92,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,22.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,51120.0,1840284720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21299.0,29520.0,1840263120.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),52.95,52.95,52.95,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,23.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,58320.0,1840291920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21299.0,29520.0,1840263120.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),35.61,35.61,35.61,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,24.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,72720.0,1840306320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21299.0,29520.0,1840263120.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.38,8.38,8.38,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,25.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21299.0,79920.0,1840313520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21299.0,29520.0,1840263120.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.63,5.63,5.63,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001303,103001303,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21292.0,29520.0,1839658320.0,21299.0,29520.0,1840263120.0,26.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21300.0,29520.0,1840349520.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21299.0,29520.0,1840263120.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.26,1.26,1.26,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,1.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,27000.0,1840433400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21301.0,29400.0,1840435800.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,2.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,31200.0,1840437600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21301.0,29400.0,1840435800.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.46,14.46,14.46,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,3.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,33000.0,1840439400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21301.0,29400.0,1840435800.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),63.12,63.12,63.12,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,4.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,34800.0,1840441200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21301.0,29400.0,1840435800.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),60.71,60.71,60.71,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,5.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,36600.0,1840443000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21301.0,29400.0,1840435800.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),217.18,217.18,217.18,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,6.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,40200.0,1840446600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21301.0,29400.0,1840435800.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),254.67,254.67,254.67,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,7.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,43800.0,1840450200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21301.0,29400.0,1840435800.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),157.5,157.50,157.50,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,8.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,47400.0,1840453800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21301.0,29400.0,1840435800.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),121.03,121.03,121.03,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,9.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,51000.0,1840457400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21301.0,29400.0,1840435800.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),86.65,86.65,86.65,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,10.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,58200.0,1840464600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21301.0,29400.0,1840435800.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),56.17,56.17,56.17,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,11.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,72600.0,1840479000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21301.0,29400.0,1840435800.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),24.05,24.05,24.05,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,12.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,79800.0,1840486200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21301.0,29400.0,1840435800.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.08,18.08,18.08,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,13.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21302.0,29400.0,1840522200.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21301.0,29400.0,1840435800.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.09,5.09,5.09,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,14.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21315.0,27000.0,1841643000.0,15.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21315.0,29400.0,1841645400.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,15.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21315.0,31200.0,1841647200.0,15.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21315.0,29400.0,1841645400.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,16.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21315.0,33000.0,1841649000.0,15.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21315.0,29400.0,1841645400.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),31.85,31.85,31.85,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,17.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21315.0,34800.0,1841650800.0,15.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21315.0,29400.0,1841645400.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),104.55,104.55,104.55,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,18.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21315.0,36600.0,1841652600.0,15.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21315.0,29400.0,1841645400.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),144.46,144.46,144.46,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,19.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21315.0,40200.0,1841656200.0,15.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21315.0,29400.0,1841645400.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),164.9,164.90,164.90,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,20.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21315.0,43800.0,1841659800.0,15.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21315.0,29400.0,1841645400.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),119.84,119.84,119.84,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,21.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21315.0,47400.0,1841663400.0,15.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21315.0,29400.0,1841645400.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),143.34,143.34,143.34,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,22.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21315.0,51000.0,1841667000.0,15.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21315.0,29400.0,1841645400.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),112.96,112.96,112.96,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,23.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21315.0,58200.0,1841674200.0,15.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21315.0,29400.0,1841645400.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),79.49,79.49,79.49,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,24.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21315.0,72600.0,1841688600.0,15.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21315.0,29400.0,1841645400.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),24.94,24.94,24.94,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,25.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21315.0,79800.0,1841695800.0,15.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21315.0,29400.0,1841645400.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.1,17.10,17.10,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001305,103001305,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29400.0,1840435800.0,21315.0,29400.0,1841645400.0,26.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21316.0,29400.0,1841731800.0,16.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21315.0,29400.0,1841645400.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.42,4.42,4.42,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,1.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,26400.0,1840432800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21301.0,28800.0,1840435200.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,2.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,30600.0,1840437000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21301.0,28800.0,1840435200.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,3.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,32400.0,1840438800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21301.0,28800.0,1840435200.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),37.64,37.64,37.64,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,4.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,34200.0,1840440600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21301.0,28800.0,1840435200.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),137.79,137.79,137.79,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,5.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,36000.0,1840442400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21301.0,28800.0,1840435200.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),238.3,238.30,238.30,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,6.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,39600.0,1840446000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21301.0,28800.0,1840435200.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),134.7,134.70,134.70,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,7.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,43200.0,1840449600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21301.0,28800.0,1840435200.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),134.0,134.00,134.00,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,8.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,46800.0,1840453200.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21301.0,28800.0,1840435200.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),120.36,120.36,120.36,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,9.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,50400.0,1840456800.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21301.0,28800.0,1840435200.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),146.54,146.54,146.54,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,10.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,57600.0,1840464000.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21301.0,28800.0,1840435200.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),77.39,77.39,77.39,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,11.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,72000.0,1840478400.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21301.0,28800.0,1840435200.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),28.47,28.47,28.47,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,12.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,79200.0,1840485600.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21301.0,28800.0,1840435200.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.63,18.63,18.63,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,13.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21302.0,28800.0,1840521600.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21301.0,28800.0,1840435200.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.42,4.42,4.42,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,14.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,26400.0,1841037600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21308.0,28800.0,1841040000.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,15.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,30600.0,1841041800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21308.0,28800.0,1841040000.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.97,10.97,10.97,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,16.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,32400.0,1841043600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21308.0,28800.0,1841040000.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),162.98,162.98,162.98,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,17.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,34200.0,1841045400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21308.0,28800.0,1841040000.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),308.36,308.36,308.36,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,18.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,36000.0,1841047200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21308.0,28800.0,1841040000.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),415.56,415.56,415.56,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,19.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,39600.0,1841050800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21308.0,28800.0,1841040000.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),298.47,298.47,298.47,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,20.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,43200.0,1841054400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21308.0,28800.0,1841040000.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),213.07,213.07,213.07,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,21.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,46800.0,1841058000.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21308.0,28800.0,1841040000.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),137.76,137.76,137.76,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,22.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,50400.0,1841061600.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21308.0,28800.0,1841040000.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),106.68,106.68,106.68,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,23.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,57600.0,1841068800.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21308.0,28800.0,1841040000.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),56.74,56.74,56.74,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,24.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,72000.0,1841083200.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21308.0,28800.0,1841040000.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),18.22,18.22,18.22,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,25.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,79200.0,1841090400.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21308.0,28800.0,1841040000.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.98,10.98,10.98,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001306,103001306,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,28800.0,1840435200.0,21308.0,28800.0,1841040000.0,26.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21309.0,28800.0,1841126400.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21308.0,28800.0,1841040000.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.98,1.98,1.98,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,1.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,26520.0,1840432920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21301.0,28920.0,1840435320.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,2.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,30720.0,1840437120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21301.0,28920.0,1840435320.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),615.18,615.18,615.18,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,3.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,32520.0,1840438920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21301.0,28920.0,1840435320.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),669.73,669.73,669.73,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,4.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,34320.0,1840440720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21301.0,28920.0,1840435320.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),628.99,628.99,628.99,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,5.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,36120.0,1840442520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21301.0,28920.0,1840435320.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),580.49,580.49,580.49,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,6.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,39720.0,1840446120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21301.0,28920.0,1840435320.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),443.17,443.17,443.17,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,7.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,43320.0,1840449720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21301.0,28920.0,1840435320.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),317.07,317.07,317.07,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,8.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,46920.0,1840453320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21301.0,28920.0,1840435320.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),225.06,225.06,225.06,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,9.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,50520.0,1840456920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21301.0,28920.0,1840435320.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),169.15,169.15,169.15,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,10.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,57720.0,1840464120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21301.0,28920.0,1840435320.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),104.12,104.12,104.12,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,11.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,72120.0,1840478520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21301.0,28920.0,1840435320.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),44.44,44.44,44.44,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,12.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,79320.0,1840485720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21301.0,28920.0,1840435320.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),28.52,28.52,28.52,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,13.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21302.0,28920.0,1840521720.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21301.0,28920.0,1840435320.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.94,8.94,8.94,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,14.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,26520.0,1841037720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21308.0,28920.0,1841040120.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,15.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,30720.0,1841041920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21308.0,28920.0,1841040120.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.04,15.04,15.04,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,16.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,32520.0,1841043720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21308.0,28920.0,1841040120.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),98.67,98.67,98.67,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,17.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,34320.0,1841045520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21308.0,28920.0,1841040120.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),174.87,174.87,174.87,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,18.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,36120.0,1841047320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21308.0,28920.0,1841040120.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),362.16,362.16,362.16,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,19.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,39720.0,1841050920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21308.0,28920.0,1841040120.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),385.49,385.49,385.49,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,20.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,43320.0,1841054520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21308.0,28920.0,1841040120.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),326.83,326.83,326.83,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,21.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,46920.0,1841058120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21308.0,28920.0,1841040120.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),285.5,285.50,285.50,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,22.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,50520.0,1841061720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21308.0,28920.0,1841040120.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),208.2,208.20,208.20,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,23.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,57720.0,1841068920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21308.0,28920.0,1841040120.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),125.33,125.33,125.33,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,24.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,72120.0,1841083320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21308.0,28920.0,1841040120.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),38.58,38.58,38.58,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,25.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,79320.0,1841090520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21308.0,28920.0,1841040120.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),23.1,23.10,23.10,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001325,103001325,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,28920.0,1840435320.0,21308.0,28920.0,1841040120.0,26.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21309.0,28920.0,1841126520.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21308.0,28920.0,1841040120.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),8.24,8.24,8.24,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,1.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,26640.0,1840433040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21301.0,29040.0,1840435440.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,2.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,30840.0,1840437240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21301.0,29040.0,1840435440.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),40.9,40.90,40.90,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,3.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,32640.0,1840439040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21301.0,29040.0,1840435440.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),186.75,186.75,186.75,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,4.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,34440.0,1840440840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21301.0,29040.0,1840435440.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),265.16,265.16,265.16,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,5.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,36240.0,1840442640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21301.0,29040.0,1840435440.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),245.72,245.72,245.72,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,6.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,39840.0,1840446240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21301.0,29040.0,1840435440.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),154.94,154.94,154.94,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,7.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,43440.0,1840449840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21301.0,29040.0,1840435440.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),135.27,135.27,135.27,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,8.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,47040.0,1840453440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21301.0,29040.0,1840435440.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),126.14,126.14,126.14,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,9.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,50640.0,1840457040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21301.0,29040.0,1840435440.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),86.17,86.17,86.17,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,10.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,57935.0,1840464335.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21301.0,29040.0,1840435440.0,8.026388888888889,HOURS,2.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),49.68,49.68,49.68,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,11.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,72240.0,1840478640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21301.0,29040.0,1840435440.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),19.08,19.08,19.08,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,12.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,79440.0,1840485840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21301.0,29040.0,1840435440.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),10.53,10.53,10.53,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,13.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21302.0,29040.0,1840521840.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21301.0,29040.0,1840435440.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.64,2.64,2.64,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,14.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,26640.0,1841037840.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21308.0,29040.0,1841040240.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,15.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,30840.0,1841042040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21308.0,29040.0,1841040240.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),243.67,243.67,243.67,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,16.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,32816.0,1841044016.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21308.0,29040.0,1841040240.0,1.048888888888889,HOURS,3.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),387.96,387.96,387.96,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,17.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,34440.0,1841045640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21308.0,29040.0,1841040240.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),316.41,316.41,316.41,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,18.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,36240.0,1841047440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21308.0,29040.0,1841040240.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),223.31,223.31,223.31,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,19.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,39840.0,1841051040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21308.0,29040.0,1841040240.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),145.62,145.62,145.62,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,20.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,43440.0,1841054640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21308.0,29040.0,1841040240.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),118.14,118.14,118.14,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,21.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,47040.0,1841058240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21308.0,29040.0,1841040240.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),94.3,94.30,94.30,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,22.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,50640.0,1841061840.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21308.0,29040.0,1841040240.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),70.04,70.04,70.04,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,23.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,57840.0,1841069040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21308.0,29040.0,1841040240.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),43.88,43.88,43.88,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,24.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,72240.0,1841083440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21308.0,29040.0,1841040240.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.06,12.06,12.06,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,25.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,79440.0,1841090640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21308.0,29040.0,1841040240.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.48,7.48,7.48,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001327,103001327,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29040.0,1840435440.0,21308.0,29040.0,1841040240.0,26.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21309.0,29040.0,1841126640.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21308.0,29040.0,1841040240.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),2.23,2.23,2.23,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,1.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,27120.0,1840433520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21301.0,29520.0,1840435920.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,2.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,31320.0,1840437720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21301.0,29520.0,1840435920.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),42.02,42.02,42.02,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,3.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,33164.0,1840439564.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21301.0,29520.0,1840435920.0,1.0122222222222221,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),186.96,186.96,186.96,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,4.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,34920.0,1840441320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21301.0,29520.0,1840435920.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),225.83,225.83,225.83,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,5.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,36720.0,1840443120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21301.0,29520.0,1840435920.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),289.16,289.16,289.16,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,6.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,40320.0,1840446720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21301.0,29520.0,1840435920.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),221.51,221.51,221.51,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,7.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,43920.0,1840450320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21301.0,29520.0,1840435920.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),140.34,140.34,140.34,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,8.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,47520.0,1840453920.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21301.0,29520.0,1840435920.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),116.54,116.54,116.54,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,9.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,51120.0,1840457520.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21301.0,29520.0,1840435920.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),97.64,97.64,97.64,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,10.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,58320.0,1840464720.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21301.0,29520.0,1840435920.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),51.33,51.33,51.33,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,11.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,72720.0,1840479120.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21301.0,29520.0,1840435920.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),19.86,19.86,19.86,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,12.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,79920.0,1840486320.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21301.0,29520.0,1840435920.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.72,12.72,12.72,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,13.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21302.0,29520.0,1840522320.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21301.0,29520.0,1840435920.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.62,3.62,3.62,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,14.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,27120.0,1841038320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21308.0,29520.0,1841040720.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,15.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,31320.0,1841042520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21308.0,29520.0,1841040720.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.17,14.17,14.17,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,16.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,33120.0,1841044320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21308.0,29520.0,1841040720.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),92.22,92.22,92.22,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,17.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,34920.0,1841046120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21308.0,29520.0,1841040720.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),134.69,134.69,134.69,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,18.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,36720.0,1841047920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21308.0,29520.0,1841040720.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),179.31,179.31,179.31,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,19.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,40320.0,1841051520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21308.0,29520.0,1841040720.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),220.98,220.98,220.98,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,20.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,43920.0,1841055120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21308.0,29520.0,1841040720.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),194.06,194.06,194.06,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,21.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,47520.0,1841058720.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21308.0,29520.0,1841040720.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),129.03,129.03,129.03,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,22.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,51120.0,1841062320.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21308.0,29520.0,1841040720.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),101.99,101.99,101.99,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,23.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,58320.0,1841069520.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21308.0,29520.0,1841040720.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),53.73,53.73,53.73,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,24.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,72720.0,1841083920.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21308.0,29520.0,1841040720.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),24.45,24.45,24.45,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,25.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,79920.0,1841091120.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21308.0,29520.0,1841040720.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),16.46,16.46,16.46,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001328,103001328,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29520.0,1840435920.0,21308.0,29520.0,1841040720.0,26.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21309.0,29520.0,1841127120.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21308.0,29520.0,1841040720.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.01,4.01,4.01,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,1.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,27240.0,1840433640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21301.0,29640.0,1840436040.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,2.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,31440.0,1840437840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21301.0,29640.0,1840436040.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),75.12,75.12,75.12,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,3.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,33240.0,1840439640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21301.0,29640.0,1840436040.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),371.54,371.54,371.54,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,4.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,35040.0,1840441440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21301.0,29640.0,1840436040.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),299.44,299.44,299.44,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,5.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,36840.0,1840443240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21301.0,29640.0,1840436040.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),260.44,260.44,260.44,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,6.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,40440.0,1840446840.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21301.0,29640.0,1840436040.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),184.14,184.14,184.14,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,7.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,44040.0,1840450440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21301.0,29640.0,1840436040.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),164.33,164.33,164.33,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,8.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,47640.0,1840454040.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21301.0,29640.0,1840436040.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),96.03,96.03,96.03,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,9.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,51240.0,1840457640.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21301.0,29640.0,1840436040.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),65.93,65.93,65.93,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,10.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,58516.0,1840464916.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21301.0,29640.0,1840436040.0,8.02111111111111,HOURS,1.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),40.21,40.21,40.21,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,11.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,72840.0,1840479240.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21301.0,29640.0,1840436040.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),12.89,12.89,12.89,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,12.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,80040.0,1840486440.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21301.0,29640.0,1840436040.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),7.71,7.71,7.71,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,13.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21302.0,29640.0,1840522440.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21301.0,29640.0,1840436040.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.92,1.92,1.92,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,14.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,27240.0,1841038440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21308.0,29640.0,1841040840.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,15.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,31440.0,1841042640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21308.0,29640.0,1841040840.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,16.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,33240.0,1841044440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21308.0,29640.0,1841040840.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.42,1.42,1.42,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,17.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,35040.0,1841046240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21308.0,29640.0,1841040840.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.08,6.08,6.08,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,18.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,36840.0,1841048040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21308.0,29640.0,1841040840.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.39,20.39,20.39,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,19.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,40440.0,1841051640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21308.0,29640.0,1841040840.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),130.48,130.48,130.48,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,20.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,44040.0,1841055240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21308.0,29640.0,1841040840.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),286.23,286.23,286.23,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,21.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,47640.0,1841058840.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21308.0,29640.0,1841040840.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),242.03,242.03,242.03,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,22.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,51240.0,1841062440.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21308.0,29640.0,1841040840.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),177.78,177.78,177.78,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,23.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,58440.0,1841069640.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21308.0,29640.0,1841040840.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),101.47,101.47,101.47,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,24.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,72840.0,1841084040.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21308.0,29640.0,1841040840.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),30.29,30.29,30.29,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,25.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,80040.0,1841091240.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21308.0,29640.0,1841040840.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),16.34,16.34,16.34,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001329,103001329,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29640.0,1840436040.0,21308.0,29640.0,1841040840.0,26.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21309.0,29640.0,1841127240.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21308.0,29640.0,1841040840.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.51,4.51,4.51,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,1.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,27360.0,1840433760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21301.0,29760.0,1840436160.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,2.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,31560.0,1840437960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21301.0,29760.0,1840436160.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),192.13,192.13,192.13,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,3.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,33360.0,1840439760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21301.0,29760.0,1840436160.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),307.37,307.37,307.37,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,4.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,35160.0,1840441560.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21301.0,29760.0,1840436160.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),214.94,214.94,214.94,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,5.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,36960.0,1840443360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21301.0,29760.0,1840436160.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),214.72,214.72,214.72,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,6.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,40560.0,1840446960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21301.0,29760.0,1840436160.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),167.25,167.25,167.25,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,7.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,44160.0,1840450560.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21301.0,29760.0,1840436160.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),117.93,117.93,117.93,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,8.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,47760.0,1840454160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21301.0,29760.0,1840436160.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),94.55,94.55,94.55,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,9.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,51360.0,1840457760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21301.0,29760.0,1840436160.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),75.97,75.97,75.97,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,10.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,58560.0,1840464960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21301.0,29760.0,1840436160.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),44.0,44.00,44.00,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,11.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,72960.0,1840479360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21301.0,29760.0,1840436160.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.49,17.49,17.49,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,12.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,80160.0,1840486560.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21301.0,29760.0,1840436160.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.32,11.32,11.32,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,13.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21302.0,29760.0,1840522560.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21301.0,29760.0,1840436160.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.06,3.06,3.06,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,14.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,27360.0,1841038560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21308.0,29760.0,1841040960.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,15.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,31560.0,1841042760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21308.0,29760.0,1841040960.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.38,6.38,6.38,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,16.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,33360.0,1841044560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21308.0,29760.0,1841040960.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),53.47,53.47,53.47,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,17.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,35160.0,1841046360.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21308.0,29760.0,1841040960.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),107.86,107.86,107.86,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,18.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,36960.0,1841048160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21308.0,29760.0,1841040960.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),166.16,166.16,166.16,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,19.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,40560.0,1841051760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21308.0,29760.0,1841040960.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),217.48,217.48,217.48,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,20.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,44160.0,1841055360.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21308.0,29760.0,1841040960.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),208.74,208.74,208.74,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,21.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,47760.0,1841058960.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21308.0,29760.0,1841040960.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),173.19,173.19,173.19,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,22.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,51360.0,1841062560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21308.0,29760.0,1841040960.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),137.86,137.86,137.86,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,23.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,58560.0,1841069760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21308.0,29760.0,1841040960.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),86.8,86.80,86.80,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,24.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,72960.0,1841084160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21308.0,29760.0,1841040960.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),30.59,30.59,30.59,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,25.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,80160.0,1841091360.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21308.0,29760.0,1841040960.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.33,20.33,20.33,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001340,103001340,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29760.0,1840436160.0,21308.0,29760.0,1841040960.0,26.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21309.0,29760.0,1841127360.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21308.0,29760.0,1841040960.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.97,3.97,3.97,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,1.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,26760.0,1840433160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21301.0,29160.0,1840435560.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,2.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,30960.0,1840437360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21301.0,29160.0,1840435560.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),206.52,206.52,206.52,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,3.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,32760.0,1840439160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21301.0,29160.0,1840435560.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),280.03,280.03,280.03,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,4.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,34560.0,1840440960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21301.0,29160.0,1840435560.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),202.99,202.99,202.99,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,5.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,36360.0,1840442760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21301.0,29160.0,1840435560.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),188.85,188.85,188.85,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,6.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,39960.0,1840446360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21301.0,29160.0,1840435560.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),107.95,107.95,107.95,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,7.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,43560.0,1840449960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21301.0,29160.0,1840435560.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),73.11,73.11,73.11,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,8.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,47160.0,1840453560.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21301.0,29160.0,1840435560.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),54.01,54.01,54.01,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,9.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,50760.0,1840457160.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21301.0,29160.0,1840435560.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),39.88,39.88,39.88,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,10.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,57960.0,1840464360.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21301.0,29160.0,1840435560.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),21.61,21.61,21.61,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,11.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,72360.0,1840478760.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21301.0,29160.0,1840435560.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.64,6.64,6.64,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,12.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21301.0,79560.0,1840485960.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21301.0,29160.0,1840435560.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.69,3.69,3.69,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,13.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21302.0,29160.0,1840521960.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21301.0,29160.0,1840435560.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,14.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,26760.0,1841037960.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21308.0,29160.0,1841040360.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,15.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,30960.0,1841042160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21308.0,29160.0,1841040360.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.04,4.04,4.04,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,16.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,32760.0,1841043960.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21308.0,29160.0,1841040360.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),41.63,41.63,41.63,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,17.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,34560.0,1841045760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21308.0,29160.0,1841040360.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),106.89,106.89,106.89,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,18.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,36360.0,1841047560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21308.0,29160.0,1841040360.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),182.16,182.16,182.16,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,19.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,39960.0,1841051160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21308.0,29160.0,1841040360.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),229.95,229.95,229.95,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,20.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,43560.0,1841054760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21308.0,29160.0,1841040360.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),149.53,149.53,149.53,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,21.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,47160.0,1841058360.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21308.0,29160.0,1841040360.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),80.72,80.72,80.72,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,22.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,50760.0,1841061960.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21308.0,29160.0,1841040360.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),66.34,66.34,66.34,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,23.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,57960.0,1841069160.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21308.0,29160.0,1841040360.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),33.57,33.57,33.57,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,24.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,72360.0,1841083560.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21308.0,29160.0,1841040360.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),11.46,11.46,11.46,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,25.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21308.0,79560.0,1841090760.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21308.0,29160.0,1841040360.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.81,6.81,6.81,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001349,103001349,001,Part B,2.0,Y,1.0,Y,1.0,2: ED,8.0,2: ED,8.0,21301.0,29160.0,1840435560.0,21308.0,29160.0,1841040360.0,26.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21309.0,29160.0,1841126760.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21308.0,29160.0,1841040360.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),1.53,1.53,1.53,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,1.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,27480.0,1840433880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21301.0,29880.0,1840436280.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,2.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,31680.0,1840438080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21301.0,29880.0,1840436280.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.41,6.41,6.41,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,3.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,33480.0,1840439880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21301.0,29880.0,1840436280.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),32.71,32.71,32.71,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,4.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,35280.0,1840441680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21301.0,29880.0,1840436280.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),102.58,102.58,102.58,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,5.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,37080.0,1840443480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21301.0,29880.0,1840436280.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),129.92,129.92,129.92,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,6.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,40680.0,1840447080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21301.0,29880.0,1840436280.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),271.14,271.14,271.14,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,7.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,44280.0,1840450680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21301.0,29880.0,1840436280.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),163.9,163.90,163.90,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,8.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,47880.0,1840454280.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21301.0,29880.0,1840436280.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),116.77,116.77,116.77,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,9.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,51480.0,1840457880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21301.0,29880.0,1840436280.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),85.83,85.83,85.83,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,10.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,58680.0,1840465080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21301.0,29880.0,1840436280.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),51.33,51.33,51.33,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,11.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,73080.0,1840479480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21301.0,29880.0,1840436280.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),21.03,21.03,21.03,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,12.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,80280.0,1840486680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21301.0,29880.0,1840436280.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.51,15.51,15.51,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,13.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21302.0,29880.0,1840522680.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21301.0,29880.0,1840436280.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),3.33,3.33,3.33,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,14.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,27480.0,1841038680.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21308.0,29880.0,1841041080.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,15.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,31680.0,1841042880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21308.0,29880.0,1841041080.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),104.45,104.45,104.45,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,16.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,33480.0,1841044680.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21308.0,29880.0,1841041080.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),134.22,134.22,134.22,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,17.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,35280.0,1841046480.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21308.0,29880.0,1841041080.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),98.83,98.83,98.83,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,18.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,37080.0,1841048280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21308.0,29880.0,1841041080.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),107.09,107.09,107.09,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,19.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,40680.0,1841051880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21308.0,29880.0,1841041080.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),80.48,80.48,80.48,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,20.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,44280.0,1841055480.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21308.0,29880.0,1841041080.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),92.36,92.36,92.36,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,21.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,47880.0,1841059080.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21308.0,29880.0,1841041080.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),89.35,89.35,89.35,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,22.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,51480.0,1841062680.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21308.0,29880.0,1841041080.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),71.27,71.27,71.27,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,23.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,58680.0,1841069880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21308.0,29880.0,1841041080.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),40.85,40.85,40.85,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,24.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,73080.0,1841084280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21308.0,29880.0,1841041080.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),20.5,20.50,20.50,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,25.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,80280.0,1841091480.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21308.0,29880.0,1841041080.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),14.05,14.05,14.05,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001354,103001354,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29880.0,1840436280.0,21308.0,29880.0,1841041080.0,26.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21309.0,29880.0,1841127480.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21308.0,29880.0,1841041080.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),4.95,4.95,4.95,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,1.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,26880.0,1840433280.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,Predose,0.0,21301.0,29280.0,1840435680.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,2.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,31080.0,1840437480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,0.5 h,0.5,21301.0,29280.0,1840435680.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,3.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,32880.0,1840439280.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1 h,1.0,21301.0,29280.0,1840435680.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,4.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,34680.0,1840441080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,1.5 h,1.5,21301.0,29280.0,1840435680.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.84,5.84,5.84,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,5.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,36480.0,1840442880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,2 h,2.0,21301.0,29280.0,1840435680.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),15.24,15.24,15.24,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,6.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,40080.0,1840446480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,3 h,3.0,21301.0,29280.0,1840435680.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),217.08,217.08,217.08,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,7.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,43680.0,1840450080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,4 h,4.0,21301.0,29280.0,1840435680.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),261.45,261.45,261.45,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,8.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,47280.0,1840453680.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,5 h,5.0,21301.0,29280.0,1840435680.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),255.67,255.67,255.67,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,9.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,50880.0,1840457280.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,6 h,6.0,21301.0,29280.0,1840435680.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),196.34,196.34,196.34,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,10.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,58080.0,1840464480.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,8 h,8.0,21301.0,29280.0,1840435680.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),124.42,124.42,124.42,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,11.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,72480.0,1840478880.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,12 h,12.0,21301.0,29280.0,1840435680.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),43.43,43.43,43.43,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,12.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21301.0,79680.0,1840486080.0,1.0,Period 1 Day 1,1.0,1.0,Period 1,14 h,14.0,21301.0,29280.0,1840435680.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),27.65,27.65,27.65,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,13.0,TREATMENT,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21302.0,29280.0,1840522080.0,2.0,Period 1 Day 2,2.0,1.0,Period 1,24 h,24.0,21301.0,29280.0,1840435680.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),6.52,6.52,6.52,ng/mL,1.0,Altasciences Company Inc.,D: Fed TBM Ubrogepant 1 x 100 mg (Test 3),D
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,14.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,26880.0,1841038080.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,Predose,0.0,21308.0,29280.0,1841040480.0,0.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),0.0,BQL,BQL,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,15.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,31080.0,1841042280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,0.5 h,0.5,21308.0,29280.0,1841040480.0,0.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),305.49,305.49,305.49,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,16.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,32880.0,1841044080.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1 h,1.0,21308.0,29280.0,1841040480.0,1.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),414.5,414.50,414.50,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,17.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,34680.0,1841045880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,1.5 h,1.5,21308.0,29280.0,1841040480.0,1.5,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),294.29,294.29,294.29,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,18.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,36480.0,1841047680.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,2 h,2.0,21308.0,29280.0,1841040480.0,2.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),280.22,280.22,280.22,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,19.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,40080.0,1841051280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,3 h,3.0,21308.0,29280.0,1841040480.0,3.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),220.58,220.58,220.58,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,20.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,43680.0,1841054880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,4 h,4.0,21308.0,29280.0,1841040480.0,4.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),172.76,172.76,172.76,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,21.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,47280.0,1841058480.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,5 h,5.0,21308.0,29280.0,1841040480.0,5.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),136.82,136.82,136.82,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,22.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,50880.0,1841062080.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,6 h,6.0,21308.0,29280.0,1841040480.0,6.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),108.78,108.78,108.78,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,23.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,58080.0,1841069280.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,8 h,8.0,21308.0,29280.0,1841040480.0,8.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),68.56,68.56,68.56,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,24.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,72480.0,1841083680.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,12 h,12.0,21308.0,29280.0,1841040480.0,12.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),25.12,25.12,25.12,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,25.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21308.0,79680.0,1841090880.0,8.0,Period 2 Day 8,8.0,2.0,Period 2,14 h,14.0,21308.0,29280.0,1841040480.0,14.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),17.28,17.28,17.28,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
3110-103-002,3110-103-002.103001358,103001358,001,Part B,2.0,Y,1.0,Y,1.0,1: DE,7.0,1: DE,7.0,21301.0,29280.0,1840435680.0,21308.0,29280.0,1841040480.0,26.0,TREATMENT,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21309.0,29280.0,1841126880.0,9.0,Period 2 Day 9,9.0,2.0,Period 2,24 h,24.0,21308.0,29280.0,1841040480.0,24.0,HOURS,0.0,1.0,Ubrogepant (ng/mL),UBRO,Ubrogepant (ng/mL),5.89,5.89,5.89,ng/mL,1.0,Altasciences Company Inc.,E: Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),E
